Go to
JCI Insight
Citations to this article
Joseph L. Goldstein, … , Edwin L. Bierman, Arno G. Motulsky
Published July 1, 1973
Citation Information: J Clin Invest. 1973;52(7):1544-1568. https://doi.org/10.1172/JCI107332.
Citation Information: J Clin Invest. 1973;52(7):1544-1568. https://doi.org/10.1172/JCI107332.
Abstract
To assess the genetics of hyperlipidemia in coronary heart disease, family studies were carried out in 2520 relatives and spouses of 176 survivors of myocardial infarction, including 149 hyperlipidemic and 27 normolipidemic individuals. The distribution of fasting plasma cholesterol and triglyceride values in relatives, together with segregation analyses, suggested the presence of five distinct lipid disorders. Three of these—familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia—appeared to represent dominant expression of three different autosomal genes, occurring in about 20% of survivors below 60 yr of age and 7% of all older survivors. Two other disorders—polygenic hypercholesterolemia and sporadic hypertriglyceridemia—each affected about 6% of survivors in both age groups.
Authors
Joseph L. Goldstein, Helmut G. Schrott, William R. Hazzard, Edwin L. Bierman, Arno G. Motulsky
Total citations by year
| Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1978 | 1977 | 1976 | 1975 | 1974 | 1973 | 1965 | 1955 | 1949 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citations: | 2 | 6 | 6 | 10 | 17 | 8 | 11 | 22 | 18 | 22 | 22 | 24 | 12 | 17 | 19 | 18 | 26 | 27 | 22 | 27 | 18 | 23 | 23 | 35 | 22 | 35 | 26 | 26 | 27 | 25 | 25 | 26 | 29 | 21 | 19 | 22 | 25 | 26 | 27 | 19 | 23 | 21 | 19 | 22 | 16 | 22 | 20 | 17 | 25 | 24 | 20 | 12 | 4 | 1 | 1 | 1 | 1083 |
Citation information
Citations to this article (1084)
| Title and authors | Publication | Year |
|---|---|---|
|
Familial Combined Hyperlipidemia: Myth or Reality?
Brouwers MC, Klop B, Ribalta J, Castro Cabezas M |
Current Atherosclerosis Reports | 2025 |
|
Genetic variants and carotid atherosclerosis progression in familial hypercholesterolemia: a comprehensive review
Bekbossynova M, Ivanova-Razumova T, Azatov Y, Sailybayeva A, Khamitov S, Daniyarova G, Akzholova K |
Frontiers in Cardiovascular Medicine | 2025 |
|
A novel mouse model of familial combined hyperlipidemia and atherosclerosis.
Chen MJ, Xu YT, Sun L, Wang ZH, Little PJ, Wang L, Xian XD, Weng JP, Xu SW |
Acta Pharmacologica Sinica | 2024 |
|
Conducting Drug Treatment Trials in Children: Opportunities and Challenges.
Erceg D, Jakirović M, Prgomet L, Madunić M, Turkalj M |
Pharmaceutical medicine | 2024 |
|
FBXO28 reduces high-fat diet-induced hyperlipidemia in mice by alleviating abnormal lipid metabolism and inflammatory responses.
Sun J, Du B, Chen M, Jia J, Wang X, Hong J |
Journal of Endocrinological Investigation | 2024 |
|
The first century of JCI and beyond
McNally EM |
The Journal of Clinical Investigation | 2024 |
|
Gene Mutation in Patients with Familial Hypercholesterolemia and Response to Alirocumab Treatment—A Single-Centre Analysis
Rogozik J, Rokicki JK, Grabowski M, Główczyńska R |
Journal of Clinical Medicine | 2024 |
|
Subclassification of obesity for precision prediction of cardiometabolic diseases.
Coral DE, Smit F, Farzaneh A, Gieswinkel A, Tajes JF, Sparsø T, Delfin C, Bauvain P, Wang K, Temprosa M, De Cock D, Blanch J, Fernández-Real JM, Ramos R, Ikram MK, Gomez MF, Kavousi M, Panova-Noeva M, Wild PS, van der Kallen C, Adriaens M, van Greevenbroek M, Arts I, Le Roux C, Ahmadizar F, Frayling TM, Giordano GN, Pearson ER, Franks PW |
Nature medicine | 2024 |
|
Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia.
Aparicio A, Villazón F, Suárez-Gutiérrez L, Gómez J, Martínez-Faedo C, Méndez-Torre E, Avanzas P, Álvarez-Velasco R, Cuesta-Llavona E, García-Lago C, Neuhalfen D, Coto E, Lorca R |
Journal of Clinical Medicine | 2023 |
|
Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients.
Salgado M, Díaz-Molina B, Cuesta-Llavona E, Aparicio A, Fernández M, Alonso V, Avanzas P, Pascual I, Neuhalfen D, Coto E, Gómez J, Lorca R |
Journal of Clinical Medicine | 2023 |
|
Age, Origin and Functional Study of the Prevalent LDLR Mutation Causing Familial Hypercholesterolaemia in Gran Canaria.
Suárez NM, Jebari-Benslaiman S, Jiménez-Monzón R, Benito-Vicente A, Brito-Casillas Y, Garcés L, González-Lleo AM, Tugores A, Boronat M, Martin C, Wägner AM, Sánchez-Hernández RM |
International journal of molecular sciences | 2023 |
|
Eupatilin Alleviates Hyperlipidemia in Mice by Inhibiting HMG-CoA Reductase.
Kim KJ, Kang NE, Oh YS, Jang SE |
Biochemistry Research International | 2023 |
|
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Yanai H, Adachi H, Hakoshima M, Katsuyama H |
International journal of molecular sciences | 2023 |
|
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H |
Journal of Atherosclerosis and Thrombosis | 2023 |
|
Sphingolipid Metabolism and Metabolic Disease
X Jiang |
2022 | |
|
Diabetes and Familial Hypercholesterolemia: Interplay between Lipid and Glucose Metabolism
A González-Lleó, R Sánchez-Hernández, M Boronat, A Wägner |
Nutrients | 2022 |
|
APOE and KLF14 genetic variants are sex-specific for low high-density lipoprotein cholesterol identified by a genome-wide association study.
Lee YH, Chang YS, Hsieh CC, Wang RT, Chang JG, Chen CJ, Chang SJ |
Genetics and molecular biology | 2022 |
|
Whole Exome/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia.
Ghaleb Y, Elbitar S, Philippi A, El Khoury P, Azar Y, Andrianirina M, Loste A, Abou-Khalil Y, Nicolas G, Le Borgne M, Moulin P, Di-Filippo M, Charrière S, Farnier M, Yelnick C, Carreau V, Ferrières J, Lecerf JM, Derksen A, Bernard G, Gauthier MS, Coulombe B, Lütjohann D, Fin B, Boland A, Olaso R, Deleuze JF, Rabès JP, Boileau C, Abifadel M, Varret M |
Metabolites | 2022 |
|
Regulatory Non-Coding RNAs in Familial Hypercholesterolemia, Theranostic Applications.
Keshavarz Alikhani H, Pourhamzeh M, Seydi H, Shokoohian B, Hossein-Khannazer N, Jamshidi-Adegani F, Al-Hashmi S, Hassan M, Vosough M |
Frontiers in Cell and Developmental Biology | 2022 |
|
The Role of Non-statin Lipid-Lowering Medications in Youth with Hypercholesterolemia.
Butt WZ, Yee JK |
Current Atherosclerosis Reports | 2022 |
|
An update on lipid apheresis for familial hypercholesterolemia.
Taylan C, Weber LT |
Pediatric nephrology (Berlin, Germany) | 2022 |
|
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia.
Mandraffino G, Morace C, Franzè MS, Nassisi V, Sinicropi D, Cinquegrani M, Saitta C, Scoglio R, Marino S, Belvedere A, Cairo V, Lo Gullo A, Scuruchi M, Raimondo G, Squadrito G |
Biomedicines | 2022 |
|
Should We Be Screening for Ischaemic Heart Disease Earlier in Childhood?
Bassareo PP, O'Brien ST, Dunne E, Duignan S, Martino E, Martino F, Mcmahon CJ |
2022 | |
|
Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.
Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD |
Journal of the American Heart Association | 2022 |
|
APOE gene variants in primary dyslipidemia
YA Khalil, JP Rabès, C Boileau, M Varret |
Atherosclerosis | 2021 |
|
Hiperlipemia familiar combinada/hiperlipemia mixta poligénica
J Pedro-Botet, E Climent, N Gabarró, J Millán |
Clínica e Investigación en Arteriosclerosis | 2021 |
|
The Genetic Basis of Hypertriglyceridemia
GD Carrasquilla, MR Christiansen, TO Kilpeläinen |
Current Atherosclerosis Reports | 2021 |
|
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia
PK Gill, JS Dron, AJ Berberich, J Wang, AD McIntyre, H Cao, RA Hegele |
Journal of Clinical Lipidology | 2021 |
|
Homozygous Familial Hypercholesterolemia
A Nohara, H Tada, M Ogura, S Okazaki, K Ono, H Shimano, H Daida, K Dobashi, T Hayashi, M Hori, K Matsuki, T Minamino, S Yokoyama, M Harada-Shiba |
Journal of Atherosclerosis and Thrombosis | 2021 |
|
ANGPTL3 gene variants in subjects with familial combined hyperlipidemia
AM Bea, E Franco-Marín, V Marco-Benedí, E Jarauta, I Gracia-Rubio, A Cenarro, F Civeira, I Lamiquiz-Moneo |
Scientific Reports | 2021 |
|
PCSK9 gene participates in the development of primary dyslipidemias
D Matías-Pérez, AD Pérez-Santiago, MA Medina, JJ Osorno, IA García-Montalvo |
Balkan Journal of Medical Genetics | 2021 |
|
Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020
TP Leren, MP Bogsrud |
Atherosclerosis | 2021 |
|
The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway
TP Leren, MP Bogsrud |
Journal of Clinical Lipidology | 2021 |
|
Effect of Ethanol Leaf Extract of Clerodendrum splendens (G. Don) (Verbenaceae) on Some Biochemical Parameters of Alloxan-Induced Diabetic Wistar rats
PE Obi, CE Chukwuebuka, UE Odoh, OO Raymond |
2021 | |
|
Nutritional status of children with familial hypercholesterolemia
DA Polunina, ME Bagaeva, EV Pavlovskaya, TV Strokova |
2021 | |
|
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease
DN Vikulova, M Trinder, GB Mancini, SN Pimstone, LR Brunham |
The Canadian journal of cardiology | 2021 |
|
Development and Validation of Q-Absorbance Ratio by UV-Spectrophotometric Method for Simultaneous Estimation of Metformin and Empagliflozin in Bulk and Combined Dosage Form
P Sharma, S Kosanam, SS Rao |
2021 | |
|
Case Studies in Pediatric Lipid Disorders and Their Management
AP Ashraf, B Sunil, V Bamba, E Breidbart, PC Brar, S Chung, A Gupta, A Khokhar, S Kumar, M Lightbourne, MK Kamboj, RS Miller, N Patni, V Raman, AS Shah, DP Wilson, B Kohn |
The Journal of clinical endocrinology and metabolism | 2021 |
|
Cardiovascular Risk Factors in Pathology
A Abukabda, M Suciu, M Andor |
2021 | |
|
The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study
K Squier, A Scott, MA Hunt, LR Brunham, DR Wilson, H Screen, CM Waugh, T Komiyama |
PloS one | 2021 |
|
Case Studies in Pediatric Lipid Disorders and Their Management.
Ashraf AP, Sunil B, Bamba V, Breidbart E, Brar PC, Chung S, Gupta A, Khokhar A, Kumar S, Lightbourne M, Kamboj MK, Miller RS, Patni N, Raman V, Shah AS, Wilson DP, Kohn B |
The Journal of clinical endocrinology and metabolism | 2021 |
|
Incidence of type 2 diabetes in familial combined hyperlipidemia
MC Brouwers, J de Graaf, N Simons, S Meex, S ten Doeschate, S van Heertum, B Heidemann, J Luijten, D de Boer, N Schaper, CD Stehouwer, MM van Greevenbroek |
BMJ Open Diabetes Research & Care | 2020 |
|
Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention
H Kitahara, T Nakayama, Y Fujimoto, Y Kobayashi |
Journal of Cardiology | 2020 |
|
Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges
EB Schmidt, BS Hedegaard, K Retterstøl |
Heart (British Cardiac Society) | 2020 |
|
Management of Familial Hypercholesterolemia: Current Status and Future Perspectives
DT Lui, AC Lee, KC Tan |
Journal of the Endocrine Society | 2020 |
|
Familial Hypercholesterolemia
JJ Kastelein, LF Reeskamp, GK Hovingh |
Journal of the American College of Cardiology | 2020 |
|
Worldwide Prevalence of Familial Hypercholesterolemia
SO Beheshti, CM Madsen, A Varbo, BG Nordestgaard |
Journal of the American College of Cardiology | 2020 |
|
An Accidental Genetic Epidemiologist
RC Elston |
Annual Review of Genomics and Human Genetics | 2020 |
|
ASPC Manual of Preventive Cardiology
ND Wong, EA Amsterdam, PP Toth |
2020 | |
|
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease C Pirazzi, L Håkansson, C Gustafsson, E Omerovic, O Wiklund, RM Mancina |
The Application of Clinical Genetics | 2019 |
|
Risk of Ischemic Stroke and Peripheral Arterial Disease in Heterozygous Familial Hypercholesterolemia: A Meta-Analysis
LE Akioyamen, JV Tu, J Genest, DT Ko, AJ Coutin, SD Shan, A Chu |
Angiology | 2019 |
|
Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden
LS Rallidis, N Kosmas, G Tsirebolos, M Rallidi, E Kiouri, D Kalpakos |
Journal of Clinical Lipidology | 2019 |
|
A comprehensive review on biological activities and toxicology of crocetin
M Hashemi, H Hosseinzadeh |
Food and Chemical Toxicology | 2019 |
|
The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia
RM Sánchez-Hernández, A Tugores, FJ Nóvoa, Y Brito-Casillas, AB Expósito-Montesdeoca, P Garay, AM Bea, M Riaño, M Pocovi, F Civeira, AM Wägner, M Boronat |
Journal of Clinical Lipidology | 2019 |
|
Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain
L Masana, D Ibarretxe, C Rodríguez-Borjabad, N Plana, P Valdivielso, J Pedro-Botet, F Civeira, J López-Miranda, C Guijarro, J Mostaza, X Pintó |
2019 | |
|
How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia
S Beheshti, CM Madsen, A Varbo, BG Nordestgaard |
The Journal of clinical endocrinology and metabolism | 2019 |
|
Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis
C Stefanutti, D Mesce, F Pacella, SD Giacomo, P Turchetti, M Forastiere, ET Battagliola, GL Torre, G Smaldone, E Pacella |
ATHEROSCLEROSIS SUPP | 2019 |
|
Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain
L Masana, D Ibarretxe, C Rodríguez-Borjabad, N Plana, P Valdivielso, J Pedro-Botet, F Civeira, J López-Miranda, C Guijarro, J Mostaza, X Pintó |
Atherosclerosis | 2019 |
|
Does Lycium europaeum leaf have antihyperglycemic, antihyperlipidemic and antioxidant effects
R Tej, A Hamdi, RS Beji, WA Wannes, IB Rebey, S Oueslati, R Ksouri, MS Tounsi, M Lachaal, NK Bouraoui |
Brazilian Journal of Pharmaceutical Sciences | 2019 |
|
The antihyperlipidemic effect of alginate-free residue from sea tangle in hyperlipidemic rats
MJ Yim, JM Lee, G Choi, SY Cho, DS Lee |
Fisheries and aquatic sciences | 2019 |
|
A Component Formula of Chinese Medicine for Hypercholesterolemia Based on Virtual Screening and Biology Network
X Huo, F Lu, L Qiao, G Li, Y Zhang |
Evidence-Based Complementary and Alternative Medicine | 2018 |
|
Response of vascular mesenchymal stem/progenitor cells to hyperlipidemia
T Chen, Y Wu, W Gu, Q Xu |
Cellular and Molecular Life Sciences | 2018 |
|
Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
Ž Reiner |
Korean Circulation Journal | 2018 |
|
A tribute to Arno Motulsky
George Stamatoyannopoulos |
Journal of Clinical Investigation | 2018 |
|
Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight
L Baila-Rueda, A Cenarro, I Lamiquiz-Moneo, S Perez-Calahorra, AM Bea, V Marco-Benedí, E Jarauta, R Mateo-Gallego, F Civeira |
The Journal of Nutritional Biochemistry | 2018 |
|
The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland
A Pelczarska, M Jakubczyk, J Jakubiak-Lasocka, M Banach, M Myśliwiec, M Gruchała, M Niewada |
Atherosclerosis | 2018 |
|
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
M Kinoshita, K Yokote, H Arai, M Iida, Y Ishigaki, S Ishibashi, S Umemoto, G Egusa, H Ohmura, T Okamura, S Kihara, S Koba, I Saito, T Shoji, H Daida, K Tsukamoto, J Deguchi, S Dohi, K Dobashi, H Hamaguchi, M Hara, T Hiro, S Biro, Y Fujioka, C Maruyama, Y Miyamoto, Y Murakami, M Yokode, H Yoshida, H Rakugi, A Wakatsuki, S Yamashita |
Journal of Atherosclerosis and Thrombosis | 2018 |
|
Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
M Mytilinaiou, I Kyrou, M Khan, DK Grammatopoulos, HS Randeva |
Frontiers in pharmacology | 2018 |
|
Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?
Y Ghaleb, S Elbitar, PE Khoury, E Bruckert, V Carreau, A Carrié, P Moulin, M Di-Filippo, S Charriere, H Iliozer, M Farnier, G Luc, JP Rabès, C Boileau, M Abifadel, M Varret |
European Journal of Human Genetics | 2018 |
|
Barriers to the identification of familial hypercholesterolemia among primary care providers
J Zimmerman, D Duprez, PM Veach, HA Zierhut |
Journal of Community Genetics | 2018 |
|
Screening test for Dendropanax morbifera Leveille extracts: in vitro comparison to ox-LDL-induced lipid accumulation, ethanol-induced fatty liver and HMG-CoA reductase inhibition
JS Youn, MS Kim, HJ Na, HR Jung, CK Song, SY Kang, JY Kim |
Journal of Applied Biological Chemistry | 2018 |
|
Rationale, design and preliminary results of the GALIPEMIAS study (prevalence and lipid control of familial dyslipidemia in Galicia, northwest Spain)
RM Argüeso-Armesto, TR Pérez-Castro, JL Díaz-Díaz, A Rodríguez-González, ME Ameneiros-Lago, A del Alamo-Alonso, JM de Toro-Santos, PÁ Fernández-Catalina, M Pena-Seijo, JA Díaz-Peromingo, A Pose-Reino, CA Názara-Otero, MR Vázquez-Freire, L Escobar-Seoane, P Gordo-Fraile, M del Mar Castellanos-Rodríguez, JÁ Rodríguez-Fernández, J Muñiz |
International Journal of Clinical Practice | 2018 |
|
Genomics-Driven Healthcare
Y Pathak |
2018 | |
|
Familial Hypercholesterolaemia Diagnosis and Management
R Alonso, LP de Isla, O Muñiz-Grijalvo, JL Diaz-Diaz, P Mata |
European Cardiology Review | 2018 |
|
Metabolic disorders and inflammation are associated with familial combined hyperlipemia
M Díaz-Ruiz, ML Martínez-Triguero, A López-Ruiz, FF la Cruz, C Bañuls, A Hernández-Mijares |
Clinica chimica acta; international journal of clinical chemistry | 2018 |
|
Dyslipidemias in clinical practice
MC Cabezas, B Burggraaf, B Klop |
Clinica chimica acta; international journal of clinical chemistry | 2018 |
|
Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary
G Paragh, M Harangi, Z Karányi, B Daróczy, Á Németh, P Fülöp |
Atherosclerosis | 2018 |
|
Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review
U Groselj, J Kovac, U Sustar, M Mlinaric, Z Fras, KT Podkrajsek, T Battelino |
Atherosclerosis | 2018 |
|
Familial hypercholesterolemia prevalence in an admixed racial society: Sex and race matter. The ELSA-Brasil
PH Harada, MH Miname, IM Benseñor, RD Santos, PA Lotufo |
Atherosclerosis | 2018 |
|
Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up study
J Luijten, MM van Greevenbroek, NC Schaper, SJ Meex, C van der Steen, LJ Meijer, D de Boer, J de Graaf, CD Stehouwer, MC Brouwers |
Atherosclerosis | 2018 |
|
ApoB in clinical care: A pros-and-cons
AD Sniderman, JG Robinson |
Atherosclerosis | 2018 |
|
Familial combined hyperlipidemia - the most common genetic dyslipidemia in population and in patients with premature atherothrombotic cardiovascular disease
H Vaverková, D Karásek |
Vnitrni lekarstvi | 2018 |
|
Hypertriglyceridaemia and risk of coronary artery disease
Ž Reiner |
Nature Reviews Cardiology | 2017 |
|
Leveraging human genetics to guide drug target discovery
NO Stitziel, S Kathiresan |
Trends in Cardiovascular Medicine | 2017 |
|
Therapeutic potentials of Crataegus azarolus var. eu- azarolus Maire leaves and its isolated compounds
E Abu-Gharbieh, NG Shehab |
BMC complementary and alternative medicine | 2017 |
|
Protective effects of Cynara scolymus leaves extract on metabolic disorders and oxidative stress in alloxan-diabetic rats
MB Salem, RB Kolsi, R Dhouibi, K Ksouda, S Charfi, M Yaich, S Hammami, Z Sahnoun, KM Zeghal, K Jamoussi, H Affes |
BMC complementary and alternative medicine | 2017 |
|
Novel avenues for drug discovery in diabetic kidney disease
MD Breyer, M Kretzler |
Expert Opinion on Drug Discovery | 2017 |
|
Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns
PN Hopkins, SR Lane |
Current Opinion in Lipidology | 2017 |
|
New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials
KL Ellis, J Pang, CJ Schultz, GF Watts |
EUR J PREV CARDIOL | 2017 |
|
On-Chip Lipid Extraction Using Superabsorbent Polymers for Mass Spectrometry
G Bang, YH Kim, J Yoon, YJ Yu, S Chung, JA Kim |
Analytical Chemistry | 2017 |
|
Frecuencia, aspectos clínicos y moleculares de la hipercolesterolemia familiar en una unidad de endocrinología de Ciudad Bolívar, Venezuela
MM Lima-Martínez, M Paoli, A Vázquez-Cárdenas, MT Magaña-Torres, O Guevara, MC Muñoz, A Parrilla-Alvarez, Y Márquez, A Medeiros, M Bourbon |
Endocrinología, Diabetes y Nutrición | 2017 |
|
Frequency and clinical and molecular aspects of familial hypercholesterolemia in an endocrinology unit in Ciudad Bolívar, Venezuela
MM Lima-Martínez, M Paoli, A Vázquez-Cárdenas, MT Magaña-Torres, O Guevara, MC Muñoz, A Parrilla-Alvarez, Y Márquez, A Medeiros, M Bourbon |
Endocrinología, Diabetes y Nutrición (English ed.) | 2017 |
|
Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit
GK Hovingh, AC Goldberg, PM Moriarty |
Journal of Clinical Lipidology | 2017 |
|
Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome: Multicenter Registration Study in Japan
H Ohmura, Y Fukushima, A Mizuno, K Niwa, Y Kobayashi, T Ebina, K Kimura, S Ishibashi, H Daida |
International Heart Journal | 2017 |
|
The continuing challenge of familial hypercholesterolaemia
RS Patel |
2017 | |
|
Hipercolesterolemia familiar heterocigota en manejo con anti–PCSK9
M Duque, MC Gaviria, J González, JE Gallo |
Revista Colombiana de Cardiología | 2017 |
|
Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
LE Akioyamen, J Genest, SD Shan, RL Reel, JM Albaum, A Chu, JV Tu |
BMJ Open | 2017 |
|
Frequency of Achilles Tendon Xanthoma in Patients with Acute Coronary Syndrome
T Harada, K Inagaki-Tanimura, M Nagao, Y Sato, M Sudo, F Okajima, H Sugihara, S Oikawa |
Journal of Atherosclerosis and Thrombosis | 2017 |
|
Acute oral toxicity evaluation of aqueous ethanolic extract of Saccharum munja Roxb. roots in albino mice as per OECD 425 TG
U Saleem, S Amin, B Ahmad, H Azeem, F Anwar, S Mary |
Toxicology Reports | 2017 |
|
Clinical, Anthropometric and Biochemical Characteristics of Patients with or without Genetically Confirmed Familial Hypercholesterolemia
AD Lorenzo, JD da Silva, CE James, AC Pereira, AS Moreira |
Arquivos brasileiros de cardiologia | 2017 |
|
Triglyceride Treatment in the Age of Cholesterol Reduction
N Agrawal, PF Corradi, N Gumaste, IJ Goldberg |
Progress in Cardiovascular Diseases | 2016 |
|
The Great Adventure of an American Human Geneticist*
AG Motulsky, MC King |
Annual Review of Genomics and Human Genetics | 2016 |
|
International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
J Pang, PJ Lansberg, GF Watts |
Journal of Atherosclerosis and Thrombosis | 2016 |
|
Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies
MD Miedema, SS Virani |
The American Journal of Cardiology | 2016 |
|
Translational Research for Improving the Care of Familial Hypercholesterolemia: The “Ten Countries Study” and Beyond
GF Watts, PY Ding, P George, MS Hagger, M Hu, J Lin, KL Khoo, AD Marais, T Miida, HM Nawawi, J Pang, JE Park, LB Gonzalez-Santos, TC Su, TH Truong, RD Santos, H Soran, S Yamashita, B Tomlinson |
Journal of Atherosclerosis and Thrombosis | 2016 |
|
Antidiabetic, antihyperlipidemic and antioxidant properties of ethanol extract of Grewia asiatica Linn. bark in alloxan-induced diabetic rats
NA Khatune, BM Rahman, RK Barman, MI Wahed |
BMC complementary and alternative medicine | 2016 |
|
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with heterozygous familial hypercholesterolemia
H Arai, T Teramoto, H Daida, K Ikewaki, Y Maeda, M Nakagomi, M Shirakawa, T Kakikawa, H Numaguchi, AO Johnson-Levonas, S Vaidya, RO Blaustein |
Atherosclerosis | 2016 |
|
Diagnosis and treatment of high density lipoprotein deficiency
EJ Schaefer, P Anthanont, MR Diffenderfer, E Polisecki, BF Asztalos |
Progress in Cardiovascular Diseases | 2016 |
|
Familial Hypercholesterolaemia in the Era of Genetic Testing
DP Hughes, A Viljoen, AS Wierzbicki |
Current Cardiology Reports | 2016 |
|
The Contribution of GWAS Loci in Familial Dyslipidemias
P Ripatti, JT Rämö, S Söderlund, I Surakka, N Matikainen, M Pirinen, P Pajukanta, AP Sarin, SK Service, PP Laurila, C Ehnholm, V Salomaa, RK Wilson, A Palotie, NB Freimer, MR Taskinen, S Ripatti, G Gibson |
PLoS genetics | 2016 |
|
Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study
MS Safarova, H Liu, IJ Kullo |
Journal of Clinical Lipidology | 2016 |
|
Leveraging Human Genetics to Guide Drug Target Discovery
NO Stitziel, S Kathiresan |
Trends in Cardiovascular Medicine | 2016 |
|
Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions
KL Ellis, J Pang, DC Chan, AJ Hooper, DA Bell, JR Burnett, GF Watts |
Journal of Clinical Lipidology | 2016 |
|
Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors
M Arca |
Atherosclerosis | 2016 |
|
Screening for genetic mutations in children and adolescents with dyslipidemia: importance of early identification and implications of missed diagnoses
DP Wilson, A la Torre, A Brautbar, L Hamilton |
Expert Opinion on Orphan Drugs | 2016 |
|
Inborn Metabolic Diseases
JM Saudubray, MR Baumgartner, J Walter |
Inborn Metabolic Diseases | 2016 |
|
Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD
RH Fairoozy, J White, J Palmen, AZ Kalea, SE Humphries, NH Bishopric |
PloS one | 2016 |
|
Triglyceride Treatment in the Age of Cholesterol Reduction
N Agrawal, PF Corradi, N Gumaste, IJ Goldberg |
Progress in Cardiovascular Diseases | 2016 |
|
Diagnosis and treatment of high density lipoprotein deficiency
EJ Schaefer, P Anthanont, MR Diffenderfer, E Polisecki, BF Asztalos |
Progress in Cardiovascular Diseases | 2016 |
|
Genetic identification of familial hypercholesterolemia within a single U.S. health care system
NS Abul-Husn, K Manickam, LK Jones, EA Wright, DN Hartzel, C Gonzaga-Jauregui, C ODushlaine, JB Leader, HL Kirchner, DA Lindbuchler, ML Barr, MA Giovanni, MD Ritchie, JD Overton, JG Reid, RP Metpally, AH Wardeh, IB Borecki, GD Yancopoulos, A Baras, AR Shuldiner, O Gottesman, DH Ledbetter, DJ Carey, FE Dewey, MF Murray |
Science | 2016 |
|
Transcription factor 7-like 2 (TCF7L2) Gene Polymorphism rs7903146 is Associated with Lipid Profile and Risk of Cardiovascular Disease in Metabolic Syndrome Subjects
M Rezaei, A Palizban, S Zamani-doabi, M Shojaee |
Journal of Biology and Today's World | 2016 |
|
Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.
Safarova MS, Liu H, Kullo IJ |
Journal of Clinical Lipidology | 2016 |
|
Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening
S Singh, V Bittner |
Current Atherosclerosis Reports | 2015 |
|
Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice
C Jiang, Q Wang, YJ Wei, N Yao, Z Wu, Y Ma, Z Lin, M Zhao, C Che, X Yao, J Zhang, Z Yin |
Journal of Ethnopharmacology | 2015 |
|
Hypertriglyceridemia in the Genomic Era: A New Paradigm
GF Lewis, C Xiao, RA Hegele |
Endocrine reviews | 2015 |
|
Genetics of Familial Hypercholesterolemia
A Brautbar, E Leary, K Rasmussen, DP Wilson, RD Steiner, S Virani |
Current Atherosclerosis Reports | 2015 |
|
New Approaches in Detection and Treatment of Familial Hypercholesterolemia
ML Hartgers, KK Ray, GK Hovingh |
Current Cardiology Reports | 2015 |
|
Next-generation gene discovery for variants of large impact on lipid traits:
E Rosenthal, E Blue, GP Jarvik |
Current Opinion in Lipidology | 2015 |
|
Treatment of primary hypertriglyceridemia states – General approach and the role of extracorporeal methods
C Stefanutti, U Julius |
Atherosclerosis Supplements | 2015 |
|
Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction
I Brænne, M Kleinecke, B Reiz, E Graf, T Strom, T Wieland, M Fischer, T Kessler, C Hengstenberg, T Meitinger, J Erdmann, H Schunkert |
European Journal of Human Genetics | 2015 |
|
The effect of an Apolipoprotein A-I- containing HDL-mimetic Particle (CER-001) on carotid artery wall thickness in Patients with Homozygous Familial Hypercholesterolemia
GK Hovingh, LP Smits, C Stefanutti, H Soran, S Kwok, J Graaf, D Gaudet, CH Keyserling, H Klepp, J Frick, JF Paolini, JL Dasseux, JJ Kastelein, ES Stroes |
American Heart Journal | 2015 |
|
Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis
F Barkas, M Elisaf, H Milionis |
Atherosclerosis | 2015 |
|
Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia
MK Ito, GF Watts |
Drugs | 2015 |
|
Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV
GD Backer, J Besseling, J Chapman, GK Hovingh, JJ Kastelein, K Kotseva, K Ray, Ž Reiner, D Wood, DD Bacquer |
Atherosclerosis | 2015 |
|
Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification and Misinterpretation versus Facts
JW Knowles, NJ Stone, CM Ballantyne |
The American Journal of Cardiology | 2015 |
|
Secondary hypertriglyceridemia in children and adolescents
PR Blackett, DP Wilson, C McNeal |
Journal of Clinical Lipidology | 2015 |
|
Primary hypertriglyceridemia in children and adolescents
AS Shah, DP Wilson |
Journal of Clinical Lipidology | 2015 |
|
Familial hypercholesterolemia in children and adolescents: A clinical perspective
SD de Ferranti |
Journal of Clinical Lipidology | 2015 |
|
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach
I Minicocci, C Prisco, A Montali, AD Costanzo, F Ceci, G Pigna, M Arca |
Atherosclerosis | 2015 |
|
Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit
J Pang, EB Poulter, DA Bell, TR Bates, VL Jefferson, GS Hillis, CJ Schultz, GF Watts |
Journal of Clinical Lipidology | 2015 |
|
Combined dyslipidemia in childhood
RE Kavey |
Journal of Clinical Lipidology | 2015 |
|
Universal Screening for Familial Hypercholesterolemia in Children
G Klančar, U Grošelj, J Kovač, N Bratanič, N Bratina, KT Podkrajšek, T Battelino |
Journal of the American College of Cardiology | 2015 |
|
Nutritional Intervention in Metabolic Syndrome
H Takahashi, L Roma, M Silva |
Nutritional Intervention in Metabolic Syndrome | 2015 |
|
Dyslipidemias: Pathophysiology, Evaluation and Management
A Garg |
2015 | |
|
Searching for missing heritability: Designing rare variant association studies
O Zuk, SF Schaffner, K Samocha, R Do, E Hechter, S Kathiresan, MJ Daly, BM Neale, SR Sunyaev, ES Lander |
Proceedings of the National Academy of Sciences | 2014 |
|
Management of Hypercholesterolemia in Children
MJ Braamskamp, BA Hutten, A Wiegman, JJ Kastelein |
Pediatric Drugs | 2014 |
|
Bile acid synthesis precursors in familial combined hyperlipidemia: The oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol
L Baila-Rueda, R Mateo-Gallego, E Jarauta, I Castro-Orós, AM Bea, A Cenarro, F Civeira |
Biochemical and Biophysical Research Communications | 2014 |
|
Familial combined hyperlipidemia: from molecular insights to tailored therapy
MM van Greevenbroek, AF Stalenhoef, J Graaf, MC Brouwers |
Current Opinion in Lipidology | 2014 |
|
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome
B Sjouke, DM Kusters, I Kindt, J Besseling, JC Defesche, EJ Sijbrands, JE van Lennep, AF Stalenhoef, A Wiegman, J Graaf, SW Fouchier, JJ Kastelein, GK Hovingh |
European Heart Journal | 2014 |
|
Antihyperlipidemic Therapies Targeting PCSK9:
M Weinreich, WH Frishman |
Cardiology in Review | 2014 |
|
The Severe Hypercholesterolemia Phenotype
AD Sniderman, S Tsimikas, S Fazio |
Journal of the American College of Cardiology | 2014 |
|
Antihyperglycemic and antihyperlipidemic effects of the methanol extracts of Cleome ramosissima Parl., Barleria bispinosa (Forssk.) Vahl. and Tribulus macropterus Boiss
SM Ezzat, E Abdel-Sattar, FM Harraz, SA Ghareib |
Bulletin of Faculty of Pharmacy Cairo University | 2014 |
|
Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study
PJ Norsworthy, J Vandrovcova, ER Thomas, A Campbell, SM Kerr, J Biggs, L Game, AK Soutar, BH Smith, AF Dominiczak, DJ Porteous, AD Morris, G Scotland, TJ Aitman |
BMC Medical Genetics | 2014 |
|
A Review on the Traditional Chinese Medicinal Herbs and Formulae with Hypolipidemic Effect
TT Sham, CO Chan, YH Wang, JM Yang, DK Mok, SW Chan |
BioMed Research International | 2014 |
|
Pharmacologic Inhibition of Sphingomyelin Synthase (SMS) Activity Reduces Apolipoprotein-B Secretion from Hepatocytes and Attenuates Endotoxin-Mediated Macrophage Inflammation
B Lou, J Dong, Y Li, T Ding, T Bi, Y Li, X Deng, D Ye, XC Jiang, D Chakravortty |
PloS one | 2014 |
|
Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia
I Brænne, B Reiz, A Medack, M Kleinecke, M Fischer, S Tuna, C Hengstenberg, P Deloukas, J Erdmann, H Schunkert |
BMC Cardiovascular Disorders | 2014 |
|
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
R Do, NO Stitziel, HH Won, AB Jørgensen, S Duga, PA Merlini, A Kiezun, M Farrall, A Goel, O Zuk, I Guella, R Asselta, LA Lange, GM Peloso, PL Auer, D Girelli, N Martinelli, DN Farlow, MA DePristo, R Roberts, AF Stewart, D Saleheen, J Danesh, SE Epstein, S Sivapalaratnam, GK Hovingh, JJ Kastelein, NJ Samani, H Schunkert, J Erdmann, SH Shah, WE Kraus, R Davies, M Nikpay, CT Johansen, J Wang, RA Hegele, E Hechter, W Marz, ME Kleber, J Huang, AD Johnson, M Li, GL Burke, M Gross, Y Liu, TL Assimes, G Heiss, EM Lange, AR Folsom, HA Taylor, O Olivieri, A Hamsten, R Clarke, DF Reilly, W Yin, MA Rivas, P Donnelly, JE Rossouw, BM Psaty, DM Herrington, JG Wilson, SS Rich, MJ Bamshad, RP Tracy, LA Cupples, DJ Rader, MP Reilly, JA Spertus, S Cresci, J Hartiala, WH Tang, SL Hazen, H Allayee, AP Reiner, CS Carlson, C Kooperberg, RD Jackson, E Boerwinkle, ES Lander, SM Schwartz, DS Siscovick, R McPherson, A Tybjaerg-Hansen, GR Abecasis, H Watkins, DA Nickerson, D Ardissino, SR Sunyaev, CJ O'Donnell, D Altshuler, S Gabriel, S Kathiresan |
Nature | 2014 |
|
Recommendations for the Management of Patients with Familial Hypercholesterolemia
DI Feldman, MJ Blaha, RD Santos, SR Jones, RS Blumenthal, PP Toth, LS Sperling, SS Martin |
Current Atherosclerosis Reports | 2014 |
|
Inducing pluripotency for disease modeling, drug development and craniofacial applications
V Rosa, WS Toh, T Cao, W Shim |
Expert Opinion on Biological Therapy | 2014 |
|
Control del colesterol-LDL en pacientes con dislipidemias genéticas seguidos en unidades de lípidos y riesgo vascular de la Sociedad Española de Arteriosclerosis
C Lahoz, JM Mostaza, X Pintó, JJ de la Cruz, JR Banegas, J Pedro-Botet |
Clínica e Investigación en Arteriosclerosis | 2014 |
|
Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver
K Kikkawa, K Nakajima, Y Shimomura, Y Tokita, T Machida, H Sumino, M Murakami |
Clinica Chimica Acta | 2014 |
|
The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes
PJ Talmud, M Futema, SE Humphries |
Current Opinion in Lipidology | 2014 |
|
Hiperlipidemia familiar combinada: documento de consenso
P Mata, R Alonso, A Ruíz-Garcia, JL Díaz-Díaz, N González, T Gijón-Conde, C Martínez-Faedo, I Morón, E Arranz, R Aguado, R Argueso, LP de Isla |
Atención Primaria | 2014 |
|
Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia
I Cruz-Bautista, R Mehta, J Cabiedes, C García-Ulloa, LE Guillen-Pineda, P Almeda-Valdés, D Cuevas-Ramos, CA Aguilar-Salinas |
Clinica Chimica Acta | 2014 |
|
Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study
J Pang, DR Sullivan, M Harada-Shiba, PY Ding, S Selvey, S Ali, GF Watts |
Journal of Clinical Lipidology | 2014 |
|
Update on Screening, Etiology, and Treatment of Dyslipidemia in Children
V Bamba |
The Journal of clinical endocrinology and metabolism | 2014 |
|
Tumor necrosis factor beta NcoI polymorphism (rs909253) is associated with inflammatory and metabolic markers in acute ischemic stroke
J de Sousa Parreira, AP Kallaur, MF Lehmann, SR Oliveira, DA Frizon, F Delongui, MC de Araújo, C Rossato, JT de Almeida, LM Pelegrino, EF Bragato, HK Morimoto, AN Simão, DR Kaimen-Maciel, EM Reiche |
Metabolic Brain Disease | 2014 |
|
Hiperlipidemia familiar combinada: documento de consenso
P Mata, R Alonso, A Ruíz-Garcia, JL Díaz-Díaz, N González, T Gijón-Conde, C Martínez-Faedo, I Morón, E Arranz, R Aguado, R Argueso, LP de Isla |
Atención Primaria | 2014 |
|
Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia
MC Brouwers, RJ Konrad, TM Himbergen, A Isaacs, S Otokozawa, JS Troutt, EJ Schaefer, MM Greevenbroek, AF Stalenhoef, J Graaf |
Nutrition, Metabolism and Cardiovascular Diseases | 2013 |
|
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio |
Emery and Rimoin's Principles and Practice of Medical Genetics | 2013 |
|
Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association
HE Bays, PP Toth, PM Kris-Etherton, N Abate, LJ Aronne, WV Brown, JM Gonzalez-Campoy, SR Jones, R Kumar, RL Forge, VT Samuel |
Journal of Clinical Lipidology | 2013 |
|
New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
A Sahebkar, GF Watts |
Cardiovascular Drugs and Therapy | 2013 |
|
Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families: Two novel mutations in apolipoprotein C3
AE Bochem, JC Capelleveen, GM Dallinga-Thie, AW Schimmel, MM Motazacker, I Tietjen, RR Singaraja, MR Hayden, JJ Kastelein, ES Stroes, GK Hovingh |
Clinical Genetics | 2013 |
|
Pediatric lipid screening
CJ McNeal, L Underland, DP Wilson, PR Blackett |
Clinical Lipidology | 2013 |
|
Joint Linkage and Association Analysis with Exome Sequence Data Implicates SLC25A40 in Hypertriglyceridemia
EA Rosenthal, J Ranchalis, DR Crosslin, A Burt, JD Brunzell, AG Motulsky, DA Nickerson, EM Wijsman, GP Jarvik |
The American Journal of Human Genetics | 2013 |
|
Antidiabetic and antihyperlipidemic activity of Piper longum root aqueous extract in STZ induced diabetic rats
SA Nabi, RB Kasetti, S Sirasanagandla, TK Tilak, MV Kumar, CA Rao |
BMC complementary and alternative medicine | 2013 |
|
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis
F Sentinelli, I Minicocci, A Montali, L Nanni, S Romeo, M Incani, MG Cavallo, A Lenzi, M Arca, MG Baroni |
Journal of Lipids | 2013 |
|
Oral administration of alkaloid fraction from Ruta graveolens inhibits oxidative stress and inflammation in hypercholesterolemic rabbits
M Ratheesh, A Helen |
Pharmaceutical Biology | 2013 |
|
Pathologie
M Stolte, J Rüschoff, G Klöppel |
Der Pathologe | 2013 |
|
Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion
M Ekholm, T Kahan, G Jörneskog, J Brinck, NH Wallén |
Journal of Renin-Angiotensin-Aldosterone System | 2013 |
|
Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice
A Yazdanyar, XC Jiang |
Hepatology | 2012 |
|
The genetics of familial combined hyperlipidaemia.
Brouwers MC, van Greevenbroek MM, Stehouwer CD, de Graaf J, Stalenhoef AF |
Nature reviews. Endocrinology | 2012 |
|
Veratric acid ameliorates hyperlipidemia and oxidative stress in Wistar rats fed an atherogenic diet
B Raja, M Saravanakumar, G Sathya |
Molecular and Cellular Biochemistry | 2012 |
|
Antidiabetic, antihyperlipidemic and antioxidant activities of methanolic extract of Amaranthus viridis Linn in alloxan induced diabetic rats
BS Kumar, K Lakshman, KN Jayaveea, DS Shekar, S Khan, BS Thippeswamy, VP Veerapur |
Experimental and Toxicologic Pathology | 2012 |
|
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
|
The genetics of familial combined hyperlipidaemia
MC Brouwers, MM van Greevenbroek, CD Stehouwer, J Graaf, AF Stalenhoef |
Nature Reviews Endocrinology | 2012 |
|
Gout
E Krishnan |
Gout & Other Crystal Arthropathies | 2012 |
|
Drug Therapy of Hypercholesterolaemia in Children and Adolescents :
MJ Braamskamp, FA Wijburg, A Wiegman |
Drugs | 2012 |
|
A Model of Care for Familial Hypercholesterolaemia: Key Role for Clinical Biochemistry
GF Watts, DR Sullivan, FM van Bockxmeer, N Poplawski, I Hamilton-Craig, PM Clifton, RC O'Brien, PM George, JR Burnett |
The Clinical Biochemist Reviews | 2012 |
|
Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia
M Solanas-Barca, I Castro-Orós, R Mateo-Gallego, M Cofán, N Plana, J Puzo, E Burillo, P Martín-Fuentes, E Ros, L Masana, M Pocoví, F Civeira, A Cenarro |
Atherosclerosis | 2012 |
|
Hiperlipidemias primarias
SV Martín, SG Pastor, ML Triguero, AH Mijares |
Medicine - Programa de Formación Médica Continuada Acreditado | 2012 |
|
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics
EJ Lamb, CP Price |
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics | 2012 |
|
Proanthocyanidin Oligomers Isolated from Salacia reticulata leaves potently Inhibit Pancreatic Lipase Activity
K Koga, M Hisamura, T Kanetaka, K Yoshino, Y Matsuo, T Tanaka |
Journal of Food Science | 2012 |
|
Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East
L Romdhane, R Kefi, H Azaiez, NB Halim, K Dellagi, S Abdelhak |
Orphanet Journal of Rare Diseases | 2012 |
|
The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism
XC Jiang, W Jin, MM Hussain |
Nutrition & Metabolism | 2012 |
|
Up-Regulation of the Complement System in Subcutaneous Adipocytes from Nonobese, Hypertriglyceridemic Subjects Is Associated with Adipocyte Insulin Resistance
MM van Greevenbroek, S Ghosh, CJ van der Kallen, MC Brouwers, CG Schalkwijk, CD Stehouwer |
The Journal of clinical endocrinology and metabolism | 2012 |
|
Drug Therapy of Hypercholesterolaemia in Children and Adolescents:
MJ Braamskamp, FA Wijburg, A Wiegman |
Drugs | 2012 |
|
Encyclopedia of Life Sciences
B Dahlbäck |
Encyclopedia of Life Sciences | 2011 |
|
Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
PN Hopkins, PP Toth, CM Ballantyne, DJ Rader |
Journal of Clinical Lipidology | 2011 |
|
A classification of lipoprotein disorders: implications for clinical management
DR Sullivan, B Lewis |
Clinical Lipidology | 2011 |
|
A Novel Pathogenic Nonsense Triple-Nucleotide Mutation in the Low-Density Lipoprotein Receptor Gene and Its Clinical Correlation with Familial Hypercholesterolemia
M Ajmal, W Ahmed, N Akhtar, A Sadeque, A Khalid, SH Ali, N Ahmed, M Azam, R Qamar |
Genetic Testing and Molecular Biomarkers | 2011 |
|
Genetics and molecular biology
J Pétremand, C Widmann |
Current Opinion in Lipidology | 2011 |
|
Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan
H Mabuchi, A Nohara, T Noguchi, J Kobayashi, M Kawashiri, H Tada, C Nakanishi, M Mori, M Yamagishi, A Inazu, J Koizumi |
Atherosclerosis | 2011 |
|
Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis
C Masoura, C Pitsavos, K Aznaouridis, I Skoumas, C Vlachopoulos, C Stefanadis |
Atherosclerosis | 2011 |
|
Future issues, public policy, and public awareness of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
AC Goldberg, JG Robinson, WC Cromwell, JL Ross, PE Ziajka |
Journal of Clinical Lipidology | 2011 |
|
Estudio genético de la implicación del gen USF1 en el desarrollo del síndrome metabólico
M Strunk, EJ Simón, AM Sanz, JP Foncillas, FC Murillo, ÁL García-Otín |
Clínica e Investigación en Arteriosclerosis | 2011 |
|
Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidaemia
MC Brouwers, MM van Greevenbroek, JS Troutt, A Bonner Freeman, A Lu, NC Schaper, RJ Konrad, CD Stehouwer |
Clinical Science | 2011 |
|
Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population
YY Zheng, X Xie, YT Ma, YN Yang, ZY Fu, XM Li, X Ma, BD Chen, F Liu |
Endocrine | 2011 |
|
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
|
Serum triglycerides and risk of cardiovascular disease
AC Boullart, J Graaf, AF Stalenhoef |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2011 |
|
Management of Type IIb Dyslipidemia
H Arai, S Ishibashi, H Bujo, T Hayashi, S Yokoyama, S Oikawa, J Kobayashi, K Shirai, T Ota, S Yamashita, T Gotoda, M Harada-Shiba, H Sone, M Eto, H Suzuki, N Yamada |
Journal of Atherosclerosis and Thrombosis | 2011 |
|
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick |
Williams Textbook of Endocrinology | 2011 |
|
Preventive Cardiology: Companion to Braunwald's Heart Disease
PN Hopkins |
Preventive Cardiology: Companion to Braunwald's Heart Disease | 2011 |
|
Genome-Wide Linkage Scan of a Pedigree with Familial Hypercholesterolemia Suggests Susceptibility Loci on Chromosomes 3q25-26 and 21q22
X Wang, X Li, YB Zhang, F Zhang, L Sun, J Lin, DM Wang, LY Wang, R Krahe |
PloS one | 2011 |
|
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.
Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, Watts GF |
European Heart Journal | 2011 |
|
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.
Criado-García J, Fuentes F, Cruz-Teno C, García-Rios A, Jiménez-Morales A, Delgado-Lista J, Mata P, Alonso R, López-Miranda J, Pérez-Jiménez F |
Lipids in Health and Disease | 2011 |
|
Encouraging appropriate treatment for familial hypercholesterolemia
PN Hopkins |
Clinical Lipidology | 2010 |
|
Linkage and association analyses identify a candidate region for apoB level on chromosome 4q32.3 in FCHL families
EM Wijsman, JH Rothstein, RP Igo, JD Brunzell, AG Motulsky, GP Jarvik |
Human Genetics | 2010 |
|
Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia
L Nanni, F Quagliarini, F Megiorni, A Montali, I Minicocci, F Campagna, A Pizzuti, M Arca |
Atherosclerosis | 2010 |
|
Carotid distension and distensibility impairment in individuals affected by familial combined hyperlipidemia
T Montalcini, G Gorgone, C Gazzaruso, A Pujia |
Atherosclerosis | 2010 |
|
Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia
E Jarauta, R Mateo-Gallego, R Gilabert, N Plana, M Junyent, E Groot, A Cenarro, L Masana, E Ros, F Civeira |
Nutrition, Metabolism and Cardiovascular Diseases | 2010 |
|
Adiponectin in Members of Families With Familial Combined Hyperlipidemia
D Karásek, H Vaverková, M Halenka, D Jackuliaková, Z Fryšák, DN Ing |
The Endocrinologist | 2010 |
|
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis
S Riggio, F Mamone, G Mandraffino, S Maimone, A Alibrandi, L Manti, C Saitta, PF Tripodi, MA Sardo, G Squadrito, A Saitta |
European Journal of Clinical Investigation | 2010 |
|
Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus
MC Brouwers, J Graaf, MM van Greevenbroek, N Schaper, CD Stehouwer, AF Stalenhoef |
Current Opinion in Lipidology | 2010 |
|
A case report of a diabetic woman with very low HDL cholesterol
L Chaychi, WB Kinlaw, BF Asztalos, EJ Schaefer |
Journal of Clinical Lipidology | 2010 |
|
Postprandial metabolic heterogeneity in men with primary dyslipidaemia
AN Pavlidis, GD Kolovou, KK Anagnostopoulou, PC Petrou, DV Cokkinos |
Archives of Medical Science : AMS | 2010 |
|
Medicina Personalizada Posgenómica. Conceptos Prácticos Para Clínicos
GS Sales, JS Tobella |
Medicina Personalizada Posgenómica. Conceptos Prácticos Para Clínicos | 2010 |
|
Hypertriglyceridaemia: Aetiology, Complications and Management
DJ Blom |
Journal of Endocrinology, Metabolism and Diabetes of South Africa | 2010 |
|
Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study
S Holewijn, AD Sniderman, M den Heijer, DW Swinkels, AF Stalenhoef, J de Graaf |
European Journal of Clinical Investigation | 2010 |
|
Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway
TM van Himbergen, S Otokozawa, NR Matthan, EJ Schaefer, A Buchsbaum, M Ai, LJ van Tits, J de Graaf, AF Stalenhoef |
Arteriosclerosis, thrombosis, and vascular biology | 2010 |
|
Atlas of Atherosclerosis and Metabolic Syndrome
SM Grundy |
2010 | |
|
High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease
EJ Schaefer |
2010 | |
|
Family Coronary Heart Disease: A Call to Action: Family coronary heart disease
HR Superko, R Roberts, B Garrett, L Pendyala, S King |
Clinical Cardiology | 2010 |
|
Molecular spectrum of autosomal dominant hypercholesterolemia in France.
Marduel M, Carrié A, Sassolas A, Devillers M, Carreau V, Di Filippo M, Erlich D, Abifadel M, Marques-Pinheiro A, Munnich A, Junien C, Boileau C, Varret M, Rabès JP |
Human Mutation | 2010 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
A Systems Genetics Approach Implicates USF1, FADS3, and Other Causal Candidate Genes for Familial Combined Hyperlipidemia
CL Plaisier, S Horvath, A Huertas-Vazquez, I Cruz-Bautista, MF Herrera, T Tusie-Luna, C Aguilar-Salinas, P Pajukanta, JD Storey |
PLoS genetics | 2009 |
|
Triglycerides and cardiovascular risk
KE Harchaoui, ME Visser, JJ Kastelein, ES Stroes, GM Dallinga-Thie |
Current cardiology reviews | 2009 |
|
The SLIM Study: Slo-Niacin(R) and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia
RH Knopp, BM Retzlaff, B Fish, A Dowdy, B Twaddell, T Nguyen, P Paramsothy |
Journal of Clinical Lipidology | 2009 |
|
Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice
S Wu, R Mar-Heyming, EZ Dugum, NA Kolaitis, H Qi, P Pajukanta, LW Castellani, AJ Lusis, TA Drake |
Human Molecular Genetics | 2009 |
|
A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia
A Huertas-Vazquez, CL Plaisier, R Geng, BE Haas, J Lee, MM Greevenbroek, C der Kallen, TW de Bruin, MR Taskinen, KN Alagramam, P Pajukanta |
Human Genetics | 2009 |
|
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism
J Perttilä, K Merikanto, J Naukkarinen, I Surakka, NW Martin, K Tanhuanpää, V Grimard, MR Taskinen, C Thiele, V Salomaa, A Jula, M Perola, I Virtanen, L Peltonen, VM Olkkonen |
Journal of Molecular Medicine | 2009 |
|
Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene
A López-Ruiz, MM Jarabo, ML Martínez-Triguero, M Morales-Suárez-Varela, E Solá, C Bañuls, M Casado, A Hernández-Mijares |
Lipids in Health and Disease | 2009 |
|
Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis
P Paramsothy, R Knopp, AG Bertoni, MY Tsai, T Rue, SR Heckbert |
Metabolism: clinical and experimental | 2009 |
|
ApoB versus non-HDL-C: What to do when they disagree
A Sniderman, K Williams, C Cobbaert |
Current Atherosclerosis Reports | 2009 |
|
Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo
M Ekholm, T Kahan, G Jörneskog, A Bröijersen, NH Wallén |
Thrombosis Research | 2009 |
|
Cardiovascular complications in familial combined hyperlipidemia: beyond the atherogenic dyslipidemia
MC Brouwers, CD Stehouwer |
Clinical Lipidology | 2009 |
|
Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia
T Hirano, K Nohtomi, Y Sato, K Kamata, Y Ito |
Atherosclerosis | 2009 |
|
Familial-combined hyperlipidaemia in very young myocardial infarction survivors (<=40 years of age)
F Wiesbauer, H Blessberger, D Azar, G Goliasch, O Wagner, L Gerhold, K Huber, K Widhalm, F Abdolvahab, G Sodeck, G Maurer, M Schillinger |
European Heart Journal | 2009 |
|
Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11β-HSD1, PEPCK and DGAT2
RA Srivastava |
European Journal of Pharmacology | 2009 |
|
Increased arterial stiffness in familial combined hyperlipidemia
MC Brouwers, KD Reesink, MM van Greevenbroek, JM Meinders, CJ van der Kallen, N Schaper, AP Hoeks, CD Stehouwer |
Journal of Hypertension | 2009 |
|
Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease
M Abifadel, JP Rab��s, M Devillers, A Munnich, D Erlich, C Junien, M Varret, C Boileau |
Human Mutation | 2009 |
|
Endothelial haemostatic markers in members of families with familial combined hyperlipidemia
D Karásek, H Vaverková, M Halenka, L Slavík, D Novotný |
Thrombosis Research | 2009 |
|
Antihyperlipidemic effect of the methanolic extract from Lagenaria siceraria Stand. fruit in hyperlipidemic rats
BV Ghule, MH Ghante, AN Saoji, PG Yeole |
Journal of Ethnopharmacology | 2009 |
|
Anti-atherogenic effects of centipede acidic protein in rats fed an atherogenic diet
Y Wu, J Li, J Wang, Q Si, J Zhang, Y Jiang, L Chu |
Journal of Ethnopharmacology | 2009 |
|
Aortic calcifications in familial hypercholesterolemia: Potential role of the low-density lipoprotein receptor gene
K Alrasadi, K Alwaili, Z Awan, D Valenti, P Couture, J Genest |
American Heart Journal | 2009 |
|
Effect of Combination Nicotinic Acid and Gemfibrozil Treatment on Intermediate Density Lipoprotein, and Subclasses of Low Density Lipoprotein and High Density Lipoprotein in Patients With Combined Hyperlipidemia
HR Superko, BC Garrett, SB King, KM Momary, NA Chronos, PD Wood |
The American Journal of Cardiology | 2009 |
|
Efficacy of Different Fractions of Anethum graveolens Leaves on Serum Lipoproteins and Serum and Liver Oxidative Status in Experimentally Induced Hypercholesterolaemic Rat Models
S Bahramikia, R Yazdanparast |
The American journal of Chinese medicine | 2009 |
|
Pharmacology and Therapeutics
BL Clarke, S Khosla |
Pharmacology & Therapeutics | 2009 |
|
Galanin Preproprotein Is Associated With Elevated Plasma Triglycerides
CL Plaisier, M Kyttälä, D Weissglas-Volkov, JS Sinsheimer, A Huertas-Vazquez, L Riba, S Ramírez-Jiménez, TW de Bruin, T Tusié-Luna, BE Aouizerat, CR Pullinger, MJ Malloy, JP Kane, I Cruz-Bautista, MF Herrera, C Aguilar-Salinas, J Kuusisto, M Laakso, MR Taskinen, CJ van der Kallen, P Pajukanta |
Arteriosclerosis, thrombosis, and vascular biology | 2009 |
|
Molecular Diagnostics: Promises and Possibilities
M Debnath, GB Prasad, PS Bisen |
2009 | |
|
Genetics of premature myocardial infarction
R Roberts |
Current Atherosclerosis Reports | 2008 |
|
Investigation and management of hypertriglyceridaemia
G Ferns, V Keti, B Griffin |
Journal of clinical pathology | 2008 |
|
Novartis Foundation Symposia
EJ Campbell |
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction | 2008 |
|
Fundamental and Clinical Cardiology Series
PD Stein |
Cardiovascular Disease in the Elderly | 2008 |
|
Insulin resistance and oxidative stress in familial combined hyperlipidemia
S Martinez-Hervas, M Fandos, JT Real, O Espinosa, FJ Chaves, GT Saez, A Salvador, C Cerdá, R Carmena, JF Ascaso |
Atherosclerosis | 2008 |
|
Frequency of Low-Density Lipoprotein Receptor Gene Mutations in Patients With a Clinical Diagnosis of Familial Combined Hyperlipidemia in a Clinical Setting
F Civeira, E Jarauta, A Cenarro, AL García-Otín, D Tejedor, D Zambón, M Mallen, E Ros, M Pocoví |
Journal of the American College of Cardiology | 2008 |
|
Advances in the management of hyperlipidemia-induced atherosclerosis
LR Tannock |
Expert Review of Cardiovascular Therapy | 2008 |
|
Tocotrienols
C Elson, H Mo |
Tocotrienols | 2008 |
|
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
TI Pollin, CM Damcott, H Shen, SH Ott, J Shelton, RB Horenstein, W Post, JC McLenithan, LF Bielak, PA Peyser, BD Mitchell, M Miller, JR O'Connell, AR Shuldiner |
Science | 2008 |
|
Hypolipidemic activity ofAnethum graveolens in rats
V Hajhashemi, N Abbasi |
Phytotherapy Research | 2008 |
|
Paraoxonase (PON1) is associated with familial combined hyperlipidemia
TM van Himbergen, LJ van Tits, E Avest, M Roest, HA Voorbij, J Graaf, AF Stalenhoef |
Atherosclerosis | 2008 |
|
Allelic Variants of Upstream Transcription Factor 1 Associate With Carotid Artery Intima-Media Thickness
A Collings, S Höyssä, M Fan, M Kähönen, N Hutri-Kähönen, J Marniemi, M Juonala, JS Viikari, OT Raitakari, TJ Lehtimäki |
Circulation Journal | 2008 |
|
A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias
J Graaf, P Couture, A Sniderman |
Nature Clinical Practice Endocrinology & Metabolism | 2008 |
|
APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia
J Wang, MR Ban, BA Kennedy, S Anand, S Yusuf, MW Huff, RL Pollex, RA Hegele |
Nature Clinical Practice Cardiovascular Medicine | 2008 |
|
Spousal Concordance for Major Coronary Risk Factors: A Systematic Review and Meta-Analysis
AD Castelnuovo, G Quacquaruccio, MB Donati, G Gaetano, L Iacoviello |
American Journal of Epidemiology | 2008 |
|
Primary Hyperlipidemia
T Teramoto, J Sasaki, H Ueshima, G Egusa, M Kinoshita, K Shimamoto, H Daida, S Biro, K Hirobe, T Funahashi, K Yokote, M Yokode |
Journal of Atherosclerosis and Thrombosis | 2008 |
|
Proposed Guidelines for Hypertriglyceridemia in Japan with Non-HDL Cholesterol as the Second Target
H Shimano, H Arai, M Harada-Shiba, H Ueshima, T Ohta, S Yamashita, T Gotoda, Y Kiyohara, T Hayashi, J Kobayashi, K Shimamoto, H Bujo, S Ishibashi, K Shirai, S Oikawa, Y Saito, N Yamada |
Journal of Atherosclerosis and Thrombosis | 2008 |
|
Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio
M Junyent, D Zambón, R Gilabert, M Cofán, I Núñez, E Ros |
Atherosclerosis | 2008 |
|
Hepatoprotective effects of Solanum nigrum Linn extract against CCl4-iduced oxidative damage in rats
HM Lin, HC Tseng, CJ Wang, JJ Lin, CW Lo, FP Chou |
Chemico-Biological Interactions | 2008 |
|
Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatment
PO Kwiterovich |
Journal of Clinical Lipidology | 2008 |
|
Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E
MC Brouwers, J Govers-Riemslag, CG Schalkwijk, MM van Greevenbroek, CJ van der Kallen, O Bekers, MP van Dieijen-Visser, J Oever, MA Bilderbeek-Beckers, TW de Bruin, H Cate, CD Stehouwer |
Thrombosis Research | 2008 |
|
Oxidación del ADN como potencial factor de riesgo cardiovascular en la hiperlipemia familiar combinada
F Civeira, A Cenarro |
Medicina Clínica | 2008 |
|
Editorial comment: Frequent detection of familial hypercholesterolemia mutations in familial combined hyperlipidemia
GP Jarvik, JD Brunzell, AG Motulsky |
Journal of the American College of Cardiology | 2008 |
|
Comprehensive Lipid Management Versus Aggressive Low-Density Lipoprotein Lowering to Reduce Cardiovascular Risk
RH Knopp, P Paramsothy, B Atkinson, A Dowdy |
The American Journal of Cardiology | 2008 |
|
Association of Stearoyl-CoA Desaturase 1 Activity With Familial Combined Hyperlipidemia
R Mar-Heyming, M Miyazaki, D Weissglas-Volkov, NA Kolaitis, N Sadaat, C Plaisier, P Pajukanta, R M., TW de Bruin, JM Ntambi, AJ Lusis |
Arteriosclerosis, thrombosis, and vascular biology | 2008 |
|
Therapeutic Lipidology
MH Davidson, PP Toth, KC Maki, AM Gotto |
2008 | |
|
Optimal medical therapy with or without percutaneous coronary intervention for stable coronary disease: the COURAGE Study
John A Farmer |
Current Atherosclerosis Reports | 2008 |
|
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: Reduction during atorvastatin and fenofibrate therapy
M Arca, S Natoli, F Micheletta, S Riggi, ED Angelantonio, A Montali, TM Antonini, R Antonini, U Diczfalusy, L Iuliano |
Free radical biology & medicine | 2007 |
|
Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet
D Weghuber, K Widhalm |
British Journal of Nutrition | 2007 |
|
Genetic heterogeneity of autosomal dominant hypercholesterolemia
M Varret, M Abifadel, JP Rabès, C Boileau |
Clinical Genetics | 2007 |
|
Hypertriglyceridemia: its etiology, effects and treatment
G Yuan, KZ Al-Shali, RA Hegele |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2007 |
|
TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia
A Huertas-Vazquez, C Plaisier, D Weissglas-Volkov, J Sinsheimer, S Canizales-Quinteros, I Cruz-Bautista, E Nikkola, M Herrera-Hernandez, A Davila-Cervantes, T Tusie-Luna, MR Taskinen, C Aguilar-Salinas, P Pajukanta |
Diabetologia | 2007 |
|
Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients
S Ying, YM Sun, XM Liu, CY An, YY Gao |
Biochemical and Biophysical Research Communications | 2007 |
|
Pioglitazone Improves Myocardial Blood Flow and Glucose Utilization in Nondiabetic Patients With Combined Hyperlipidemia
RP Naoumova, H Kindler, L Leccisotti, M Mongillo, MT Khan, C Neuwirth, M Seed, P Holvoet, J Betteridge, PG Camici |
Journal of the American College of Cardiology | 2007 |
|
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia
M Arca, A Montali, G Pigna, R Antonini, TM Antonini, P Luigi, A Fraioli, M Mastrantoni, M Maddaloni, C Letizia |
Metabolism | 2007 |
|
Kakkalide and Irisolidone: HMG-CoA Reductase Inhibitors Isolated from the Flower of Pueraria thunbergiana
SW Min, DH Kim |
Biological & Pharmaceutical Bulletin | 2007 |
|
High prevalence of major cardiovascular risk factors in first-degree relatives of individuals with familial premature coronary artery disease—The GENECARD project
C Hurrell, V Wietlisbach, V Jotterand, M Volet, V Lenain, P Nicod, R Darioli, F Paccaud, G Waeber, V Mooser |
Atherosclerosis | 2007 |
|
Fatty liver–based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia
MC Brouwers, MM van Greevenbroek, MA Bilderbeek-Beckers, MG Robertus-Teunissen, CJ van der Kallen, CD Stehouwer, TW de Bruin |
Metabolism | 2007 |
|
Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content
EL Thomas, E Potter, I Tosi, J Fitzpatrick, G Hamilton, V Amber, R Hughes, C North, P Holvoet, M Seed, DJ Betteridge, JD Bell, RP Naoumova |
Atherosclerosis | 2007 |
|
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?
VG Athyros, K Tziomalos, DP Mikhailidis, ED Pagourelias, AI Kakafika, A Skaperdas, A Hatzitolios, A Karagiannis |
Expert Opinion on Pharmacotherapy | 2007 |
|
Hypertriglyceridemia
JD Brunzell |
New England Journal of Medicine | 2007 |
|
Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia
W Pei, Y Sun, Q Liu, W Zheng, J Zhang, C Zhang, J Gong, PN Hopkins, R Hui, L Liu, Y Yang |
International Journal of Cardiology | 2007 |
|
Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia
W Pei, Y Sun, B Lu, Q Liu, C Zhang, J Zhang, Y Jia, Z Lu, R Hui, L Liu, Y Yang |
International Journal of Cardiology | 2007 |
|
Premature coronary artery disease and apolipoprotein B and apolipoprotein A-I
AF Ayyobi, A Zambon, JD Brunzell |
International Congress Series | 2007 |
|
Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia
GM van der Vleuten, A Isaacs, WW Zeng, E Avest, PJ Talmud, GM Dallinga-Thie, CM van Duijn, AF Stalenhoef, J Graaf |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2007 |
|
Comprehensive Management of High Risk Cardiovascular Patients
N Kopyt |
Comprehensive Management of High Risk Cardiovascular Patients | 2007 |
|
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes |
2007 | |
|
High Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia
J de Graaf, GM van der Vleuten, E ter Avest, GM Dallinga-Thie, AF Stalenhoef |
The Journal of clinical endocrinology and metabolism | 2007 |
|
Hypolipidemic Effects of Biopolymers Extracted from Culture Broth, Mycelia, and Fruiting Bodies of Auricularia auricula-judae in Dietary-induced Hyperlipidemic Rats.
Jeong H, Yang BK, Jeong YT, Kim GN, Jeong YS, Kim SM, Mehta P, Song CH |
Mycobiology | 2007 |
|
Unraveling the complex genetics of familial combined hyperlipidemia
E Suviolahti, HE Lilja, P Pajukanta |
Annals of Medicine | 2006 |
|
A moderate-fat diet for combined hyperlipidemia and metabolic syndrome
RH Knopp, B Fish, A Dowdy, B Retzlaff, C Walden, I Rusanu, P Paramsothy |
Current Atherosclerosis Reports | 2006 |
|
Encyclopedia of Molecular Cell Biology and Molecular Medicine
E Beutler |
Encyclopedia of Molecular Cell Biology and Molecular Medicine | 2006 |
|
Clinical trials report
RH Knopp, P Paramsothy |
Current Atherosclerosis Reports | 2006 |
|
The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion
SF Wung, MV Kulkarni, CR Pullinger, MJ Malloy, JP Kane, BE Aouizerat |
Lipids in Health and Disease | 2006 |
|
Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia
MD Michele, A Iannuzzi, A Salvato, P Pauciullo, M Gentile, G Iannuzzo, S Panico, A Pujia, GM Bond, P Rubba |
Heart (British Cardiac Society) | 2006 |
|
Recurrent acute pancreatitis in a patient with type IIb hyperlipoproteinemia: a case report and review of the literature in Korea
BK Kim, MJ Kim, WC Chang, KH Yoo, YG Shin, CH Chung |
Yonsei Medical Journal | 2006 |
|
The Importance of Written Information Packages in Support of Case-Finding Within Families at Risk for Inherited High Cholesterol
HW Nieuwenhoff, I Mesters, JJ Nellissen, AF Stalenhoef, NK Vries |
Journal of Genetic Counseling | 2006 |
|
Hiperlipidemia familiar combinada, síndrome metabólico y enfermedad cardiovascular
S Martinez-Hervás, JT Real, A Priego, J Sanz, JM Martín, R Carmena, JF Ascaso |
Revista Española de Cardiología | 2006 |
|
Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease
A Zambon, BG Brown, SS Deeb, JD Brunzell |
Journal of Internal Medicine | 2006 |
|
Genetic susceptibility to coronary artery disease: from promise to progress
H Watkins, M Farrall |
Nature Reviews Genetics | 2006 |
|
Genetics of familial combined hyperlipidemia
J Naukkarinen, C Ehnholm, L Peltonen |
Current Opinion in Lipidology | 2006 |
|
HEPATOPROTECTIVE AND HYPOLIPIDAEMIC EFFECTS OF GLYCOPROTEIN ISOLATED FROM GARDENIA JASMINOIDES ELLIS IN MICE
SJ Lee, PS Oh, KT Lim |
Clinical and Experimental Pharmacology and Physiology | 2006 |
|
Apolipoprotein E Polymorphism Influences Lipid Phenotypes in Chinese Families With Familial Combined Hyperlipidemia
WD Pei, YH Zhang, YH Sun, YC Gu, YF Wang, CY Zhang, J Zhang, LS Liu, RT Hui, YQ Liu, YJ Yang |
Circulation Journal | 2006 |
|
Genetics of familial combined hyperlipidemia:
J Naukkarinen, C Ehnholm, L Peltonen |
Current Opinion in Lipidology | 2006 |
|
Case Studies in Lipid Management: the case of triglycerides
M Cabezas, T Rabelink |
Case Studies in Lipid Management: the case of triglycerides | 2006 |
|
Case Studies in Lipid Management
J Burnett, G Watts |
Case Studies in Lipid Management: the case of triglycerides | 2006 |
|
Familial Combined Hyperlipidemia, Metabolic Syndrome and Cardiovascular Disease
S Martinez-Hervás, JT Real, A Priego, J Sanz, JM Martín, R Carmena, JF Ascaso |
Revista Española de Cardiología (English Edition) | 2006 |
|
Apolipoprotein A1 and B
AD Sniderman, SM Marcovina |
Clinics in Laboratory Medicine | 2006 |
|
Common Hepatic Nuclear Factor-4 Variants Are Associated With High Serum Lipid Levels and the Metabolic Syndrome
D Weissglas-Volkov, A Huertas-Vazquez, E Suviolahti, J Lee, C Plaisier, S Canizales-Quinteros, T Tusie-Luna, C Aguilar-Salinas, MR Taskinen, P Pajukanta |
Diabetes | 2006 |
|
Case Studies in Lipid Management: a feature of insulin resistance, dyslipidemia and atherosclerosis?
D Müller-Wieland |
Case Studies in Lipid Management: a feature of insulin resistance, dyslipidemia and atherosclerosis? | 2006 |
|
Genomic characterization of five deletions in the LDL receptor gene in Danish Familial Hypercholesterolemic subjects
PH Nissen, D Damgaard, A Stenderup, GG Nielsen, ML Larsen, O Færgeman |
BMC Medical Genetics | 2006 |
|
Heritability and genetic loci of fatty liver in familial combined hyperlipidemia
MC Brouwers, RM Cantor, N Kono, J Yoon, CJ van der Kallen, MA Bilderbeek-Beckers, MM van Greevenbroek, AJ Lusis, TW de Bruin |
Journal of lipid research | 2006 |
|
The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia
GM van der Vleuten, A Isaacs, A Hijmans, CM van Duijn, AF Stalenhoef, J Graaf |
Journal of lipid research | 2006 |
|
Characterization of Cq3, a Quantitative Trait Locus that Controls Plasma Cholesterol and Phospholipid Levels in Mice
J SUTO |
Journal of Veterinary Medical Science | 2006 |
|
A Functional Polymorphism in the Glucocorticoid Receptor Gene and Its Relation to Cardiovascular Disease Risk in Familial Hypercholesterolemia
KC Koeijvoets, EF van Rossum, GM Dallinga-Thie, EW Steyerberg, JC Defesche, JJ Kastelein, SW Lamberts, EJ Sijbrands |
The Journal of clinical endocrinology and metabolism | 2006 |
|
The Importance of Written Information Packages in Support of Case-Finding Within Families at Risk for Inherited High Cholesterol
HW van den Nieuwenhoff, I Mesters, JJ Nellissen, AF Stalenhoef, NK de Vries |
Journal of Genetic Counseling | 2006 |
|
USF1 and dyslipidemias: converging evidence for a functional intronic variant
J Naukkarinen, M Gentile, A Soro-Paavonen, J Saarela, HA Koistinen, P Pajukanta, MR Taskinen, L Peltonen |
Human Molecular Genetics | 2005 |
|
Pathophysiology of dyslipidaemia in the metabolic syndrome
GD Kolovou, KK Anagnostopoulou, DV Cokkinos |
Postgraduate medical journal | 2005 |
|
Treatment of dyslipidemia in children and adolescents
KW Holmes, PO Kwiterovich |
Current Cardiology Reports | 2005 |
|
Up‐regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia
SJ Meex, CJ Kallen, MM Greevenbroek, PM Eurlings, ME Hasnaoui, CT Evelo, PJ Lindsey, JJ Luiken, JF Glatz, TW Bruin |
The FASEB Journal | 2005 |
|
A SCIENCE OF THE INDIVIDUAL: Implications for a Medical School Curriculum
B Childs, C Wiener, D Valle |
Annual Review of Genomics and Human Genetics | 2005 |
|
Characterisation of the lipoprotein structure in the St. Thomas’ Mixed Hyperlipidaemic (SMHL) rabbit
B Roos, MJ Caslake, K Milliner, GM Benson, KE Suckling, CJ Packard |
Atherosclerosis | 2005 |
|
Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia
F Gagnon, GP Jarvik, MD Badzioch, AG Motulsky, JD Brunzell, EM Wijsman |
Human Genetics | 2005 |
|
Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides
H Coon, Y Xin, PN Hopkins, RM Cawthon, SJ Hasstedt, SC Hunt |
Human Genetics | 2005 |
|
Antihyperlipidemic Effect of Crocin Isolated from the Fructus of Gardenia jasminoides and Its Metabolite Crocetin
IA Lee, JH Lee, NI Baek, DH Kim |
Biological & Pharmaceutical Bulletin | 2005 |
|
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin
CR Sirtori, L Calabresi, L Pisciotta, L Cattin, P Pauciullo, M Montagnani, E Manzato, GB Bon, R Fellin |
Nutrition, Metabolism and Cardiovascular Diseases | 2005 |
|
Hiperlipemia familiar combinada. Criterios diagnósticos y terapéuticos
EM Ibarra, PM Fuentes, FC Murillo |
Clínica e Investigación en Arteriosclerosis | 2005 |
|
Visión actualizada de la hiperlipidemia familiar combinada aplicada a la mejora de su diagnóstico
J Ribalta, M Castro-Cabezas, N Plana, L Masana |
Clínica e Investigación en Arteriosclerosis | 2005 |
|
Soluble cell adhesion molecules s-vcam-1 and s-icam-1 in subjects with familial combined hyperlipidemia
D Karasek, H Vaverkova, M Halenka, M Budikova, D Novotny |
Biomedical Papers | 2005 |
|
Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia
D Steinberg |
Journal of lipid research | 2005 |
|
Lipid Profile of Children with a Family History of Coronary Heart Disease or Hyperlipidemia: 9-Year Experience of an Outpatient Clinic for the Prevention of Cardiovascular Diseases
A Makedou, M Kourti, K Makedou, S Lazaridou, G Varlamis |
Angiology | 2005 |
|
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia
Y Yu, DF Wyszynski, DM Waterworth, SD Wilton, PJ Barter, YA Kesäniemi, RW Mahley, R McPherson, G Waeber, TP Bersot, Q Ma, SS Sharma, DS Montgomery, LT Middleton, SS Sundseth, V Mooser, SM Grundy, LA Farrer |
Journal of lipid research | 2005 |
|
150kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse
SJ Lee, JH Ko, K Lim, KT Lim |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2005 |
|
Signaling Pathways in Liver Diseases
JF Dufour, PA Clavien, C Trautwein, R Graf |
2005 | |
|
Rat model of familial combined hyperlipidemia as a result of comparative mapping
T Ueno, J Tremblay, J Kunes, J Zicha, Z Dobesova, Z Pausova, AY Deng, YL Sun, HJ Jacob, P Hamet |
Physiological genomics | 2004 |
|
Blasts from the past
PA Insel, S Kornfeld, PW Majerus, AR Marks, PA Marks, AS Relman, BF Scharschmidt, TP Stossel, AP Varki, SJ Weiss, JD Wilson |
Journal of Clinical Investigation | 2004 |
|
Reflecting on 80 years of excellence
U Savla |
Journal of Clinical Investigation | 2004 |
|
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
WL Goff, M Guerin, MJ Chapman |
Pharmacology & Therapeutics | 2004 |
|
Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy
GL Vega |
Endocrinology & Metabolism Clinics of North America | 2004 |
|
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia
ML Liu, RW James, K Ylitalo, MR Taskinen |
Nutrition, Metabolism and Cardiovascular Diseases | 2004 |
|
Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity
K Yamazaki, H Bujo, K Taira, N Itou, M Shibasaki, K Takahashi, Y Saito |
Atherosclerosis | 2004 |
|
TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study
H Coon, N Singh, D Dunn, JH Eckfeldt, MA Province, PN Hopkins, R Weiss, SC Hunt, MF Leppert |
Atherosclerosis | 2004 |
|
Contribution of Chromosome 1q21-q23 to Familial Combined Hyperlipidemia in Mexican Families
A Huertas-Vázquez, JP Rincón, S Canizales-Quinteros, L Riba, G Vega-Hernández, S Ramírez-Jiménez, M Aurón-Gómez, FJ Gómez-Pérez, CA Aguilar-Salinas, MT Tusié-Luna |
Annals of Human Genetics | 2004 |
|
Statin myotoxicity is associated with changes in the cardiopulmonary function
PS Phillips, CT Phillips, MJ Sullivan, RK Naviaux, RH Haas |
Atherosclerosis | 2004 |
|
5-Hydroxy-7-(4′-hydroxy-3′-methoxyphenyl)-1-phenyl-3-heptanone: A Pancreatic Lipase Inhibitor Isolated from Alpinia officinarum
JE Shin, MJ Han, MC Song, NI Baek, DH Kim |
Biological & Pharmaceutical Bulletin | 2004 |
|
Apolipoprotein B as a Marker of Familial Hyperlipoproteinemia
T Sveger, K Nordborg |
Journal of Atherosclerosis and Thrombosis | 2004 |
|
An ω-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia
L Calabresi, B Villa, M Canavesi, CR Sirtori, RW James, F Bernini, G Franceschini |
Metabolism | 2004 |
|
Hypolipidemic effect of different extracts of Clerodendron colebrookianum Walp in normal and high-fat diet fed rats
R Devi, DK Sharma |
Journal of Ethnopharmacology | 2004 |
|
Hiperlipidemias: concepto, clasificación y mecanismo etiopatogénico. Hiperlipidemias primarias
MP Mieras, PM Alonso, PC Gómez |
Medicine - Programa de Formación Médica Continuada Acreditado | 2004 |
|
Diagnóstico y tratamiento de las hiperlipemias familiares
TM Morató, R Alonso, P Mata |
Atención Primaria | 2004 |
|
How more effective diagnosis of familial combined hyperlipidemia could lead to more effective therapy
AD Sniderman, JC Engert, MC Cabezas |
Drug Discovery Today: Disease Mechanisms | 2004 |
|
Abdominal Obesity and Expression of Familial Combined Hyperlipidemia
CJ van der Kallen, C Voors-Pette, TW de Bruin |
Obesity research | 2004 |
|
Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II
W Putt, J Palmen, V Nicaud, DA Tregouet, N Tahri-Daizadeh, DM Flavell, SE Humphries, PJ Talmud |
Human Molecular Genetics | 2004 |
|
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)
P Pajukanta, HE Lilja, JS Sinsheimer, RM Cantor, AJ Lusis, M Gentile, XJ Duan, A Soro-Paavonen, J Naukkarinen, J Saarela, M Laakso, C Ehnholm, MR Taskinen, L Peltonen |
Nature Genetics | 2004 |
|
Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia
HE Lilja, E Suviolahti, A Soro-Paavonen, T Hiekkalinna, A Day, K Lange, E Sobel, MR Taskinen, L Peltonen, M Perola, P Pajukanta |
Journal of lipid research | 2004 |
|
Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia
S Eichenbaum-Voline, M Olivier, EL Jones, RP Naoumova, B Jones, B Gau, HN Patel, M Seed, DJ Betteridge, DJ Galton, EM Rubin, J Scott, CC Shoulders, LA Pennacchio |
Arteriosclerosis, thrombosis, and vascular biology | 2004 |
|
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
MC Carr, JD Brunzell |
The Journal of clinical endocrinology and metabolism | 2004 |
|
Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia
A Nordoy, B Svensson, JB Hansen |
Journal of Thrombosis and Haemostasis | 2003 |
|
Hypercholesterolemia and Dyslipidemia: Issues for the clinician
HR Superko, NA Chronos |
Current Treatment Options in Cardiovascular Medicine | 2003 |
|
Effects of HIV protease inhibitor therapy on lipid metabolism
DY Hui |
Progress in Lipid Research | 2003 |
|
Dyslipidaemia
P Durrington |
The Lancet | 2003 |
|
Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q
P Pajukanta, H Allayee, KL Krass, A Kuraishy, A Soro, HE Lilja, R Mar, MR Taskinen, I Nuotio, M Laakso, JI Rotter, TW de Bruin, RM Cantor, AJ Lusis, L Peltonen |
The American Journal of Human Genetics | 2003 |
|
Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controls
D Delawi, S Meijssen, MC Cabezas |
Clinica Chimica Acta | 2003 |
|
3-Methylethergalangin Isolated from Alpinia officinarum Inhibits Pancreatic Lipase
JE Shin, MJ Han, DH Kim |
Biological & Pharmaceutical Bulletin | 2003 |
|
Novel microsomal triglyceride transfer protein inhibitors
SJ Williams, JD Best |
Expert Opinion on Therapeutic Patents | 2003 |
|
Role of stearoyl-coenzyme A desaturase in lipid metabolism
M Miyazaki, JM Ntambi |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2003 |
|
Screening for Familial Combined Hyperlipidemia in Children Using Lipid Phenotypes
F Iwata, T Okada, Y Kuromori, M Hara, K Harada |
Journal of Atherosclerosis and Thrombosis | 2003 |
|
Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men
A Takahashi-Yasuno, H Masuzaki, T Miyawaki, Y Ogawa, N Matsuoka, T Hayashi, K Hosoda, G Inoue, Y Yoshimasa, K Nakao |
Diabetes Research and Clinical Practice | 2003 |
|
Genetic disorders of lipoprotein transport in children
SB Clauss, PO Kwiterovich |
Progress in Pediatric Cardiology | 2003 |
|
Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia
AF Ayyobi, JD Brunzell |
The American Journal of Cardiology | 2003 |
|
Lung Biology in Health and Disease
N Zamel |
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential | 2003 |
|
Familial hypercholesterolemia—Improving treatment and meeting guidelines
PN Hopkins |
International Journal of Cardiology | 2003 |
|
Disturbed regulation of cholesterol synthesis in monocytes of obese patients with hypercholesterolemia
G Paragh, Z Balogh, E Kovács, M Szabolcs, J Szabó, K Csapó, G Fóris |
Metabolism | 2003 |
|
Determinants of low HDL levels in familial combined hyperlipidemia
A Soro, M Jauhiainen, C Ehnholm, MR Taskinen |
Journal of lipid research | 2003 |
|
Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia
C Verseyden, S Meijssen, H Dijk, H Jansen, MC Cabezas |
Journal of lipid research | 2003 |
|
Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia
MA Austin, KL Edwards, SA Monks, KM Koprowicz, JD Brunzell, AG Motulsky, MC Mahaney, JE Hixson |
Journal of lipid research | 2003 |
|
Xanthoma of Bone: First Sign of Hyperlipidemia Type IIB: A Case Report
D Dallari, A Marinelli, A Pellacani, L Valeriani, C Lesi, F Bertoni, A Giunti |
Clinical Orthopaedics and Related Research® | 2003 |
|
Atherosclerosis, Hypertension and Diabetes
GN Pierce, M Nagano, P Zahradka, NS Dhalla |
2003 | |
|
Atlas of Atherosclerosis
PW Wilson |
2003 | |
|
Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment
F Gagnon, GP Jarvik, AG Motulsky, SS Deeb, JD Brunzell, EM Wijsman |
Human Genetics | 2003 |
|
A mission statement for the JCI at the dawn of the 21st Century
Andrew Marks |
Journal of Clinical Investigation | 2002 |
|
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
Y Hata, H Mabuchi, Y Saito, H Itakura, G Egusa, H Ito, T Teramoto, M Tsushima, N Tada, S Oikawa, N Yamada, S Yamashita, N Sakuma, J Sasaki |
Journal of Atherosclerosis and Thrombosis | 2002 |
|
Dyslipidemia in young Japanese children: its relation to familial hypercholesterolemiaand familial combined hyperlipidemia
T Ohta, K Kiwaki, F Endo, H Umehashi, I Matsuda |
Pediatrics International | 2002 |
|
Mouse Models of Atherosclerosis
A Daugherty |
The American Journal of the Medical Sciences | 2002 |
|
Getting insurance after genetic screening on familial hypercholesterolaemia; the need to educate both insurers and the public to increase adherence to national guidelines in The Netherlands
PJ de Mheen, MC van Maarle, ME Stouthard |
Journal of epidemiology and community health | 2002 |
|
Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids
J Graaf, MJ Veerkamp, AF Stalenhoef |
Journal of the Royal Society of Medicine | 2002 |
|
Relationship inference from trios of individuals, in the presence of typing error
SK Sieberts, EM Wijsman, EA Thompson |
The American Journal of Human Genetics | 2002 |
|
Reduced structural and functional skin capillaries in familial combined hyperlipidemia affected men, associated with increased remnant-like lipoprotein cholesterol levels
ET Keulen, NC Schaper, AJ Houben, JM van Lin, I Lutgens, K Rijkers, GM Dallinga-Thie, TW de Bruin |
Atherosclerosis | 2002 |
|
Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia
K Ylitalo, M Syvänne, R Salonen, I Nuotio, MR Taskinen, JT Salonen |
Atherosclerosis | 2002 |
|
Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia
PM Eurlings, CJ van der Kallen, JM Geurts, DM Flavell, TW de Bruin |
Molecular Genetics and Metabolism | 2002 |
|
Daio-Orengedokuto Inhibits HMG-CoA Reductase and Pancreatic Lipase
YS Kim, EA Jung, JE Shin, JC Chang, HK Yang, NJ Kim, KH Cho, HS Bae, SK Moon, DH Kim |
Biological & Pharmaceutical Bulletin | 2002 |
|
Risk perception of participants in a family-based genetic screening program on familial hypercholesterolemia
MC Maarle, ME Stouthard, GJ Bonsel |
American Journal of Medical Genetics | 2002 |
|
Heritabilities of Apolipoprotein and Lipid Levels in Three Countries
M Beekman, BT Heijmans, NG Martin, NL Pedersen, JB Whitfield, U DeFaire, GC van Baal, H Snieder, GP Vogler, PE Slagboom, DI Boomsma |
Twin Research and Human Genetics | 2002 |
|
An Internist???s Update on Cholesterol Management
HE Holman, GS Hicks, AK Low, MJ Bouldin, LD Russell, CA Friedrich, CA Brown |
The American Journal of the Medical Sciences | 2002 |
|
Familial Combined Hyperlipidemia (FCHL) in Children: The Significance of Early Development of HyperapoB Lipoproteinemia, Obesity and Aging
Y Kuromori, T Okada, F Iwata, M Hara, N Noto, K Harada |
Journal of Atherosclerosis and Thrombosis | 2002 |
|
A proposal to redefine familial combined hyperlipidaemia - Third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the Scientific Sessions of the European Society for Clinical Investigation
AD Sniderman, MC Cabezas, J Ribalta, R Carmena, TW de Bruin, J Graaf, DW Erkelens, SE Humphries, L Masana, JT Real, PJ Talmud, MR Taskinen |
European Journal of Clinical Investigation | 2002 |
|
Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents
J Lapinleimu, IO Nuotio, H Lapinleimu, OG Simell, L Rask-Nissilä, JS Viikari |
Atherosclerosis | 2002 |
|
contribution of major cardiovascular risk factors to familial premature coronary artery disease
V Jomini, S Oppliger-Pasquali, V Wietlisbach, N Rodondi, V Jotterand, F Paccaud, R Darioli, P Nicod, V Mooser |
Journal of the American College of Cardiology | 2002 |
|
N-3 fatty acids and diabetes
CR Sirtori, C Galli |
Biomedicine & Pharmacotherapy | 2002 |
|
Angptl3 regulates lipid metabolism in mice
R Koishi, Y Ando, M Ono, M Shimamura, H Yasumo, T Fujiwara, H Horikoshi, H Furukawa |
Nature Genetics | 2002 |
|
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
PO Kwiterovich |
The American Journal of Cardiology | 2002 |
|
Combination therapy for combined dyslipidemia
AM Xydakis, CM Ballantyne |
The American Journal of Cardiology | 2002 |
|
Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia
J Vakkilainen, P Pajukanta, RM Cantor, IO Nuotio, S Lahdenperä, K Ylitalo, J Pihlajamäki, PT Kovanen, M Laakso, JS Viikari, L Peltonen, MR Taskinen |
European Journal of Human Genetics | 2002 |
|
Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia
AD Attie, RM Krauss, MP Gray-Keller, A Brownlie, M Miyazaki, JJ Kastelein, AJ Lusis, AF Stalenhoef, JP Stoehr, MR Hayden, JM Ntambi |
Journal of lipid research | 2002 |
|
Hypertriglyceridemia: A Review Beyond Low-Density Lipoprotein:
RJ Rapp |
Cardiology in Review | 2002 |
|
Locus for Elevated Apolipoprotein B Levels on Chromosome 1p31 in Families With Familial Combined Hyperlipidemia
H Allayee, KL Krass, P Pajukanta, R M., CJ van der Kallen, R Mar, JI Rotter, TW de Bruin, L Peltonen, AJ Lusis |
Circulation research | 2002 |
|
Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families: Results of a 5-Year Follow-Up Study
MJ Veerkamp, J de Graaf, SJ Bredie, JC Hendriks, PN Demacker, AF Stalenhoef |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
|
Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B
ET Keulen, M Kruijshoop, NC Schaper, AP Hoeks, TW de Bruin |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
|
Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia
S Meijssen, H van Dijk, C Verseyden, DW Erkelens, MC Cabezas |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
|
Association Between Carotid Intima-Media Thickness and Low-Density Lipoprotein Size and Susceptibility of Low-Density Lipoprotein to Oxidation in Asymptomatic Members of Familial Combined Hyperlipidemia Families
ML Liu, K Ylitalo, I Nuotio, R Salonen, JT Salonen, MR Taskinen |
Stroke; a journal of cerebral circulation | 2002 |
|
In Vivo Modulation of Plasma Free Fatty Acids in Patients with Familial Combined Hyperlipidemia Using Lipid-Lowering Medication
S Meijssen, RJ Derksen, S Bilecen, DW Erkelens, MC Cabezas |
The Journal of clinical endocrinology and metabolism | 2002 |
|
Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia
C Verseyden, S Meijssen, MC Cabezas |
Journal of lipid research | 2002 |
|
LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
J Vakkilainen, M Jauhiainen, K Ylitalo, IO Nuotio, JS Viikari, C Ehnholm, MR Taskinen |
Journal of lipid research | 2002 |
|
Identification of differentially expressed genes in subcutaneous adipose tissue from subjects with familial combined hyperlipidemia
PM Eurlings, CJ van der Kallen, JM Geurts, P Kouwenberg, WD Boeckx, TW de Bruin |
Journal of lipid research | 2002 |
|
Newly Identified Apolipoprotein AV Gene Predisposes to High Plasma Triglycerides in Familial Combined Hyperlipidemia
J Ribalta, L Figuera, J Fernández-Ballart, E Vilella, MC Cabezas, L Masana, J Joven |
Clinical chemistry | 2002 |
|
Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia
M Groenendijk, RM Cantor, H Funke, GM Dallinga-Thie |
European Journal of Clinical Investigation | 2001 |
|
Monogenic Dyslipidemias: Window on Determinants of Plasma Lipoprotein Metabolism
RA Hegele |
The American Journal of Human Genetics | 2001 |
|
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
C Lahoz, EJ Schaefer, LA Cupples, PW Wilson, D Levy, D Osgood, S Parpos, J Pedro-Botet, JA Daly, JM Ordovas |
Atherosclerosis | 2001 |
|
Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia
H Kim, SM Marcovina, KL Edwards, B McKnight, CM Bradley, MJ McNeely, BM Psaty, AG Motulsky, MA Austin |
Clinical Genetics | 2001 |
|
Insulin resistance in the St. Thomas' mixed hyperlipidaemic (SMHL) rabbit, a model for familial combined hyperlipidaemia
B Roos |
Atherosclerosis | 2001 |
|
Genetic Dissection of Familial Combined Hyperlipidemia
PM Eurlings, CJ van der Kallen, JM Geurts, MM van Greevenbroek, TW de Bruin |
Molecular Genetics and Metabolism | 2001 |
|
Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity
C Voors-Pette, TW de Bruin |
Atherosclerosis | 2001 |
|
Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study
MJ McNeely, KL Edwards, SM Marcovina, JD Brunzell, AG Motulsky, MA Austin |
Atherosclerosis | 2001 |
|
Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the −93G/D9N variant predisposes to low HDL-C/high triglycerides
ME Samuels, KC Forbey, JE Reid, V Abkevich, K Bulka, BR Wardell, BR Bowen, PN Hopkins, SC Hunt, DG Ballinger, MH Skolnick, S Wagner |
Clinical Genetics | 2001 |
|
The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance
J Pihlajamaki, R Valve, L Karjalainen, P Karhapaa, I Vauhkonen, M Laakso |
European Journal of Clinical Investigation | 2001 |
|
Coronary Heart Disease, Hypercholesterolemia, and Atherosclerosis I. False Premises
WE Stehbens |
Experimental and Molecular Pathology | 2001 |
|
Coronary Heart Disease, Hypercholesterolemia, and Atherosclerosis II. Misrepresented Data
WE Stehbens |
Experimental and Molecular Pathology | 2001 |
|
Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia
M Miller, C Dolinar, W Cromwell, JD Otvos |
The American Journal of Cardiology | 2001 |
|
Pediatric Gastroenterology and Nutrition in Clinical Practice
B Stoll, D Burrin |
Pediatric Gastroenterology and Nutrition in Clinical Practice | 2001 |
|
Hyperlipidemia in children and adolescents
AM Valente, JW Newburger, RM Lauer |
American Heart Journal | 2001 |
|
Erratum: Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency
XC Jiang, S Qin, C Qiao, K Kawano, M Lin, A Skold, X Xiao, AR Tall |
Nature Medicine | 2001 |
|
Relationship of Insulin Sensitivity and ApoB Levels to Intra-abdominal Fat in Subjects With Familial Combined Hyperlipidemia
JQ Purnell, SE Kahn, RS Schwartz, JD Brunzell |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
|
Familial Combined Hyperlipidemia and Insulin Resistance: Distant Relatives Linked by Intra-abdominal Fat?
RH Eckel |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
|
Analysis of the Ileal Bile Acid Transporter Gene, SLC10A2 , in Subjects With Familial Hypertriglyceridemia
MW Love, AL Craddock, B Angelin, JD Brunzell, WC Duane, PA Dawson |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
|
Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p
H Allayee, TW de Bruin, KM Dominguez, LS Cheng, E Ipp, R M., KL Krass, ET Keulen, BE Aouizerat, AJ Lusis, JI Rotter |
Hypertension | 2001 |
|
Positional cloning of the combined hyperlipidemia gene Hyplip1
JS Bodnar, A Chatterjee, LW Castellani, DA Ross, J Ohmen, J Cavalcoli, C Wu, KM Dains, J Catanese, M Chu, SS Sheth, K Charugundla, P Demant, DB West, P de Jong, AJ Lusis |
Nature Genetics | 2001 |
|
New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia
M Groenendijk, R M., TW Bruin, GM Dallinga-Thie |
Journal of lipid research | 2001 |
|
Hypercholesterolemia and dyslipidemia
HR Superko |
Current Treatment Options in Cardiovascular Medicine | 2000 |
|
Lipid metabolism
J Stocks |
Current Opinion in Lipidology | 2000 |
|
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow |
Annual Review of Genetics | 2000 |
|
Evidence of Linkage of Familial Hypoalphalipoproteinemia to a Novel Locus on Chromosome 11q23
EN Kort, DG Ballinger, W Ding, SC Hunt, BR Bowen, V Abkevich, K Bulka, B Campbell, C Capener, A Gutin, K Harshman, M McDermott, T Thorne, H Wang, B Wardell, J Wong, PN Hopkins, M Skolnick, M Samuels |
The American Journal of Human Genetics | 2000 |
|
Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
L Calabresi, D Donati, F Pazzucconi, CR Sirtori, G Franceschini |
Atherosclerosis | 2000 |
|
Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families
K Ylitalo, V Large, P Pajukanta, S Reynisdottir, KV Porkka, J Vakkilainen, I Nuotio, MR Taskinen, P Arner |
Atherosclerosis | 2000 |
|
Hereditary dyslipidemias and combined risk factors in children with a family history of premature coronary artery disease
T Sveger, CE Flodmark, K Nordborg, P Nilsson-Ehle, N Borgfors |
Archives of disease in childhood | 2000 |
|
One-Year Effects of Increasingly Fat-Restricted, Carbohydrate-Enriched Diets on Lipoprotein Levels in Free-Living Subjects
RH Knopp, B Retzlaff, C Walden, B Fish, B Buck, B McCann |
Proceedings of the Society for Experimental Biology and Medicine | 2000 |
|
Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype
MA Austin |
Current Atherosclerosis Reports | 2000 |
|
Les dyslipoprotéinémies athérogènes
G Turpin, E Bruckert, P Giral |
Annales de l'Institut Pasteur/Actualités | 2000 |
|
Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia
PN Demacker, MJ Veerkamp, SJ Bredie, SM Marcovina, J Graaf, AF Stalenhoef |
Atherosclerosis | 2000 |
|
The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia
MJ Hoffer, H Snieder, SJ Bredie, PN Demacker, JJ Kastelein, RR Frants, AF Stalenhoef |
Atherosclerosis | 2000 |
|
Introduction: Low-Saturated Fat, High-Carbohydrate Diets: Effects on Triglyceride and LDL Synthesis, the LDL Receptor, and Cardiovascular Disease Risk
RH Knopp |
Proceedings of the Society for Experimental Biology and Medicine | 2000 |
|
Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families
W Pei, H Baron, B Müller-Myhsok, H Knoblauch, SA Al-Yahyaee, R Hui, X Wu, L Liu, A Busjahn, FC Luft, H Schuster |
Clinical Genetics | 2000 |
|
Hypocholesterolemic effects of crude extract of leaf of Moringa oleifera Lam in high-fat diet fed wistar rats
S Ghasi, E Nwobodo, JO Ofili |
Journal of Ethnopharmacology | 2000 |
|
Hypertriglyceridemia and Low High-Density Lipoprotein: Risks for Coronary Artery Disease?:
C Lamendola |
The Journal of cardiovascular nursing | 2000 |
|
Prevention of coronary heart disease
PR Liebson, EA Amsterdam |
Disease-a-Month | 2000 |
|
Preventing, stopping, or reversing coronary artery disease— triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: The need for recognition and treatment
EE Ferguson |
Disease-a-Month | 2000 |
|
Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm
A D Sniderman, X J Zhang, K Cianflone |
Atherosclerosis | 2000 |
|
Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A
CJ der Kallen, RM Cantor, MM Greevenbroek, JM Geurts, FG Bouwman, BE Aouizerat, H Allayee, WA Buurman, AJ Lusis, JI Rotter, TW Bruin |
International Journal of Obesity | 2000 |
|
Cardiovascular risk factors and testing of relatives amongst patients with familial hyperlipidaemia one decade after a clinical trial
S Tonstad, I Hjermann |
Journal of Internal Medicine | 2000 |
|
Effect of ω-3 Fatty Acids and Simvastatin on Hemostatic Risk Factors and Postprandial Hyperlipemia in Patients With Combined Hyperlipemia
A Nordøy, KH Bønaa, PM Sandset, JB Hansen, H Nilsen |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
|
Impaired Free Fatty Acid Suppression During Hyperinsulinemia Is a Characteristic Finding in Familial Combined Hyperlipidemia, but Insulin Resistance Is Observed Only in Hypertriglyceridemic Patients
J Pihlajamäki, L Karjalainen, P Karhapää, I Vauhkonen, M Laakso |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
|
Cardiovascular Disease Mortality in Familial Forms of Hypertriglyceridemia: A 20-Year Prospective Study
MA Austin, B McKnight, KL Edwards, CM Bradley, MJ McNeely, BM Psaty, JD Brunzell, AG Motulsky |
Circulation | 2000 |
|
Replication of Linkage of Familial Combined Hyperlipidemia to Chromosome 1q With Additional Heterogeneous Effect of Apolipoprotein A-I/C-III/A-IV Locus: The NHLBI Family Heart Study
H Coon, RH Myers, IB Borecki, DK Arnett, SC Hunt, MA Province, L Djousse, MF Leppert |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
|
Genetic Localization to Chromosome 1p32 of the Third Locus for Familial Hypercholesterolemia in a Utah Kindred
SC Hunt, PN Hopkins, K Bulka, MT McDermott, TL Thorne, BB Wardell, BR Bowen, DG Ballinger, MH Skolnick, ME Samuels |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
|
Prevention Conference V: Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Medical Office Assessment : Writing Group I
SM Grundy, T Bazzarre, J Cleeman, RB DAgostino, M Hill, N Houston-Miller, WB Kannel, R Krauss, HM Krumholz, RM Lauer, IS Ockene, RC Pasternak, T Pearson, PM Ridker, D Wood |
Circulation | 2000 |
|
G-250A Substitution in Promoter of Hepatic Lipase Gene Is Associated With Dyslipidemia and Insulin Resistance in Healthy Control Subjects and in Members of Families With Familial Combined Hyperlipidemia
J Pihlajamäki, L Karjalainen, P Karhapää, I Vauhkonen, MR Taskinen, SS Deeb, M Laakso |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
|
Lipoprotein Metabolism and Atherogenesis
T Kita, M Yokode |
2000 | |
|
Homocysteine and Vascular Disease
K Robinson |
2000 | |
|
Age-related Increases in Plasma Phosphatidylcholine Hydroperoxide Concentrations in Control Subjects and Patients with Hyperlipidemia
M Kinoshita, S Oikawa, K Hayasaka, A Sekikawa, T Nagashima, T Toyota, T Miyazawa |
Clinical chemistry | 2000 |
|
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
JC Escolà-Gil, J Julve, À Marzal-Casacuberta, J Ordóñez-Llanos, F González-Sastre, F Blanco-Vaca |
Journal of lipid research | 2000 |
|
In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia
S Meijssen, MC Cabezas, TB Twickler, H Jansen, DW Erkelens |
Journal of lipid research | 2000 |
|
Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers: potential interaction with the polymorphic marker D1S104 on chromosome 1q21–q23
B Hölzl, HG Kraft, H Wiebusch, A Sandhofer, J Patsch, F Sandhofer, B Paulweber |
Journal of lipid research | 2000 |
|
Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia
H Allayee, KM Dominguez, BE Aouizerat, RM Krauss, JI Rotter, J Lu, R M., TW de Bruin, AJ Lusis |
Journal of lipid research | 2000 |
|
Insulin resistance and familial dyslipidaemias
JF Ascaso, JT Real, R Carmena |
Diabetes, Obesity and Metabolism | 1999 |
|
PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia
A Cenarro, E Casao, F Civeira, HK Jensen, O Færgeman, M Pocovı́ |
Atherosclerosis | 1999 |
|
Novel genes for familial combined hyperlipidemia
BE Aouizerat, H Allayee, J Bodnar, KL Krass, L Peltonen, TW de Bruin, JI Rotter, AJ Lusis |
Current Opinion in Lipidology | 1999 |
|
Genomewide Scan for Familial Combined Hyperlipidemia Genes in Finnish Families, Suggesting Multiple Susceptibility Loci Influencing Triglyceride, Cholesterol, and Apolipoprotein B Levels
P Pajukanta, JD Terwilliger, M Perola, T Hiekkalinna, I Nuotio, P Ellonen, M Parkkonen, J Hartiala, K Ylitalo, J Pihlajamäki, K Porkka, M Laakso, J Viikari, C Ehnholm, MR Taskinen, L Peltonen |
The American Journal of Human Genetics | 1999 |
|
A Genome Scan for Familial Combined Hyperlipidemia Reveals Evidence of Linkage with a Locus on Chromosome 11
BE Aouizerat, H Allayee, RM Cantor, RC Davis, CD Lanning, PZ Wen, GM Dallinga-Thie, TW de Bruin, JI Rotter, AJ Lusis |
The American Journal of Human Genetics | 1999 |
|
Genetics of familial combined hyperlipidemia
P Pajukanta, KV Porkka |
Current Atherosclerosis Reports | 1999 |
|
Studies in hypertriglyceridaemia VI: serum lathosterol concentration is raised in hypertriglyceridaemic non-diabetic males with hyperinsulinaemia
A Asplund-Carlson, E Lund, I Bjorkhem, LA Carlson |
Journal of Internal Medicine | 1999 |
|
Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia
N Nakamura, T Hamazaki, M Ohta, K Okuda, M Urakaze, S Sawazaki, K Yamazaki, A Satoh, R Temaru, Y Ishikura, M Takata, M Kishida, M Kobayashi |
International Journal of Clinical & Laboratory Research | 1999 |
|
Elementary phenotypes in the neurobiological and genetic study of schizophrenia
LE Adler, R Freedman, RG Ross, A Olincy, MC Waldo |
Biological Psychiatry | 1999 |
|
Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: Additive effects of combination treatment on lipid regulation
D Zambón, E Ros, C Rodriguez-Villar, JC Laguna, M Vázquez, C Sanllehy, E Casals, JM Sol, G Hernández |
Metabolism | 1999 |
|
ROLE OF THE ENTEROHEPATIC CIRCULATION OF BILE SALTS IN LIPOPROTEIN METABOLISM
AD Cooper |
Gastroenterology Clinics of North America | 1999 |
|
Nutrition
&NA; |
Current Opinion in Lipidology | 1999 |
|
Drug Treatment of Lipid Disorders
AJ Wood, RH Knopp |
New England Journal of Medicine | 1999 |
|
Role of fibrates in the management of hypertriglyceridemia
DJ Rader, SM Haffner |
The American Journal of Cardiology | 1999 |
|
Combined hyperlipidemia as a risk factor for premature atherosclerotic disease
C East |
The American Journal of Medicine | 1999 |
|
Epidemiology of hypertriglyceridemia and cardiovascular disease
MA Austin |
The American Journal of Cardiology | 1999 |
|
Familial Hypercholesterolemia in Utah Kindred with Novel 2412-6 Ins G Mutations in Exon 17 of the LDL Receptor Gene
Y NOBE, M EMI, H KATSUMATA, T NAKAJIMA, T HIRAYAMA, LL WU, SH STEPHENSON, PN HOPKINS, RR WILLIAMS |
Japanese Heart Journal | 1999 |
|
Coronary Flow Reserve in Young Men With Familial Combined Hyperlipidemia
OP Pitkänen, P Nuutila, OT Raitakari, K Porkka, H Iida, I Nuotio, T Rönnemaa, J Viikari, MR Taskinen, C Ehnholm, J Knuuti |
Circulation | 1999 |
|
Linkage of a Candidate Gene Locus to Familial Combined Hyperlipidemia: Lecithin:Cholesterol Acyltransferase on 16q
BE Aouizerat, H Allayee, R M., GM Dallinga-Thie, CD Lanning, TW de Bruin, AJ Lusis, JI Rotter |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
|
Mutations in the lipoprotein lipase Gene Associated With Ischemic Heart Disease in Men: The Copenhagen City Heart Study
HH Wittrup, A Tybjærg-Hansen, R Steffensen, SS Deeb, JD Brunzell, G Jensen, BG Nordestgaard |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
|
Pleiotropic Genetic Effects on LDL Size, Plasma Triglyceride, and HDL Cholesterol in Families
KL Edwards, MC Mahaney, AG Motulsky, MA Austin |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
|
Contemporary Concepts in Cardiology
R Gorlin, G Dangas, PK Toutouzas, MM Konstadoulakis |
1999 | |
|
Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains
E Voyiaziakis, C Ko, SM O'Rourke, LS Huang |
Journal of lipid research | 1999 |
|
Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia
J Ribalta, J Girona, JC Vallvé, AE Ville, M Heras, L Masana |
Journal of lipid research | 1999 |
|
Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
M Groenendijk, R, NH Blom, JI Rotter, TW de Bruin, GM Dallinga-Thie |
Journal of lipid research | 1999 |
|
Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit
HA Ardern, GM Benson, KE Suckling, MJ Caslake, J Shepherd, CJ Packard |
Journal of lipid research | 1999 |
|
GENETICS OF LIPOPROTEIN DISORDERS
J Davignon, J Genest |
Endocrinology & Metabolism Clinics of North America | 1998 |
|
Defects of lipoprotein metabolism in familial combined hyperlipidaemia
J Graaf, AF Stalenhoef |
Current Opinion in Lipidology | 1998 |
|
Gender-related association between the −93T→G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia
MJ Hoffer, SJ Bredie, H Snieder, PW Reymer, PN Demacker, LM Havekes, DI Boomsma, AF Stalenhoef, RR Frants, JJ Kastelein |
Atherosclerosis | 1998 |
|
Glucose intolerance in familial combined hyperlipidaemia
Vakkilainen, Porkka, Nuotio, Pajukanta, Suurinkeroinen, Ylitalo, Viikari, Ehnholm, Taskinen |
European Journal of Clinical Investigation | 1998 |
|
Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype
H Allayee, BE Aouizerat, RM Cantor, GM Dallinga-Thie, RM Krauss, CD Lanning, JI Rotter, AJ Lusis, TW de Bruin |
The American Journal of Human Genetics | 1998 |
|
A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia
SH Juo, SJ Bredie, LA Kiemeney, PN Demacker, AF Stalenhoef |
The American Journal of Human Genetics | 1998 |
|
Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins
MA Austin, PJ Talmud, LA Luong, L Haddad, IN Day, B Newman, KL Edwards, RM Krauss, SE Humphries |
The American Journal of Human Genetics | 1998 |
|
A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients
JF Ascaso, A Merchante, RI Lorente, JT Real, J Martinez-Valls, R Carmena |
Metabolism | 1998 |
|
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
D Wood, GD Backer, O Faergeman, I Graham, G Mancia, K Pyörälä |
Atherosclerosis | 1998 |
|
Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in Familial combined hyperlipidemia
J Ribalta, AE la Ville, JC Vallvé, J Girona, L Masana |
Atherosclerosis | 1998 |
|
Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians
D Gaudet, MC Vohl, P Julien, G Tremblay, P Perron, C Gagné, J Bergeron, S Moorjani, JP Després |
The American Journal of Cardiology | 1998 |
|
Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the β3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia
J Pihlajamäki, J Rissanen, R Valve, S Heikkinen, L Karjalainen, M Laakso |
Metabolism | 1998 |
|
Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23
P Pajukanta, I Nuotio, JD Terwilliger, KV Porkka, K Ylitalo, J Pihlajamäki, AJ Suomalainen, AC Syvänen, T Lehtimäki, JS Viikari, M Laakso, MR Taskinen, C Ehnholm, L Peltonen |
Nature Genetics | 1998 |
|
Mapping a gene for combined hyperlipidaemia in a mutant mouse strain
LW Castellani, A Weinreb, J Bodnar, AM Goto, M Doolittle, M Mehrabian, P Demant, AJ Lusis |
Nature Genetics | 1998 |
|
Serum Lipid Physiology and the Influence of Glaucoma Medications
WC Stewart, J Osterman |
Survey of Ophthalmology | 1998 |
|
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner |
Advances in Protein Chemistry | 1998 |
|
Use of Niacin, Statins, and Resins in Patients With Combined Hyperlipidemia
BG PhD, AZ MD, DP BS, AR MS, VM MD, JW BS, JJ PhD, JD MD |
The American Journal of Cardiology | 1998 |
|
Markedly high prevalence of coronary risk factors in apparently healthy african-american and white siblings of persons with premature coronary heart disease
DM Becker, RM Yook, TF Moy, RS Blumenthal, LC Becker |
The American Journal of Cardiology | 1998 |
|
Role of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (“Statins”) in Familial Combined Hyperlipidemia
GS MD, CA MD, NE MD |
The American Journal of Cardiology | 1998 |
|
Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia
E Tahvanainen, P Pajukanta, K Porkka, S Nieminen, L Ikävalko, I Nuotio, MR Taskinen, L Peltonen, C Ehnholm |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
|
Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia
Y Huang, XQ Liu, SC Rall, JM Taylor, A Eckardstein, G Assmann, RW Mahley |
The Journal of biological chemistry | 1998 |
|
Impaired Insulin-Stimulated Glucose Oxidation and Free Fatty Acid Suppression in Patients with Familial Combined Hyperlipidemia: A Precursor Defect for Dyslipidemia?
L Karjalainen, J Pihlajamäki, P Karhapää, M Laakso |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
|
The Adipocyte, Fatty Acid Trapping, and Atherogenesis
AD Sniderman, K Cianflone, P Arner, LK Summers, KN Frayn |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
|
Evidence Against Linkage of Familial Combined Hyperlipidemia to the Apolipoprotein AI-CIII-AIV Gene Complex
EM Wijsman, JD Brunzell, GP Jarvik, MA Austin, AG Motulsky, SS Deeb |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
|
Klinische Angiologie
H Rieger, W Schoop |
1998 | |
|
Herz-Kreislauf-Erkrankungen
D Ganten, K Ruckpaul |
1998 | |
|
Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes
GM Dallinga-Thie, ML Trip, JI Rotter, RM Cantor, X Bu, AJ Lusis, TW de Bruin |
Journal of Clinical Investigation | 1997 |
|
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies
JE Hokanson |
International Journal of Clinical & Laboratory Research | 1997 |
|
The Relationship of Conjoint Traits of Dyslipidemias between Young Offspring and Their Parents in a Community-Based Sample
W Chen, SR Srinivasan, W Bao, WA Wattigney, GS Berenson |
Preventive Medicine | 1997 |
|
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD |
The Annals of Thoracic Surgery | 1997 |
|
Genetics of type III hyperlipoproteinemia
G Feussner, S Piesch, J Dobmeyer, C Fischer |
Genetic Epidemiology | 1997 |
|
The acylation stimulating protein pathway: Clinical implications
K Cianflone |
Clinical Biochemistry | 1997 |
|
Gene therapy for atherosclerosis
DJ Rader |
International Journal of Clinical & Laboratory Research | 1997 |
|
Phenotype expression in familial combined hyperlipidemia
KV Porkka, I Nuotio, P Pajukanta, C Ehnholm, L Suurinkeroinen, M Syvänne, T Lehtimäki, AT Lahdenkari, S Lahdenperä, K Ylitalo, M Antikainen, M Perola, OT Raitakari, P Kovanen, JS Viikari, L Peltonen, MR Taskinen |
Atherosclerosis | 1997 |
|
Ziele und praktische Durchführung der Lipidtherapie bei koronarer Herzkrankheit
FU Beil, E Windler |
Herz | 1997 |
|
Comparison of Pravastatin With Crystalline Nicotinic Acid Monotherapy in Treatment of Combined Hyperlipidemia
JM MD, IS MD, GL PhD, SM PhD |
The American Journal of Cardiology | 1997 |
|
Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels
S Pay, N Özcan, SL Tokgözoğlu |
International Journal of Cardiology | 1997 |
|
Serum complement and familial combined hyperlipidemia
K Ylitalo, KV Porkka, S Meri, I Nuotio, L Suurinkeroinen, J Vakkilainen, P Pajukanta, JS Viikari, L Peltonen, C Ehnholm, MR Taskinen |
Atherosclerosis | 1997 |
|
Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia
C Napoli, S Lepore, P Chiariello, M Condorelli, M Chiariello |
Journal of cardiovascular pharmacology and therapeutics | 1997 |
|
Frequencies of a C-T Mutation in Lipoprotein Lipase and a G-A Mutation in Alipoprotein-A1 in Saudi Arabia
J Buraiki, AI Butt, SS Hussain |
Annals of Saudi medicine | 1997 |
|
Detection and characterization of a novel splice mutation in the LDL receptor intron 12 resulting in two different mutant mRNA variants
H Nissen, AB Hansen, P Guldberg, NE Petersen, TS Hansen, M Hørder |
Atherosclerosis | 1997 |
|
A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin
P Nestel, L Simons, P Barter, P Clifton, D Colquhoun, I Hamilton-Craig, K Sikaris, D Sullivan |
Atherosclerosis | 1997 |
|
The Redox Status of Coenzyme Q10 in Total LDL as an Indicator of In Vivo Oxidative Modification: Studies on Subjects With Familial Combined Hyperlipidemia
YB de Rijke, SJ Bredie, PN Demacker, JM Vogelaar, HL Hak-Lemmers, AF Stalenhoef |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Defects of Insulin Action on Fatty Acid and Carbohydrate Metabolism in Familial Combined Hyperlipidemia
TJ Aitman, IF Godsland, B Farren, D Crook, HJ Wong, J Scott |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Segregation Analysis of Plasma Apolipoprotein B Levels in Familial Combined Hyperlipidemia
SJ Bredie, J van Drongelen, LA Kiemeney, PN Demacker, TH Beaty, AF Stalenhoef |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
No Evidence of Linkage Between Familial Combined Hyperlipidemia and Genes Encoding Lipolytic Enzymes in Finnish Families
P Pajukanta, KV Porkka, M Antikainen, MR Taskinen, M Perola, S Murtomäki-Repo, S Ehnholm, I Nuotio, L Suurinkeroinen, AT Lahdenkari, AC Syvänen, JS Viikari, C Ehnholm, L Peltonen |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Codon 54 Polymorphism of the Human Intestinal Fatty Acid Binding Protein 2 Gene Is Associated With Dyslipidemias But Not With Insulin Resistance in Patients With Familial Combined Hyperlipidemia
J Pihlajamäki, J Rissanen, S Heikkinen, L Karjalainen, M Laakso |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Etiologic Heterogeneity of Hyperapobetalipoproteinemia (HyperapoB): Results From Segregation Analysis in Families With Premature Coronary Artery Disease
SH Juo, TH Beaty, PO Kwiterovich |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Heritability Analysis of Lipids and Three Gene Loci in Twins Link the Macrophage Scavenger Receptor to HDL Cholesterol Concentrations
H Knoblauch, A Busjahn, S Münter, Z Nagy, HD Faulhaber, H Schuster, FC Luft |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Nonobese Patients With Familial Combined Hyperlipidemia Are Insulin Resistant Compared With Their Nonaffected Relatives
SJ Bredie, CJ Tack, P Smits, AF Stalenhoef |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia
J Ribalta, AE Ville, JC Vallvé, S Humphries, PR Turner, L Masana |
Journal of lipid research | 1997 |
|
Low plasma vitamin A concentrations in familial combined hyperlipidemia
J Ribalta, AE LaVille, J Girona, JC Vallvé, L Masana |
Clinical chemistry | 1997 |
|
Hyperlipidemias
GG Russo |
Clinics in Dermatology | 1996 |
|
High density lipoproteins and coronary heart disease
PJ Barter, KA Rye |
Atherosclerosis | 1996 |
|
The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood
R Shamir, AM Tershakovec, PR Gallagher, CA Liacouras, LL Hayman, JA Cortner |
Atherosclerosis | 1996 |
|
Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the “French Canadian Mutation”
L Yu, S Qiu, J Genest |
Atherosclerosis | 1996 |
|
Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia
TW de Bruin, F Mailly, HH van Barlingen, R Fisher, MC Cabezas, P Talmud, GM Dallinga-Thie, SE Humphries |
European Journal of Clinical Investigation | 1996 |
|
In vitro lipolysis of human VLDL: Effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia
HH van Barlingen, LA Kock, FH de Man, DW Erkelens, TW de Bruin |
Atherosclerosis | 1996 |
|
The lipoprotein lipase (Asn291 → Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia
MJ Hoffer, SJ Bredie, DI Boomsma, PW Reymer, JJ Kastelein, P Knijff, PN Demacker, AF Stalenhoef, LM Havekes, RR Frants |
Atherosclerosis | 1996 |
|
Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity
SS Deeb, DN Nevin, L Iwasaki, JD Brunzell |
Human Mutation | 1996 |
|
Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia
SJ Bredie, LA Kiemeney, AF de Haan, PN Demacker, AF Stalenhoef |
The American Journal of Human Genetics | 1996 |
|
Recent trends in the consumption of lipid-lowering drugs in Finland
J Martikainen, T Klaukka, A Reunanen, S Peura, H Wahlroos |
Journal of Clinical Epidemiology | 1996 |
|
Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia
SJ Bredie, JM Vogelaar, PN Demacker, AF Stalenhoef |
Atherosclerosis | 1996 |
|
Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia
H Baron, S Fung, A Aydin, S Bähring, FC Luft, H Schuster |
Nature Biotechnology | 1996 |
|
TREATMENT OF DYSLIPIDEMIAS
PH MD |
Endocrine Practice | 1996 |
|
Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects
JS Cohn, M Tremblay, M Amiot, D Bouthillier, M Roy, J Genest, J Davignon |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
|
Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined Hyperlipidemia
M Guérin, E Bruckert, PJ Dolphin, G Turpin, MJ Chapman |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
|
Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes: A Preliminary Report
DL Sprecher, BV Harris, EA Stein, PS Bellet, LM Keilson, LA Simbartl |
Circulation | 1996 |
|
Herzkrankheiten
H Roskamm, H Reindell |
1996 | |
|
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson |
1996 | |
|
Analysis of Apolipoproteins
MF Laker, K Evans |
Annals of Clinical Biochemistry | 1996 |
|
Interaction of the lipoprotein lipase asparagine 291–>serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults
RM Fisher, F Mailly, RE Peacock, A Hamsten, M Seed, JS Yudkin, U Beisiegel, G Feussner, G Miller, SE Humphries |
Journal of lipid research | 1996 |
|
Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects
M Marcil, B Boucher, E Gagné, J Davignon, M Hayden, J Genest |
Journal of lipid research | 1996 |
|
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease
WS Yang, DN Nevin, L Iwasaki, R Peng, BG Brown, JD Brunzell, SS Deeb |
Journal of lipid research | 1996 |
|
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway
J Bjorkegren, CJ Packard, A Hamsten, D Bedford, M Caslake, L Foster, J Shepherd, P Stewart, F Karpe |
Journal of lipid research | 1996 |
|
Monomethylethanolamine reduces plasma triacylglycerols and apolipoprotein B and increases apolipoprotein A-I rats without induction of fatty liver
AE Rusiñol, PS Lysak, GT Sigurdson, JE Vance |
Journal of lipid research | 1996 |
|
Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III
GM Dallinga-Thie, XD Bu, M van Linde-Sibenius Trip, JI Rotter, AJ Lusis, TW de Bruin |
Journal of lipid research | 1996 |
|
Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia
S Reynisdottir, M Eriksson, B Angelin, P Arner |
Journal of Clinical Investigation | 1995 |
|
Lipids and atherosclerosis
MJ Halpern |
Molecular Aspects of Medicine | 1995 |
|
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity
WS Yang, DN Nevin, R Peng, JD Brunzell, SS Deeb |
Proceedings of the National Academy of Sciences | 1995 |
|
FH Tulsa-1 and -2: Two unique alleles for familial hypercholesterolemia presenting in an affected two-year-old African-American male
PR Blackett, DH Altmiller, D Jelley, DP Wilson |
American Journal of Medical Genetics | 1995 |
|
Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women
B Solymoss, M Marcil, M Chaour, B Gilfix, A Poitras, L Campeau |
The American Journal of Cardiology | 1995 |
|
Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability
SJ Bredie, TW de Bruin, PN Demacker, JJ Kastelein, AF Stalenhoef |
The American Journal of Cardiology | 1995 |
|
Effect of nibbling versus gorging on cardiovascular risk factors: Serum uric acid and blood lipids
DJ Jenkins, A Khan, AL Jenkins, R Illingworth, AS Pappu, TM Wolever, V Vuksan, G Buckley, AV Rao, SC Cunnane, F Brighenti, M Hawkins, M Abdolell, P Corey, R Patten, RG Josse |
Metabolism | 1995 |
|
Alterations of serum lipid levels and their biological relevances during and after pregnancy
C An-Na, Y Man-Li, H Jeng-Hsiu, C Pesus, S Shin-Kuo, N Heung-Tat |
Life Sciences | 1995 |
|
Management of Primary Hyperlipidemia
AJ Wood, RJ Havel, E Rapaport |
New England Journal of Medicine | 1995 |
|
The genetic determinants of plasma cholesterol and response to diet
SE Humphries, RE Peacock, PJ Talmud |
Baillière's Clinical Endocrinology and Metabolism | 1995 |
|
Clustering of cardiovascular risk factors: Targeting high-risk individuals
J Genest, JS Cohn |
The American Journal of Cardiology | 1995 |
|
Signal sorting by G-protein-linked receptors
G Milligan |
Advances in pharmacology (San Diego, Calif.) | 1995 |
|
Decreases in plasma lipid content and thrombotic activity by ethyl icosapentate purified from fish oils
K Hayashi, H Ohtani, H Kurushima, SI Nomura, K Koide, T Kunita, K Tanaka, Y Yasunobu, M Kambe, G Kajiyama |
Current Therapeutic Research | 1995 |
|
Long-term treatment with simvastatin in patients with familial combined hyperlipidemia
C Napoli, S Lepore, M Condorelli, M Chiariello |
Current Therapeutic Research | 1995 |
|
Antioxidants and Cardiovascular Disease
KR Bruckdorfer |
1995 | |
|
Lipid Profile in the First-Degree Relatives of Patients with Precocious Coronary Heart Disease in Rohtak Area (Northern India)
S Ahlawat, S Gupta, SB Siwach, S Mohan |
Angiology | 1995 |
|
Plasma HDL Cholesterol, Triglycerides, and Adiposity: A Quantitative Genetic Test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study
MC Mahaney, J Blangero, AG Comuzzie, JL VandeBerg, MP Stern, JW MacCluer |
Circulation | 1995 |
|
Elevated Concentrations of Plasma Lipids and Apolipoproteins B, C-III, and E Are Associated With the Progression of Coronary Artery Disease in Familial Hypercholesterolemic Swine
J Hasler-Rapacz, MF Prescott, JV Linden-Reed, JM Rapacz, Z Hu, J Rapacz |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Ten LDL Receptor Mutants Explain One Third of Familial Hypercholesterolemia in a German Sample
H Schuster, C Keller, G Wolfram, N Zöllner |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti |
1995 | |
|
Effects of Different Phenotypes of Hyperlipoproteinemia and of Treatment With Fibric Acid Derivatives on the Rates of Cholesterol 7α-Hydroxylation in Humans
M Bertolotti, M Concari, P Loria, N Abate, A Pinetti, ME Guicciardi, N Carulli |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
LDL Physical and Chemical Properties in Familial Combined Hyperlipidemia
JE Hokanson, RM Krauss, JJ Albers, MA Austin, JD Brunzell |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
A Common Variant in the Gene for Lipoprotein Lipase (Asp9→Asn): Functional Implications and Prevalence in Normal and Hyperlipidemic Subjects
F Mailly, Y Tugrul, PW Reymer, T Bruin, M Seed, BF Groenemeyer, A Asplund-Carlson, D Vallance, AF Winder, GJ Miller, JJ Kastelein, A Hamsten, G Olivecrona, SE Humphries, PJ Talmud |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
|
Cardiovascular Disease 2
LL Gallo |
1995 | |
|
Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent
A Minnich, A Kessling, M Roy, C Giry, G DeLangavant, J Lavigne, S Lussier-Cacan, J Davignon |
Journal of lipid research | 1995 |
|
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque
BS Horowitz, IJ Goldberg, J Merab, TM Vanni, R Ramakrishnan, HN Ginsberg |
Journal of Clinical Investigation | 1994 |
|
Familial lipoprotein disorders and premature coronary artery disease
EJ Schaefer, JJ Genest, JM Ordovas, DN Salem, PW Wilson |
Atherosclerosis | 1994 |
|
ACAT inhibitors as antiatherosclerotic agents: Compounds and mechanisms
K Matsuda |
Medicinal Research Reviews | 1994 |
|
Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents
PO Kwiterovich |
Atherosclerosis | 1994 |
|
Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia
CF Xu, P Talmud, H Schuster, R Houlston, G Miller, S Humphries |
Clinical Genetics | 1994 |
|
Small, dense low-density lipoprotein as a risk factor for coronary heart disease
MA Austin |
International Journal of Clinical & Laboratory Research | 1994 |
|
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque
BS Horowitz, IJ Goldberg, J Merab, TM Vanni, R Ramakrishnan, HN Ginsberg |
Journal of Clinical Investigation | 1994 |
|
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque
BS Horowitz, IJ Goldberg, J Merab, TM Vanni, R Ramakrishnan, HN Ginsberg |
Journal of Clinical Investigation | 1994 |
|
Familial combined hyperlipidemia in children: Clinical expression, metabolic defects, and management
JA Cortner, PM Coates, CA Liacouras, GP Jarvik |
Current Problems in Pediatrics | 1994 |
|
Combined Treatment with Pravastatin and Gemfibrozil in Patients with Refractory Familial Combined Hyperlipidaemia: A Clinical Study
VG Athyros, AA Papageorgiou, HJ Hagikonstantinou, GV Papadopoulos, CX Zamboulis, AG Kontopoulos |
Drug Investigation | 1994 |
|
Dyslipidemias and the secondary prevention of coronary heart disease
RS Rosenson, WA Frauenheim, CC Tangney |
Disease-a-Month | 1994 |
|
Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease
MA Austin, JE Hokanson |
Medical Clinics of North America | 1994 |
|
Lipoprotein lipase activity in patients with combined hyperlipidaemia
M Seed, F Mailly, D Vallance, E Doherty, A Winder, P Talmud, SE Humphries |
Journal of Molecular Medicine | 1994 |
|
Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia
P Cullen, B Farren, J Scott, M Farrall |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern
G Franceschini, M Cassinotti, G Vecchio, G Gianfranceschi, F Pazzucconi, T Murakami, M Sirtori, AL D'Acquarica, CR Sirtori |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype
GP Jarvik, JD Brunzell, MA Austin, RM Krauss, AG Motulsky, E Wijsman |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Associations of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intima-media thickness and plasma lipid transport in hypercholesterolemic-hypertriglyceridemic humans
W Patsch, AR Sharrett, IY Chen, YC Lin-Lee, SA Brown, AM Gotto, E Boerwinkle |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Conjoint high triglycerides and low HDL cholesterol across generations. Analysis of proband hypertriglyceridemia and lipid/lipoprotein disorders in first-degree family members
DL Sprecher, MJ Hein, PM Laskarzewski |
Circulation | 1994 |
|
DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population
RK Mattu, EW Needham, R Morgan, A Rees, AK Hackshaw, J Stocks, PC Elwood, DJ Galton |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Response to HMG CoA reductase inhibitors in heterozygous familial hypercholesterolemia due to the 10-kb deletion ("French Canadian mutation") of the LDL receptor gene
L Karayan, S Qiu, C Betard, R Dufour, G Roederer, A Minnich, J Davignon, J Genest |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Familial and diet-induced hypercholesterolemia in swine. Lipid, ApoB, and ApoA-I concentrations and distributions in plasma and lipoprotein subfractions
JO Hasler-Rapacz, TC Nichols, TR Griggs, DA Bellinger, J Rapacz |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
|
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
|
Principles and Treatment of Lipoprotein Disorders
G Schettler, AJ Habenicht |
1994 | |
|
Lipoprotein(a) : new insights into an atherogenic lipoprotein
W Bartens, C Wanner |
The Clinical Investigator | 1994 |
|
Variability of lipid phenotypes in hyperuricaemic-hyperlipidemic patients
E Collantes, F J Tinahones, A Cisnal, J Añon, P Sanchez-Guijo |
Clinical Rheumatology | 1994 |
|
Pravastatin treatment in combined hyperlipidaemia: Effect on plasma lipoprotein levels and size
S Zambon, A Cortella, G Sartore, G Baldo-Enzi, E Manzato, G Crepaldi |
European Journal of Clinical Pharmacology | 1994 |
|
Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance
MC Cabezas, TW de Bruin, HW de Valk, CC Shoulders, H Jansen, DW Erkelens |
Journal of Clinical Investigation | 1993 |
|
Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes
DE Wilson, A Hata, LK Kwong, A Lingam, J Shuhua, DN Ridinger, C Yeager, KC Kaltenborn, PH Iverius, JM Lalouel |
Journal of Clinical Investigation | 1993 |
|
Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor
W März, MW Baumstark, H Scharnagl, V Ruzicka, S Buxbaum, J Herwig, T Pohl, A Russ, L Schaaf, A Berg |
Journal of Clinical Investigation | 1993 |
|
Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia
E Bruckert, S Dejager, MJ Chapman |
Atherosclerosis | 1993 |
|
Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis
A Tybjærg-Hansen, BG Nordestgaard, LU Gerdes, O Færgeman, SE Humphries |
Atherosclerosis | 1993 |
|
Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects
OK Rødningen, TP Leren, O Røsby, S Tonstad, L Ose, K Berg |
Clinical Genetics | 1993 |
|
Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia
GP Jarvik, TH Beaty, PR Gallagher, PM Coates, JA Cortner |
Genetic Epidemiology | 1993 |
|
The HGAR1 familial hypercholesterolemia pedigree
JE Bailey-Wilson, RC Elston |
Genetic Epidemiology | 1993 |
|
Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion
MC Cabezas, TW de Bruin, LA Kock, W Kortlandt, MV Trip, H Jansen, DW Erkelens |
Metabolism | 1993 |
|
Tulp syndrome
DW Erkelens, TW Bruin, MC Cabezas |
The Lancet | 1993 |
|
Genetic and Environmental Influences on Serum Lipid Levels in Twins
DA Heller, U Faire, NL Pedersen, G Dahlen, GE McClearn |
New England Journal of Medicine | 1993 |
|
Effect on Blood Lipids of Very High Intakes of Fiber in Diets Low in Saturated Fat and Cholesterol
D Jenkins, T Wolever, AV Rao, RA Hegele, SJ Mitchell, T Ransom, DL Boctor, PJ Spadafora, AL Jenkins, C Mehling, LK Relle, PW Connelly, JA Story, EJ Furumoto, P Corey, P Wursch |
New England Journal of Medicine | 1993 |
|
Selection bias in the study of spouse similarity for psychiatric morbidity in clinical samples
GG du Fort, JF Boivin, V Kovess |
Comprehensive Psychiatry | 1993 |
|
Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged ≤50 years) and women (≤60 years) with coronary artery disease
PO Kwiterovich, J Coresh, PS Bachorik |
The American Journal of Cardiology | 1993 |
|
Use of cholestyramine in the treatment of children with familial combined hyperlipidemia
CA Liacouras, PM Coates, PR Gallagher, JA Cortner |
The Journal of Pediatrics | 1993 |
|
Identification and treatment of heterozygous familial hypercholesterolemia in children and adolescents
PO Kwiterovich |
The American Journal of Cardiology | 1993 |
|
Molecular Epidemiology
FP Perera, R Santella |
Molecular Epidemiology | 1993 |
|
Metabolic abnormalities in hyperlipidemias
G Marotta, P Pauciullo, M Mancini |
Nutrition Research | 1993 |
|
Tolerability and efficacy of combination therapy with simvastatin plus gemfibrozil in type IIb refractory familial combined hyperlipidemia
PG Col, M Fonda, M Fisicaro, M Tonizzo, M Valenti, L Cattin |
Current Therapeutic Research | 1993 |
|
Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia
C Contacos, PJ Barter, DR Sullivan |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Familial hypoalphalipoproteinemia in premature coronary artery disease
J Genest, JM Bard, JC Fruchart, JM Ordovas, EJ Schaefer |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Impaired chylomicron remnant clearance in familial combined hyperlipidemia
MC Cabezas, TW de Bruin, H Jansen, LA Kock, W Kortlandt, DW Erkelens |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations
HN Ginsberg, C Ngai, XJ Wang, R Ramakrishnan |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Obese men with type IIB hyperlipidemia are insulin resistant
P Karhapää, E Voutilainen, M Malkki, M Laakso |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia
JA Cortner, MJ Bennett, , PM Coates |
Journal of Inherited Metabolic Disease | 1993 |
|
Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia
S Venkatesan, P Cullen, P Pacy, D Halliday, J Scott |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
|
Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia
S Dejager, E Bruckert, MJ Chapman |
Journal of lipid research | 1993 |
|
Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction
UM Koivisto, L Hämäläinen, Taskinen, K Kettunen, K Kontula |
Journal of lipid research | 1993 |
|
Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia
F Tat, C Keller, G Wolfram |
The Clinical Investigator | 1993 |
|
Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins
JA Cortner, NA Le, PM Coates, MJ Bennett, DR Cryer |
European Journal of Clinical Investigation | 1992 |
|
Molecular genetics of the LDL receptor gene in familial hypercholesterolemia
HH Hobbs, MS Brown, JL Goldstein |
Human Mutation | 1992 |
|
Molecular Genetics of Familial Hypercholesterolaemia: Common and Rare Mutations of the Low Density Lipoprotein Receptor Gene
K Kontula, UM Koivisto, P Koivisto, H Turtola |
Annals of Medicine | 1992 |
|
Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy
S Ericsson, M Eriksson, L Berglund, B Angelin |
Journal of Internal Medicine | 1992 |
|
Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families
J Graaf, DW Swinkels, AF de Haan, PN Demacker, AF Stalenhoef |
The American Journal of Human Genetics | 1992 |
|
Genetic Epidemiology of Low-Density Lipoprotein Subclass Phenotypes
MA Austin |
Annals of Medicine | 1992 |
|
Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: Evidence for reduced assembly and secretion of triglyceride-rich lipoproteins
Y Arad, R Ramakrishnan, HN Ginsberg |
Metabolism | 1992 |
|
Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: Influence of apolipoprotein E-3/E-2 pattern
SM Haffner, RS Kushwaha, WR Hazzard |
Metabolism | 1992 |
|
Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia
MA Austin, H Horowitz, E Wijsman, RM Krauss, J Brunzell |
Atherosclerosis | 1992 |
|
Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland
K Aalto-Setälä, UM Koivisto, TA Miettinen, H Gylling, YA Kesäniemi, M Savolainen, K Pyörälä, T Ebeling, I Mononen, H Turtola, J Viikari, K Kontula |
Journal of Internal Medicine | 1992 |
|
Hypertriglyceridemia: Risks and perspectives
AM Gotto |
The American Journal of Cardiology | 1992 |
|
Therapeutic management of triglycerides: An international perspective
TA Pearson |
The American Journal of Cardiology | 1992 |
|
Epidemiology of triglycerides: A view from Framingham
WP Castelli |
The American Journal of Cardiology | 1992 |
|
A clinical overview of dyslipidemias: Treatment strategies
PH Jones |
The American Journal of Medicine | 1992 |
|
Postprandial Lipoprotein Metabolism in Obese Patients with Moderate Hypertriglyceridaemia: Effects of Gemfibrozil
HH Ditschuneit, M Flechtner-Mors, E Hagel, H Ditschuneit |
J INT MED RES | 1992 |
|
The effect of interferon on the metabolism of LDLs
G Schectman, S Kaul, RA Mueller, EC Borden, AH Kissebah |
Arteriosclerosis Thrombosis and Vascular Biology | 1992 |
|
Familial lipoprotein disorders in patients with premature coronary artery disease
JJ Genest, SS Martin-Munley, JR McNamara, JM Ordovas, J Jenner, RH Myers, SR Silberman, PW Wilson, DN Salem, EJ Schaefer |
Circulation | 1992 |
|
Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. The PCV METRA Group
JL Megnien, V Sene, S Jeannin, A Hernigou, MC Plainfosse, I Merli, V Atger, N Moatti, J Levenson, A Simon |
Circulation | 1992 |
|
The management of hyperlipidaemia: are specialist lipid clinics needed?
M Roche, D Grice, H A Neil, D R Matthews |
Journal of the Royal College of Physicians of London | 1992 |
|
Transgenic mice expressing full-length human apolipoprotein B-100. Full-length human apolipoprotein B mRNA is essentially not edited in mouse intestine or liver
W Xiong, E Zsigmond, AM Gotto, LW Reneker, L Chan |
The Journal of biological chemistry | 1992 |
|
Gene-environment interactions in atherosclerosis
RA Hegele |
Molecular and Cellular Biochemistry | 1992 |
|
Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene
D Ameis, J Kobayashi, RC Davis, O Ben-Zeev, MJ Malloy, JP Kane, G Lee, H Wong, RJ Havel, MC Schotz |
Journal of Clinical Investigation | 1991 |
|
Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver
JA Cortner, PM Coates, MJ Bennett, DR Cryer, NA Le |
Journal of Inherited Metabolic Disease | 1991 |
|
Plasma Lipid and Lipoprotein Levels in Childhood
PO Kwiterovich |
Annals of the New York Academy of Sciences | 1991 |
|
Gemfibrozil in familial combined hyperlipidaemia: effect of added low-dose cholestyramine on plasma and biliary lipids
B Ödman, S Ericsson, M Lindmark, L Berglund, B Angelin |
European Journal of Clinical Investigation | 1991 |
|
Genetic Forms of Dyslipidemia in Children
AL Drash |
Annals of the New York Academy of Sciences | 1991 |
|
Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia
MA Austin, E Wijsman, S Guo, RM Krauss, JD Brunzell, S Deeb, GP Vogler |
Genetic Epidemiology | 1991 |
|
Low-density lipoprotein subclass phenotypes and familial combined hyperlipidemia
MA Austin |
Diabetes / Metabolism Reviews | 1991 |
|
The cornea and disorders of lipid metabolism
BJ Barchiesi, RH Eckel, PP Ellis |
Survey of Ophthalmology | 1991 |
|
3. Genetic (primary) forms of hypertriglceridemia
G Assmann, HB Brewer |
The American Journal of Cardiology | 1991 |
|
Oxidative Damage & Repair
A Sevanian |
Oxidative Damage & Repair | 1991 |
|
Alternative fat-restricted diets for hypercholesterolemia and combined hyperlipidemia: feasibility, design, subject recruitment, and baseline characteristics of the dietary alternatives study
CE Walden, BS McCann, B Retzlaff, A Dowdy, M Hanson, B Fish, V Fitzpatrick, W Follette, D Parker, G Gey |
Journal of the American College of Nutrition | 1991 |
|
Myocardial infarction at a young age: mechanisms and management
A Hamsten |
1991 | |
|
Plasma triglyceride and coronary heart disease
MA Austin |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
|
Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia
KE Friday, RA Failor, MT Childs, EL Bierman |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
|
Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24
AP Wojciechowski, M Farrall, P Cullen, TM Wilson, JD Bayliss, B Farren, BA Griffn, MJ Caslake, CJ Packard, J Shepherd, R Thakker, J Scott |
Nature | 1991 |
|
Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes
M Emi, RM Hegele, PN Hopkins, LL Wu, R Plaetke, RR Williams, JM Lalouel |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
|
DNA Polymorphisms as Disease Markers
DJ Galton, G Assmann |
1991 | |
|
Prevention of coronary heart disease: putting theory into practice
B Lewis, G Rose |
Journal of the Royal College of Physicians of London | 1991 |
|
Clinical Value of Apolipoprotein Measurement
D Bhatnagar, PN Durrington |
Annals of Clinical Biochemistry | 1991 |
|
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation
DE Wilson, M Emi, PH Iverius, A Hata, LL Wu, E Hillas, RR Williams, JM Lalouel |
Journal of Clinical Investigation | 1990 |
|
Biliary lipids in familial combined hyperlipidaemia: effects of acipimox therapy
S Ericsson, M Eriksson, B Angelin |
European Journal of Clinical Investigation | 1990 |
|
Increased degradation of low density lipoproteins by mononuclear leukocytes associated with coronary artery disease
F Shi, PG Hurst, DJ McNamara |
Atherosclerosis | 1990 |
|
Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children
CF Xu, MN Nanjee, J Savill, PJ Talmud, F Angelico, MD Ben, R Antonini, B Mazzarella, N Miller, SE Humphries |
The American Journal of Human Genetics | 1990 |
|
Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia
G Rauh, H Schuster, B Miller, S Schewe, C Keller, G Wolfram, N Zöllner |
Atherosclerosis | 1990 |
|
Wives of coronary high-risk men - are they also at higher risk? The Tromsø Heart Study
SF Knutsen, R Knutsen |
Journal of Internal Medicine | 1990 |
|
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
G Brown, JJ Albers, LD Fisher, SM Schaefer, JT Lin, C Kaplan, XQ Zhao, BD Bisson, VF Fitzpatrick, HT Dodge |
New England Journal of Medicine | 1990 |
|
Rising cholesterol levels in children with Familial Hypercholesterolaemia
AM Kessling, M Seed, R Taylor, V Wynn, SE Humphries |
Biomedicine & Pharmacotherapy | 1990 |
|
Aspects génétiques et physiopathologiques des dyslipoprotéinémies athérogènes
G Turpin, E Bruckert |
La Revue de Médecine Interne | 1990 |
|
Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia
SM Grundy, GL Vega, A Garg |
The American Journal of Cardiology | 1990 |
|
Prevalence and expression of familial combined hyperlipidemia in childhood
JA Cortner, PM Coates, PR Gallagher |
The Journal of Pediatrics | 1990 |
|
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
MA Austin, MC King, KM Vranizan, RM Krauss |
Circulation | 1990 |
|
2 Practical drug therapy for common hyperlipidaemias
MJ Tikkanen |
Baillière's Clinical Endocrinology and Metabolism | 1990 |
|
Lipoprotein (A)
EF Plow, LA Miles |
Lipoprotein (A) | 1990 |
|
Diagnosis and Management of Familial Dyslipoproteinemia in Children and Adolescents
PO Kwiterovich |
Pediatric Clinics of North America | 1990 |
|
Drug Therapy in Dyslipidemia
SM Grundy |
Scandinavian Journal of Clinical & Laboratory Investigation | 1990 |
|
Genetics of Common Diseases of Adulthood
MB Lubin, HJ Lin, CM Vadheim, JI Rotter |
Clinics in Perinatology | 1990 |
|
Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia
MA Austin, JD Brunzell, WL Fitch, RM Krauss |
Arteriosclerosis (Dallas, Tex.) | 1990 |
|
Causes of high blood cholesterol
SM Grundy, GL Vega |
Circulation | 1990 |
|
Current Status of Clinical Cardiology 1990
DG Julian |
1990 | |
|
Advances in Human Genetics
H Harris, K Hirschhorn |
1990 | |
|
Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production
Y Arad, R Ramakrishnan, HN Ginsberg |
Journal of lipid research | 1990 |
|
DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects
JC Chamberlain, JA Thorn, K Oka, DJ Galton, J Stocks |
Atherosclerosis | 1989 |
|
Regulation of cholesterol synthesis and the potential for its pharmacologic manipulation
RA Davis, M Sinensky, LH Junker |
Pharmacology & Therapeutics | 1989 |
|
Genetic influences on susceptibility to atherosclerosis in the young
PO Kwiterovich |
Bulletin of the New York Academy of Medicine | 1989 |
|
Polymorphic DNA haplotypes at the LDL receptor locus
E Leitersdorf, A Chakravarti, HH Hobbs |
The American Journal of Human Genetics | 1989 |
|
Risk factors in middle age that predict early and late onset of coronary heart disease
RJ Benfante, DM Reed, CJ MacLean, K Yano |
Journal of Clinical Epidemiology | 1989 |
|
Different localization of early arterial lesions in insulin-dependent diabetes mellitus and in familial hypercholesterolemia
P Rubba, G Riccardi, P Pauciullo, O Vaccaro, L Carbone, M Mancini |
Metabolism | 1989 |
|
Comparative Study of Bezafibrate and Probucol in Hyperlipidaemia
JP Moreno, G Gonzàlez |
Current Medical Research and Opinion | 1989 |
|
The Xba1 polymorphism of the apolipoprotein B gene influences the degradation of low density lipoprotein in vitro
J Series, I Cameron, M Caslake, D Gaffney, CJ Packard, J Shepherd |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1989 |
|
Effect of low density lipoproteins, high density lipoproteins, and cholesterol on apolipoprotein A-I mRNA in Hep G2 cells
JC Monge, JM Hoeg, SW Law, HB Brewer |
FEBS Letters | 1989 |
|
Nutritional Management of Plasma Lipid Disorders
S Margolis, AS Dobs |
Journal of the American College of Nutrition | 1989 |
|
Nibbling versus Gorging: Metabolic Advantages of Increased Meal Frequency
DJ Jenkins, TM Wolever, V Vuksan, F Brighenti, SC Cunnane, AV Rao, AL Jenkins, G Buckley, R Patten, W Singer, P Corey, RG Josse |
New England Journal of Medicine | 1989 |
|
The Hyperlipoproteinemias
W Patsch, JR Patsch, AM Gotto |
Medical Clinics of North America | 1989 |
|
A Review of Combined Hyperlipidaemia and Its Treatment with Fenofibrate
HR Superko |
J INT MED RES | 1989 |
|
The Status of Hypertriglyceridemia as a Risk Factor for Coronary Heart Disease
AL Avins, RJ Haber, SB Hulley |
Clinics in Laboratory Medicine | 1989 |
|
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency
SP Babirak, PH Iverius, WY Fujimoto, JD Brunzell |
Arteriosclerosis (Dallas, Tex.) | 1989 |
|
Enhanced lipoprotein lipase secretion from human monocyte-derived macrophages caused by hypertriglyceridemic very low density lipoproteins
S Ishibashi, N Mori, T Murase, H Shimano, T Gotohda, M Kawakami, Y Akanuma, F Takaku, N Yamada |
Arteriosclerosis (Dallas, Tex.) | 1989 |
|
Rational therapy of familial hypercholesterolemia
GA Reynolds |
Circulation | 1989 |
|
Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension
SC Hunt, LL Wu, PN Hopkins, BM Stults, H Kuida, ME Ramirez, JM Lalouel, RR Williams |
Arteriosclerosis (Dallas, Tex.) | 1989 |
|
Homozygous familial hypercholesterolemia among French Canadians in Québec Province
S Moorjani, M Roy, C Gagné, J Davignon, D Brun, M Toussaint, M Lambert, L Campeau, S Blaichman, P Lupien |
Arteriosclerosis (Dallas, Tex.) | 1989 |
|
Apolipoproteins in lipid transport, an impressionist view
DW Erkelens |
Postgraduate medical journal | 1989 |
|
Borderline hypercholesterolaemia: when to introduce drugs
D Bhatnagar, PN Durrington |
Postgraduate medical journal | 1989 |
|
Lipoprotein Subfractions Omega-3 Fatty Acids
HU Klör |
1989 | |
|
Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals
DW Swinkels, PN Demacker, JC Hendriks, |
Arteriosclerosis (Dallas, Tex.) | 1989 |
|
Relationships between LDL density and kinetic heterogeneity in subjects with normolipidemia and familial combined hyperlipidemia using density gradient ultracentrifugation
CA Marzetta, DM Foster, JD Brunzell |
Journal of lipid research | 1989 |
|
Genetic analysis of total cholesterol and triglycerides in a pedigree of St. Thomas rabbits
TH Beaty, PO Kwiterovich, A Laville, B Lewis |
Journal of lipid research | 1989 |
|
Clinical consequences of hyperlipidaemia
GR Thompson |
Journal of Inherited Metabolic Disease | 1988 |
|
Serum lipid levels in elementary and junior high school children and their relationship to relative weight
A Yamamoto, H Horibe, S Sawada, M Uyama, Y Matsuzawa, T Yamamura, S Yokoyama, F Kasagi, K Kameda |
Preventive Medicine | 1988 |
|
Risk factors in siblings of people with premature coronary heart disease
DM Becker, LC Becker, TA Pearson, DJ Fintel, DM Levine, PO Kwiterovich |
Journal of the American College of Cardiology | 1988 |
|
Inborn errors of lipid metabolism-dermatological aspects
R Knobler, S Becerano, W Gebhart |
Clinical and Experimental Dermatology | 1988 |
|
Biochemical, clinical, genetic and metabolic studies of hyperapo-β-lipoproteinaemia
PO Kwiterovich |
Journal of Inherited Metabolic Disease | 1988 |
|
Apolipoproteins, Dyslipoproteinaemia and Premature Coronary Heart Disease
A Hamsten |
Acta Medica Scandinavica | 1988 |
|
Effect of the amount of body fat on the age-associated increase in serum cholesterol
JP Després, A Tremblay, C Leblanc, C Bouchard |
Preventive Medicine | 1988 |
|
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis
MA Austin, MC King, KM Vranizan, B Newman, RM Krauss |
The American Journal of Human Genetics | 1988 |
|
The Salmon lecture. Some perspectives on human obesity: its causes
AJ Stunkard |
Bulletin of the New York Academy of Medicine | 1988 |
|
Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia
SW Rabkin, M Hayden, J Frohlich |
Atherosclerosis | 1988 |
|
Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays
PS Bachorik, PO Kwiterovich |
Clinica Chimica Acta | 1988 |
|
Cases are not incidence and Vice Versa
CR Scriver |
Genetic Epidemiology | 1988 |
|
The effects of ω3 and ω6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia
RA Failor, MT Childs, EL Bierman |
Metabolism | 1988 |
|
Receptors
ML Welton, E Passaro |
The American Journal of Surgery | 1988 |
|
HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
JA Oates, AJ Wood, SM Grundy |
New England Journal of Medicine | 1988 |
|
Lessons from the Helsinki Heart Study: Fibric acid therapy for dyslipidemia
SM Grundy |
Postgraduate Medicine | 1988 |
|
Plasma cholesterol esterification rate in hyperlipoproteinaemia: Relation to cholesterol elimination
B Angelin, K Einarsson, B Leijd, L Wallentin |
Scandinavian Journal of Clinical & Laboratory Investigation | 1988 |
|
Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Evidence for genetic control of triglyceride removal
T Sane, EA Nikkilä |
Arteriosclerosis (Dallas, Tex.) | 1988 |
|
Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study
M Modan, H Halkin, A Lusky, P Segal, Z Fuchs, A Chetrit |
Arteriosclerosis (Dallas, Tex.) | 1988 |
|
Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis
CL Malmendier, P Alaupovic |
1988 | |
|
Studies in Inherited Metabolic Disease
RJ Pollitt, RA Harkness, GM Addison |
1988 | |
|
Diagnosis of Familial Hypercholesterolaemia Using DNA Probes for the Low-Density Lipoprotein (LDL) Receptor Gene
AE Armston, SA Iversen, JF Burke |
Annals of Clinical Biochemistry | 1988 |
|
Genetic factors affecting blood lipoproteins: the candidate gene approach
AJ Lusis |
Journal of lipid research | 1988 |
|
Cell type-specific expression of the human apoB gene is controlled by two cis-acting regulatory regions
HK Das, T Leff, JL Breslow |
The Journal of biological chemistry | 1988 |
|
Assay of unesterified cholesterol-5,6-epoxide in human serum by isotope dilution mass spectrometry. Levels in the healthy state and in hyperlipoproteinemia
I Björkhem, O Breuer, B Angelin, SA Wikström |
Journal of lipid research | 1988 |
|
Normal and Pathological Lipoprotein Metabolism:
GR Thompson |
Drugs | 1988 |
|
Introduction
LD Peachey, JP Heath, KR Porter, HP Thompson, KR Porter, F Kallman |
Journal of Electron Microscopy Technique | 1987 |
|
Pharmacological treatment of lipid disorders in diabetes mellitus
MF Lopes-Virella, JA Colwell |
Diabetes / Metabolism Reviews | 1987 |
|
Abstract
A Bardo |
Acta Paediatrica | 1987 |
|
Likelihoods in pedigree analysis under sequential sampling
E Thompson |
The American Journal of Human Genetics | 1987 |
|
Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia
B Angelin, KS Hershon, JD Brunzell |
Proceedings of the National Academy of Sciences | 1987 |
|
DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias
MR Hayden, H Kirk, C Clark, J Frohlich, S Rabkin, R McLeod, J Hewitt |
The American Journal of Human Genetics | 1987 |
|
Borderline fasting hypertriglyceridemia: Absence of excess risk of all-cause and cardiovascular disease mortality in healthy men without hypercholesterolemia
E Barrett-Connor, KT Khaw |
Preventive Medicine | 1987 |
|
Genetic analysis of serum lipid levels and blood pressure in a large kindred
ML Marazita, RC Elston, KK Namboodiri, CG Hames, JM Opitz, JF Reynolds |
American Journal of Medical Genetics | 1987 |
|
DISEASE, LIFESTYLE, AND CONSANGUINITY IN 58 AMERICAN GYPSIES
JD Thomas, MM Doucette, DC Thomas, JD Stoeckle |
The Lancet | 1987 |
|
Apolipoprotein E polymorphism and plasma cholesterol response to probucol
AC Nestruck, D Bouthillier, CF Sing, J Davignon |
Metabolism | 1987 |
|
Effects of benfluorex on patients with endogenous hypertriglyceridaemia
R Ranquin |
Current Medical Research and Opinion | 1987 |
|
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
A Hamsten, G Walldius, A Szamosi, M Blombäck, UD Faire, G Dahlén, C Landou, B Wiman |
The Lancet | 1987 |
|
Hyperlipidemia in School Children with Family Histories of Premature Coronary Heart Disease
T Sveger, G Fex, N Borgfors |
Acta Paediatrica | 1987 |
|
8 Dietary therapy of hyperlipidaemia
SM Grundy |
Baillière's Clinical Endocrinology and Metabolism | 1987 |
|
Risk factors for coronary artery disease in families of young men with myocardial infarction
A Hamsten, U Faire |
The American Journal of Cardiology | 1987 |
|
Lipoprotein abnormalities in hypertriglyceridemia: Significance in atherosclerosis
S Eisenberg |
American Heart Journal | 1987 |
|
Potential use of fenofibrate and other fibric acid derivatives in the clinic
WV Brown |
The American Journal of Medicine | 1987 |
|
Severe Hypertriglyceridemia, large lipoproteins and protection against atherosclerosis
BG Nordestgaard, S Stender, K Kjeldsen |
Scandinavian Journal of Clinical & Laboratory Investigation | 1987 |
|
Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia
PO Kwiterovich, S White, T Forte, PS Bachorik, H Smith, A Sniderman |
Arteriosclerosis (Dallas, Tex.) | 1987 |
|
Dietary therapy for different forms of hyperlipoproteinemia
SM Grundy |
Circulation | 1987 |
|
Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid
PT Kuo, JF Toole, JA Schaaf, A Jones, AC Wilson, JB Kostis, AE Moreyra |
Stroke; a journal of cerebral circulation | 1987 |
|
Expanding Horizons in Atherosclerosis Research
G Schlierf, H Mörl |
1987 | |
|
Human Genetics
F Vogel, K Sperling |
Human Genetics | 1987 |
|
Identification of deletions in the human low density lipoprotein receptor gene
B Horsthemke, A Dunning, S Humphries |
Journal of medical genetics | 1987 |
|
Atherogenesis and Aging
SR Bates, EC Gangloff |
1987 | |
|
Lipid-Lowering Drugs: An Overview of Indications and Optimum Therapeutic Use
DR Illingworth |
Drugs | 1987 |
|
Association of a DNA polymorphism in the apolipoprotein C-III gene with diverse hyperlipidaemic phenotypes
H E Henderson, S V Landon, J Michie, G M Berger |
Human Genetics | 1987 |
|
Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia
B Teng, AD Sniderman, AK Soutar, GR Thompson |
Journal of Clinical Investigation | 1986 |
|
Ein Rezeptor-vermittelter Stoffwechselweg für die Cholesterin-Homöostase (Nobel-Vortrag)
MS Brown, JL Goldstein |
Angewandte Chemie | 1986 |
|
GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES
MA Austin, RM Krauss |
The Lancet | 1986 |
|
Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II and B
A Hamsten, L Iselius, G Dahlén, U Faire |
Atherosclerosis | 1986 |
|
Effect of Gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects
A Gnasso, B Lehner, W Haberbosch, O Leiss, K Bergmann, J Augustin |
Metabolism | 1986 |
|
Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: Kinetic analysis using an integrated model
A Chait, DM Foster, JJ Albers, RA Failor, JD Brunzell |
Metabolism | 1986 |
|
The Relation of Apolipoproteins A-I and B in Children to Parental Myocardial Infarction
DS Freedman, SR Srinivasan, CL Shear, FA Franklin, LS Webber, GS Berenson |
New England Journal of Medicine | 1986 |
|
Health Effects of Polyunsaturated Fatty Acids in Seafoods
SM Grundy |
Health Effects of Polyunsaturated Fatty Acids in Seafoods | 1986 |
|
Hyperlipoproteinaemia and Xanthomatosis as a Model of Cholesterol Ester Accumulation
BJ Vermeer |
The Journal of Dermatology | 1986 |
|
Identification and Relative Weight of Cardiovascular Risk Factors
PN Hopkins, RR Williams |
Cardiology Clinics | 1986 |
|
Genetic aspects of arteriosclerosis
U Goldbourt, HN Neufeld |
Arteriosclerosis (Dallas, Tex.) | 1986 |
|
Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia
AF Stalenhoef, PN Demacker, JA Lutterman, |
Arteriosclerosis (Dallas, Tex.) | 1986 |
|
Genetic Disorders and the Fetus
A Milunsky |
1986 | |
|
Persistent Renal-Genitourinary Disorders
J Strauss |
1986 | |
|
Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan
S Jiao, K Kameda, Y Matsuzawa, S Tarui |
Annals of the rheumatic diseases | 1986 |
|
A receptor-mediated pathway for cholesterol homeostasis
Brown, JL Goldstein |
Science | 1986 |
|
The Genetics of Cardiovascular Disease
ME Pierpont, JH Moller |
1986 | |
|
Receptor-Mediated Uptake in the Liver
H Greten, E Windler, U Beisiegel |
1986 | |
|
Der Stoffwechsel der Plasmalipoproteine und seine Bedeutung für die Pathogenese der Arteriosklerose
G Schettler |
1986 | |
|
Genetische Aspekte von Herz- und Kreislaufkrankheiten
H Moser |
Sozial- und Präventivmedizin SPM | 1985 |
|
The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits An animal model for familial hypercholesterolemia
Y Watanabe, T Ito, M Shiomi |
Atherosclerosis | 1985 |
|
A COMMON DNA POLYMORPHISM OF THE LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR GENE AND ITS USE IN DIAGNOSIS
SE Humphries, B Horsthemke, M Seed, M Holm, V Wynn, AM Kessling, JA Donald, N Jowett, DJ Galton, R Williamson |
The Lancet | 1985 |
|
Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment
RB Goldberg, ML Reeves, DE Seigler, EA Ryan, N Miller, SL Hsia, JS Skyler |
Acta Diabetologica Latina | 1985 |
|
Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia
FL Dunn, SM Grundy, DW Bilheimer, RJ Havel, P Raskin |
Metabolism | 1985 |
|
Familial associations of lipids and lipoproteins in a highly consanguineous population: The Limone sul Garda study
V Gualandri, GB Orsini, A Cerrone, G Franceschini, CR Sirtori |
Metabolism | 1985 |
|
Effects of high cholesterol high fat diet on plasma lipoproteins in familial hypercholesterolemia
TG Cole, B Pfleger, O Hitchins, G Schonfeld |
Metabolism | 1985 |
|
Altered HDL subclasses in endogenous hypertriglyceridemia are not affected by weight reduction
B Gonen, W Patsch, I Kuisk, A Goldberg, R Phair, G Schonfeld |
Metabolism | 1985 |
|
Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin
RH Knopp, J Ginsberg, JJ Albers, C Hoff, JT Ogilvie, GR Warnick, E Burrows, B Retzlaff, M Poole |
Metabolism | 1985 |
|
Improved reactive hyperemia test after plasma exchange in familial hypercholesterolemia
P Rubba, A Postiglione, N Scarpato, A Iannuzzi, M Mancini |
Atherosclerosis | 1985 |
|
Xanthomas and hyperlipidemias
F Parker |
Journal of the American Academy of Dermatology | 1985 |
|
Familial aggregation and early expression of hyperapobetalipoproteinemia
A Sniderman, B Teng, J Genest, K Cianflone, S Wacholder, P Kwiterovich |
The American Journal of Cardiology | 1985 |
|
Genetic and Metabolic Disease in Pediatrics
L Pinsky, M Kaufman |
Genetic and Metabolic Disease in Pediatrics | 1985 |
|
Pathogenesis and Management of Lipoprotein Disorders
JS Flier, LH Underhill, EJ Schaefer, RI Levy |
New England Journal of Medicine | 1985 |
|
Characterization of plasma lipids and lipoproteins in cholesteryl ester storage disease
DR Kelly, JM Hoeg, SJ Demosky, HB Brewer |
Biochemical Medicine | 1985 |
|
Familial Combined Hyperlipidemia and Otosclerosis—The Occurrence in a Large Kindred
Y Levy, MD Silva, I Eliachar, Z Glick-Avraham, RJ Viskoper, JG Brook |
The American Journal of the Medical Sciences | 1985 |
|
Apo E allele frequency in primary endogenous hypertriglyceridemia (type IV) with and without hyperapobetalipoproteinemia
S Lussier-Cacan, D Bouthillier, J Davignon |
Arteriosclerosis (Dallas, Tex.) | 1985 |
|
Relative contribution of triglyceride-rich lipoprotein particle size and number to plasma triglyceride concentration
M Poapst, M Reardon, G Steiner |
Arteriosclerosis (Dallas, Tex.) | 1985 |
|
Drugs Affecting Lipid Metabolism VIII
D Kritchevsky, WL Holmes, R Paoletti |
1985 | |
|
Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia
B Horsthemke, AM Kessling, M Seed, V Wynn, R Williamson, SE Humphries |
Human Genetics | 1985 |
|
Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia
SM Grundy, GL Vega |
Journal of lipid research | 1985 |
|
Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease
GL Vega, WF Beltz, SM Grundy |
Journal of lipid research | 1985 |
|
When and How to Treat Hyperlipidemia
PT Kuo |
Primary care | 1985 |
|
Plasma and lipoprotein lipid responses to four hypolipid drugs
WR Hazzard, PW Wahl, C Gagne, D Applebaum-Bowden, GR Warnick, JJ Albers |
Lipids | 1984 |
|
Family history as an independent risk factor for coronary artery disease
S Shea, R Ottman, C Gabrieli, Z Stein, A Nichols |
Journal of the American College of Cardiology | 1984 |
|
The use of polymorphic DNA and protein markers for the third complement component for determining linkage of familial hypercholesterolaemia
SE Humphries, JA Donald, JJ McFadden, S Shull, R Williamson, NI Jowett, DJ Galton, JO Julsrud, K Berg, A Heiberg, S Ball, G Fey, M Seed, V Wynn |
Atherosclerosis | 1984 |
|
Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk
G Thompson |
British heart journal | 1984 |
|
Comparisons of different sampling designs for the determination of genetic transmission mechanisms in quantitative traits
TL Burns, PP Moll, MA Schork |
The American Journal of Human Genetics | 1984 |
|
Hyperlipemia and arteriosclerotic cardiovascular disease in the Polynesian population of Rarotonga
G Egusa, PH Bennett, K Aleck, R Taylor, BV Howard |
Atherosclerosis | 1984 |
|
The collaborative lipid research clinics program family study: Detection of major genes influencing lipid levels by examination of heterogeneity of familial variances
P Green, AR Owen, K Namboodiri, D Hewitt, LR Williams, RC Elston, BM Rifkind, DC Rao |
Genetic Epidemiology | 1984 |
|
The effect of diabetic control on very low-density lipoprotein—Triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia
FL Dunn, P Raskin, DW Bilheimer, SM Grundy |
Metabolism | 1984 |
|
Hyperlipoproteinemia: Metabolic basis and rationale for therapy
SM Grundy |
The American Journal of Cardiology | 1984 |
|
Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients
DL Sprecher, EJ Schaefer, KM Kent, RE Gregg, LA Zech, JM Hoeg, B McManus, WC Roberts, HB Brewer |
The American Journal of Cardiology | 1984 |
|
Low-dose colestipol plus probucol for hypercholesterolemia
CA Dujovne, SB Chernoff, P Krehbiel, B Jackson, S DeCoursey, H Taylor |
The American Journal of Cardiology | 1984 |
|
Genetic Factors in Nutrition
NW Solomons |
Genetic Factors in Nutrition | 1984 |
|
Treating Hyperlipidemia to Provide Salutary Effect on Coronary Artery Disease
PT Kuo |
Chest | 1984 |
|
Treatment of common lipoprotein disorders
WV Brown, IJ Goldberg, HN Ginsberg |
Progress in Cardiovascular Diseases | 1984 |
|
Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression
AH Kissebah, S Alfarsi, DJ Evans |
Arteriosclerosis (Dallas, Tex.) | 1984 |
|
Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Possible markers for the diagnosis of "prelipemia"
A Montes, CE Walden, RH Knopp, M Cheung, MB Chapman, JJ Albers |
Arteriosclerosis (Dallas, Tex.) | 1984 |
|
Apoproteins B and A-I and coronary artery disease in humans
JD Brunzell, AD Sniderman, JJ Albers, PO Kwiterovich |
Arteriosclerosis (Dallas, Tex.) | 1984 |
|
Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque
A Faggiotto, R Ross |
Arteriosclerosis (Dallas, Tex.) | 1984 |
|
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation
A Faggiotto, R Ross, L Harker |
Arteriosclerosis (Dallas, Tex.) | 1984 |
|
Premature development of iliac artery stenosis in asymptomatic type II hyperlipoproteinemia
P Rubba, A Postiglione, BD Simone, F Faccenda, G Riccardi, M Mancini |
Arteriosclerosis (Dallas, Tex.) | 1984 |
|
Pathogenesis of hyperlipoproteinemia
SM Grundy |
Journal of lipid research | 1984 |
|
Conference on Blood Lipids in Children: Optimal Levels for Early Prevention of Coronary Artery Disease
RW Wissler, HC McGill |
Preventive Medicine | 1983 |
|
Screening for Health Risks
G Sigurdsson, N Sigfusson, T Thorsteinsson, O Olafsson, D Davidsson, S Samuelsson |
Acta Medica Scandinavica | 1983 |
|
Atherosclerosis and apoproteins B and A-I
PO Kwiterovich, AD Sniderman |
Preventive Medicine | 1983 |
|
Low density lipoprotein degradation by mononuclear cells from normal and dyslipoproteinemic subjects
AM Lees, RS Lees |
Proceedings of the National Academy of Sciences | 1983 |
|
Normocholesterolemic tendon xanthomatosis with overproduction of apolipoprotein B
GL Vega, DR Illingworth, SM Grundy, FT Lindgren, WE Connor |
Metabolism | 1983 |
|
Severe hypertriglyceridemia: Role of familial and acquired disorders
A Chait, JD Brunzell |
Metabolism | 1983 |
|
Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency
DE Wilson, CQ Edwards, IF Chan |
Metabolism | 1983 |
|
New Comprehensive Biochemistry
S Yamamoto |
New Comprehensive Biochemistry | 1983 |
|
Genetic and familial factors in essential hypertension and related traits
RM Siervogel |
American Journal of Physical Anthropology | 1983 |
|
Defective Lipoprotein Receptors and Atherosclerosis: Lessons from an Animal Counterpart of Familial Hypercholesterolemia
FH Epstein, JL Goldstein, T Kita, MS Brown |
New England Journal of Medicine | 1983 |
|
Developments in Statistics
S Karlin, EC Cameron, PT Williams |
Developments in Statistics | 1983 |
|
Disorders of lipid transport—Update 1983
G Schonfeld |
Progress in Cardiovascular Diseases | 1983 |
|
Overproduction of low density lipoproteins associated with coronary heart disease
YA Kesaniemi, SM Grundy |
Arteriosclerosis (Dallas, Tex.) | 1983 |
|
Influence of weight reduction on plasma lipoproteins in obese patients
RN Wolf, SM Grundy |
Arteriosclerosis (Dallas, Tex.) | 1983 |
|
Hyperlipidemia in the Pacific Northwest Bell Telephone Company Health Survey. Part 1. Lipoprotein cholesterol and triglyceride concentrations
CE Walden, PW Wahl, RH Knopp, GR Warnick, JT Ogilvie, WR Hazzard, JJ Hoover, JJ Albers |
Arteriosclerosis (Dallas, Tex.) | 1983 |
|
Hyperlipidemia in the Pacific Northwest Bell Telephone Company Health Survey. Part 2. Lipoprotein lipid interrelationships
CE Walden, RH Knopp, PW Wahl, JJ Hoover, JJ Albers, WR Hazzard, JT Ogilvie, GR Warnick |
Arteriosclerosis (Dallas, Tex.) | 1983 |
|
Interaction of two lipid disorders in a large French-Canadian kindred
J Davignon, S Lussier-Cacan, A Gattereau, PP Moll, CF Sing |
Arteriosclerosis (Dallas, Tex.) | 1983 |
|
Arterial Pollution
H Peeters, GA Gresham, R Paoletti |
1983 | |
|
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
JD Brunzell, JJ Albers, A Chait, SM Grundy, E Groszek, GB McDonald |
Journal of lipid research | 1983 |
|
Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man
YA Kesaniemi, SM Grundy |
Journal of Clinical Investigation | 1982 |
|
Fettstoffwechselstörungen bei Nierenkrankheiten — Pathogenetische Mechanismen
WH Hörl, M Hörl, A Heidland |
Klinische Wochenschrift | 1982 |
|
Genetic mediation of cholesterol metabolism in the baboon (Papio cynocephalus)
BL Flow, GE Mott |
Atherosclerosis | 1982 |
|
Predictors of outcome in a risk factor intervention trial using behavior modification
DA Streja, E Boyko, SW Rabkin |
Preventive Medicine | 1982 |
|
Clustering and interrelationships of high-, low-, and very low-density lipoproteins in randomly recalled children and adults: The Cincinnati lipid research clinic's princeton school prevalence study
PS Gartside, JA Morrison, P Khoury, MJ Mellies, KA Kelly, CJ Glueck |
Preventive Medicine | 1982 |
|
The Cincinnati Lipid Research Clinic family study: cultural and biological determinants of lipids and lipoprotein concentrations
DC Rao, PM Laskarzewski, JA Morrison, P Khoury, K Kelly, R Wette, J Russell, CJ Glueck |
The American Journal of Human Genetics | 1982 |
|
Trials of structural exploratory data analysis
NE Morton, WR Williams, R Lew |
The American Journal of Human Genetics | 1982 |
|
Plasma lipid and lipoprotein concentrations in an Egyptian male sample
MI Shoukry, S Fareed |
Lipids | 1982 |
|
Tangier Disease with Normal Serum Cholesterol*
RW Frith, SF Hannan, JP Simcock, PJ Scott |
Australian and New Zealand Journal of Medicine | 1982 |
|
Type III hyperlipoproteinemia and atherosclerosis: A case report and re-evaluation
AM Gown, WR Hazzard, EP Benditt |
Human Pathology | 1982 |
|
Incorporation of cholesterol into serum high and low density lipoproteins
B Lundberg, M Lampero, L Suominen |
Chemistry and Physics of Lipids | 1982 |
|
Protection of myocardium by the compensatory mechanism of coronary collaterals after total occlusion of major coronary arteries shown in patients with familial hypercholesterolemia
PT Kuo, JB Kostis, AE Moreyra |
American Heart Journal | 1982 |
|
Lipoprotein Kinetics and Modeling
SM Grundy, GL Vega |
Lipoprotein Kinetics and Modeling | 1982 |
|
The Muscatine Cholesterol Family Study: Distribution of cholesterol levels within families of probands with high, low and middle cholesterol levels
KD Bucher, HG Schrott, WR Clarke, RM Lauer |
Journal of Chronic Diseases | 1982 |
|
Spouse concordance of plasma cholesterol and triglyceride
E Barrett-Connor, L Suarez, MH Criqui |
Journal of Chronic Diseases | 1982 |
|
Triglyceride and cholesterol metabolism in primary hypertriglyceridemia
U Beil, SM Grundy, JR Crouse, L Zech |
Arteriosclerosis (Dallas, Tex.) | 1982 |
|
Coronary artery disease mortality in relatives of hypertriglyceridemic school children: the Muscatine study
HG Schrott, WR Clarke, P Abrahams, DA Wiebe, RM Lauer |
Circulation | 1982 |
|
Risikofaktoren - Medizin
KD Bock |
1982 | |
|
Treatment of Hyperlipidemic Pancreatitis in Pregnancy With Total Parenteral Nutrition
RB Weinberg, MD Sitrin, GM Adkins, CC Lin |
Gastroenterology | 1982 |
|
Changes in the metabolism of fatty acids in adipose tissue in obese patients with primary hypertriacylglycerolemia
P Arner, P Engfeldt, J Ostman |
Journal of lipid research | 1982 |
|
A survey of 246 suggested coronary risk factors
PN Hopkins, RR Williams |
Atherosclerosis | 1981 |
|
The contrasting effects of a dietary soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial hypercholesterolemic subjects
MT Childs, JA Bowlin, JT Ogilvie, WR Hazzard, JJ Albers |
Atherosclerosis | 1981 |
|
Relationships of gender, sex hormone use, and age with lipoprotein cholesterol/triglyceride ratios in an adult population The Pacific Northwest Bell Telephone Company health survey
RH Knopp, GR Warnick, CE Walden, PW Wahl, JJ Hoover, RO Bergelin, JT Ogilvie, JJ Albers, WR Hazzard |
Atherosclerosis | 1981 |
|
Genes and nutrition in the regulation of human lipoprotein metabolism
B Lewis |
Klinische Wochenschrift | 1981 |
|
The genetic component in coronary heart disease – a review
FW Robertson |
Genetical Research | 1981 |
|
Clustering and interrelationships of high, low, and very low-density lipoproteins in hypolipidemic children and adults: The Cincinnati lipid research clinic's Princeton school prevalence study
PS Gartside, JA Morrison, P Khoury, P Laskarzewski, CJ Glueck |
Preventive Medicine | 1981 |
|
Angiographic and risk factor characteristics of subjects with early onset ischaemic heart disease
S Nitter-Hauge, J Erikssen, E Thaulow, K Vatne |
British heart journal | 1981 |
|
Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: Normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia
AH Kissebah, S Alfarsi, PW Adams |
Metabolism | 1981 |
|
Cholesterin und Triglyceride im Serum einer Münchner Bevölkerungsgruppe: Beziehungen zu Alter und Geschlecht
K Henze, A Wallmüller-Strycker, M Bauer, C Barth, G Wolfram, N Zöllner |
Clinical Chemistry and Laboratory Medicine | 1981 |
|
Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: Relationship to dysbetalipoproteinemia and hyperlipidemia
WR Hazzard, GR Warnick, G Utermann, JJ Albers |
Metabolism | 1981 |
|
Hereditary aspects of coronary artery disease
RI Hamby |
American Heart Journal | 1981 |
|
Hormones, Lipoproteins and Atherosclerosis
L Winkler, B Schlag, R Dargel, G Stein, R Fünfstück |
Hormones, Lipoproteins and Atherosclerosis | 1981 |
|
Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease
R Tatami, H Mabuchi, K Ueda, R Ueda, T Haba, T Kametani, S Ito, J Koizumi, M Ohta, S Miyamoto, A Nakayama, H Kanaya, H Oiwake, A Genda, R Takeda |
Circulation | 1981 |
|
Regulation of Plasma Cholesterol by Lipoprotein Receptors
MS Brown, PT Kovanen, JL Goldstein |
Science | 1981 |
|
Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man
SM Grundy, HY Mok, L Zech, M Berman |
Journal of lipid research | 1981 |
|
Zum praktischen Wert des Lymphozytenmodells f�r die pathogenetische Beurteilung einzelner Serumcholesterinfraktionen des Menschen bei der autosomal-monogenen Hypercholesterin�mie
T Wichmann, HA Freye, K Berndt |
Human Genetics | 1981 |
|
Familial combined hyperlipoproteinemia. Evidence for a role of growth hormone deficiency in effecting its manifestation
TJ Merimee |
Journal of Clinical Investigation | 1980 |
|
Kinetic bases of the primar hperlipidaemias: studies of apolipoprotein B turnover in geneticall defined subjects
ED Janus, AM Nicoll, PR Turner, P Magill, B Lewis |
European Journal of Clinical Investigation | 1980 |
|
High density lipoproteins during hypolipidemic therapy
MC Cheung, JJ Albers, PW Wahl, WR Hazzard |
Atherosclerosis | 1980 |
|
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
A Chait, JJ Albers, JD Brunzell |
European Journal of Clinical Investigation | 1980 |
|
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]
A Sniderman, S Shapiro, D Marpole, B Skinner, B Teng, PO Kwiterovich |
Proceedings of the National Academy of Sciences | 1980 |
|
Interrelationships among subgroups of serum lipoproteins in normal human subjects
RM Krauss, FT Lindgren, RM Ray |
Clinica Chimica Acta | 1980 |
|
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia
AP Goldberg, A Chait, JD Brunzell |
Metabolism | 1980 |
|
CLOFIBRATE AND HYPERLIPIDAEMIA
H Keen, B Lewis, NE Miller, V Wynn |
The Lancet | 1980 |
|
Prevalence of coronary heart disease in the framingham offspring study: Role of lipoprotein cholesterols
PW Wilson, RJ Garrison, WP Castelli, M Feinleib, PM McNamara, WB Kannel |
The American Journal of Cardiology | 1980 |
|
Plasma Lipids
H Malmros |
Plasma Lipids | 1980 |
|
Sibling correlations and genetic estimates for selected blood variables in French Canadian children
C Bouchard, A Demirjian, E Mongeau |
Human Genetics | 1980 |
|
Genetic--epidemiologic study of early-onset ischemic heart disease
JJ Nora, RH Lortscher, RD Spangler, AH Nora, WJ Kimberling |
Circulation | 1980 |
|
Verhandlungen der Deutschen Gesellschaft für innere Medizin
B Schlegel |
1980 | |
|
Atherosclerosis V
AM Gotto, LC Smith, B Allen |
1980 | |
|
Clinical Applications of Cardiovascular Drugs
LS Dreifus, AN Brest |
1980 | |
|
Verhandlungen der Deutschen Gesellschaft für innere Medizin: 86. Kongreß, 13.–17. April 1980, Wiesbaden
B Schlegel |
1980 | |
|
Neonatal Screening for Inborn Errors of Metabolism
H Bickel, R Guthrie, G Hammersen |
1980 | |
|
Biliary lipid composition in normo- and hyperlipoproteinemia
J Ahlberg, B Angelin, K Einarsson, K Hellström, B Leijd |
Gastroenterology | 1980 |
|
Current Developments in Anthropological Genetics
JH Mielke, MH Crawford |
1980 | |
|
Effects of cholic acid on the metabolism of endogenous plasma triglyceride and on biliary lipid composition in hyperlipoproteinemia
B Angelin, B Leijd |
Journal of lipid research | 1980 |
|
Prediction of the parameters of whole body cholesterol metabolism in humans
DS Goodman, FR Smith, AH Seplowitz, R Ramakrishnan, RB Dell |
Journal of lipid research | 1980 |
|
Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy
HS Kruth, M Vaughan |
Journal of lipid research | 1980 |
|
Defekte an Zellrezeptoren als Ursache endokriner und metabolischer Krankheiten
W Gerok |
Klinische Wochenschrift | 1979 |
|
Heterozygous familial hypercholesterolemia
C Gagné, S Moorjani, D Brun, M Toussaint, PJ Lupien |
Atherosclerosis | 1979 |
|
High and low density lipoprotein cholesterol levels in hypercholesterolemic school children
JA Morrison, I Groot, KA Kelly, BK Edwards, MJ Mellies, S Tillett, P Khoury, CJ Glueck |
Lipids | 1979 |
|
DIETARY FATS AND CORONARY HEART DISEASE: UNFINISHED BUSINESS
EH Ahrens |
The Lancet | 1979 |
|
Genetic and environmental variation in serum lipoproteins in relation to coronary heart disease
FW Robertson, AM Cumming |
Journal of medical genetics | 1979 |
|
The William Allan Memorial Award address: On phosphate transport and genetic screening. "Understanding backward--living forward" in human genetics
CR Scriver |
The American Journal of Human Genetics | 1979 |
|
Dalzeil's disease--66 years on
J Kyle |
British medical journal | 1979 |
|
Lipid-lipoprotein composition in hypercholesterolemic children and their parents
A Pagnan, M Vincenzi, E Barbieri, G Zanetti, P Guarini, CD Palu' |
Atherosclerosis | 1979 |
|
Nature of the familial influence on plasma lipid levels
D Hewitt, GJ Jones, GJ Godin, D Wraight, WC Breckenridge, JA Little, G Steiner, MA Mishkel |
Atherosclerosis | 1979 |
|
Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. V. Variance components estimated from pedigrees
PP Moll, R Powsner, CF Sing |
Annals of Human Genetics | 1979 |
|
Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia
AP Goldberg, DM Applebaum-Bowden, WR Hazzard |
Metabolism | 1979 |
|
Cultural and biological determinants of lipoprotein concentrations
DC Rao, NE Morton, CL Gulbrandsen, GG Rhoads, A Kagan, S Yee |
Annals of Human Genetics | 1979 |
|
Detection of rare major genes in lipid levels
J Ott |
Human Genetics | 1979 |
|
Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia
PT Kuo, K Hayase, JB Kostis, AE Moreyra |
Circulation | 1979 |
|
Increased coronary mortality in relatives of hypercholesterolemic school children: the Muscatine study
HG Schrott, WR Clarke, DA Wiebe, WE Connor, RM Lauer |
Circulation | 1979 |
|
Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments
NE Miller |
Journal of clinical pathology | 1979 |
|
Genetic Diseases of the Skin
VM der Kaloustian, AK Kurban |
1979 | |
|
Hepatic cholesterol metabolism in normo- and hyperlipidemic patients with cholesterol gallstones
J Ahlberg, B Angelin, I Björkhem, K Einarsson, B Leijd |
Journal of lipid research | 1979 |
|
High and low density lipoprotein cholesterol levels in hypercholesterolemic school children
JA Morrison, I de Groot, KA Kelly, BK Edwards, MJ Mellies, S Tillett, P Khoury, CJ Glueck |
Lipids | 1979 |
|
Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia
DW Bilheimer, YK Ho, MS Brown, RG Anderson, JL Goldstein |
Journal of Clinical Investigation | 1978 |
|
Hyperlipidemia and premature arteriosclerosis
FR Smith |
Lipids | 1978 |
|
Regulation of cholesterol synthesis in the hyperlipoproteinaemias — Polymorphonuclear leucocyte abnormality specific to familial type II hypercholesterolaemia
WF Bremner, JL Third, B Clark, C Corstorphine, TD Lawrie |
Atherosclerosis | 1978 |
|
Cholesterol metabolism in man
SM Grundy |
The Western journal of medicine | 1978 |
|
Hypothesis into theory--the development of aetiological concepts of ischaemic heart disease: a review
B Lewis |
Journal of the Royal Society of Medicine | 1978 |
|
Medical and human genetics 1977: trends and directions
AG Motulsky |
The American Journal of Human Genetics | 1978 |
|
Pathophysiology of lipoprotein transport
JD Brunzell, A Chait, EL Bierman |
Metabolism | 1978 |
|
Plasma apoprotein and lipoprotein lipid levels in vegetarians
J Burslem, G Schonfeld, MA Howald, SW Weidman, JP Miller |
Metabolism | 1978 |
|
Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia
H Mabuchi, R Tatami, T Haba, K Ueda, R Ueda, S Ito, T Karnetani, J Koizurni, S Miyarnoto, M Ohta, R Takeda, T Takegoshi, H Takeshita |
Metabolism | 1978 |
|
CLOFIBRATE
B Lewis, N Miller, JD Brunzell, M Eastwood |
The Lancet | 1978 |
|
Homozygous familial hypercholesterolemia in Japan
H Mabuchi, R Tatami, T Haba, K Ueda, R Ueda, T Kametani, S Itoh, J Koizumi, M Oota, S Miyamoto, R Takeda, H Takeshita |
The American Journal of Medicine | 1978 |
|
Status of coronary heart disease risk factors
WB Kannel |
Journal of Nutrition Education and Behavior | 1978 |
|
Study of 100 Patients with Bilateral Sensorineural Hearing Loss for Lipid Abnormalities
LD Lowry, SR Isaacson |
The Annals of otology, rhinology, and laryngology | 1978 |
|
Hypothesis into Theory – the Development of Aetiological Concepts of Ischaemic Heart Disease: A Review
B Lewis |
Journal of the Royal Society of Medicine | 1978 |
|
Noninvasive evaluation of the patient with suspected coronary artery disease
JS Karliner |
Current Problems in Cardiology | 1978 |
|
Diet and sire effects on serum cholesterol and cholesterol absorption in infant baboons (Papio cynocephalus)
GE Mott, CA McMahan, HC McGill |
Circulation research | 1978 |
|
Bile acid kinetics in relation to endogenous tryglyceride metabolism in various types of hyperlipoproteinemia
B Angelin, K Einarsson, K Hellström, B Leijd |
Journal of lipid research | 1978 |
|
Segregation and linkage analyses of a large pedigree with hypertriglyceridemia
KK Namboodiri, RC Elston, C Hames, EA Murphy |
American Journal of Medical Genetics | 1977 |
|
DOSE-EFFECT RELATION OF CHOLESTYRAMINE IN CHILDREN AND YOUNG ADULTS WITH FAMILIAL HYPERCHOLESTEROLÆMIA
JR Farah, PO Kwiterovich, CA Neill |
The Lancet | 1977 |
|
Persistent echoes of the nature-nurture argument
B Childs |
The American Journal of Human Genetics | 1977 |
|
Commingling in distributions of lipids and related variables
NE Morton, CJ MacLean, A Kagan, CL Gulbrandsen, GG Rhoads, S Yee, R Lew |
The American Journal of Human Genetics | 1977 |
|
Cost/benefit analysis of treatment and prevention of myocardial infarction
S Cretin |
Health Services Research | 1977 |
|
Inheritance of type-III hyperlipoproteinemia. Lipoprotein patterns in first-degree relatives
B Vessby, H Hedstrand, LG Lundin, U Olsson |
Metabolism | 1977 |
|
Prevalence of serum lipid abnormalities in chronic hemodialysis
JD Brunzell, JJ Albers, LB Haas, AP Goldberg, L Agadoa, DJ Sherrard |
Metabolism | 1977 |
|
Familial hypercholesterolemia: Diagnosis, metabolic defect and management
RL Jackson, LC Smith, OD Taunton, AM Gotto |
Life Sciences | 1977 |
|
Plasma lipid changes in the female in aging and the menopause. Results from three population studies
A Svanborg, C Bengtsson, O Lindquist, S Roupe, B Steen |
Clinica Chimica Acta | 1977 |
|
Macromolecular dispersion of human plasma low-density lipoproteins in hyperlipoproteinemia
MG Hammond, MC Mengel, GL Warmke, WR Fisher |
Metabolism | 1977 |
|
Atherosclerosis: The low-density lipoprotein receptor hypothesis
JL Goldstein, MS Brown |
Metabolism | 1977 |
|
Plasma cholesterol and triglyceride levels in 6775 school children, ages 6–17
JA Morrison, I deGroot, BK Edwards, KA Kelly, JL Rauh, M Mellies, CJ Glueck |
Metabolism | 1977 |
|
Ascertainment in the sequential sampling of pedigrees
C Cannings, EA Thompson |
Clinical Genetics | 1977 |
|
In vitro regulation of cholesterol metabolism by low density lipoproteins in skin fibroblasts from hypo- and hyperresponding squirrel monkeys
LS Guertler, RW Clair |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1977 |
|
Diet, heredity and heart disease
TD Lawrie, JL Third |
Proceedings of the Nutrition Society | 1977 |
|
GENETIC ANALYSIS OF THE NEPHROGENIC DIABETES INSIPIDUS DEFECT IN SWV MICE
NS Virgo, JR Miller |
Canadian Journal of Genetics and Cytology | 1977 |
|
Relationship between plasma lipid concentrations and coronary artery disease in 496 patients
AM Gotto, GA Gorry, JR Thompson, JS Cole, R Trost, D Yeshurun, ME DeBakey |
Circulation | 1977 |
|
The Cultured Cell and Inherited Metabolic Disease
RA Harkness, F Cockburn |
1977 | |
|
Diabetes mellitus • B
R Beckmann, M Berger, A Beringer, P Berchtold, J Beyer, A Bischoff, G Brehm, BF Clarke, GR Constam, LJ Duncan, FA Gries, A Hasselblatt, R Hild, K Irmscher, K Jahnke, J Kühnau, H Liebermeister, K Lundbaek, G Meyer-Schwickerath, S Napp-Mellinghoff, M Neubauer, F Nobbe, K Oberdisse, P Petrides, R Petzoldt, H Sauer, K Schöffling, M Spitznas, J Steinke, M Vogel, KH Vogelberg, A Wessing |
1977 | |
|
Coronary artery disease and its risk factors in families of young men with angina pectoris and in controls
AM Rissanen, EA Nikkila |
Heart (British Cardiac Society) | 1977 |
|
Monogenic disorders
CO Carter |
Journal of medical genetics | 1977 |
|
Medico-Social Management of Inherited Metabolic Disease
DN Raine |
1977 | |
|
Bile Acid Metabolism in Hyperlipoproteinaemia
K Hellström, K Einarsson |
1977 | |
|
Mechanism of induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human leukocytes
AM Fogelman, J Seager, PA Edwards, G Popják |
The Journal of biological chemistry | 1977 |
|
Diet, energy balance, and genes--and serum cholesterol.
|
British medical journal | 1977 |
|
Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans
FR Smith, RB Dell, RP Noble, DS Goodman |
Journal of Clinical Investigation | 1976 |
|
Analbuminemia in an American Indian girl
H Boman, M Hermodson, CA Hammond, AG Motulsky |
Clinical Genetics | 1976 |
|
Inheritance of xanthomatosis and hyper-β-lipoproteinaemia: A study of 7 large kind reds
A Heiberg |
Clinical Genetics | 1976 |
|
Prenatal diagnosis of homozygous familial hypercholesterolemia: Investigation of a case at risk
TF Wienker, G Utermann, HH Ropers |
Clinical Genetics | 1976 |
|
The common hyperlipidaemias
B Lewis |
Postgraduate medical journal | 1976 |
|
Physiological and analytical variation in cholesterol and triglycerides
GR Warnick, JJ Albers |
Lipids | 1976 |
|
Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-β disease (type III hyperlipoproteinemia)
WR Hazzard, EL Bierman |
Metabolism | 1976 |
|
Halofenate in the treatment of type II hyperlipoproteinemia Double blind comparison with clofibrate
ED Rees, RD Hamilton, IF Kanner, S Wasson, T Hearn |
Atherosclerosis | 1976 |
|
Triglyceride accumulation in cultured human fibroblasts
BV Howard, WJ Howard, MD la Llera, NA Kefalides |
Atherosclerosis | 1976 |
|
Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients
CJ Packard, JL Third, J Shepherd, AR Lorimer, HG Morgan, TD Lawrie |
Metabolism | 1976 |
|
Myocardial infarction in the familial forms of hypertriglyceridemia
JD Brunzell, HG Schrott, AG Motulsky, EL Bierman |
Metabolism | 1976 |
|
Thyrotropin levels in hyperlipidemic survivors of myocardial infarction
WL Green, WR Hazzard, JM Hershman |
Metabolism | 1976 |
|
The inheritance of hyperipoproteinaemia with xanthomatosis:A study of 132 kindreds
A Heiberg, K Berg |
Clinical Genetics | 1976 |
|
Maximal exercise stress testing in normal and hyperlipidemic children
FW James, CJ Glueck, RW Fallat, F Millett, S Kaplan |
Atherosclerosis | 1976 |
|
Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatoses
JG Jong, CM Gent, JW Delleman |
Clinical Neurology and Neurosurgery | 1976 |
|
Nutrition Longevity, and Aging
LF Jakubczak |
Nutrition Longevity, and Aging | 1976 |
|
Combined para-aminosalicylic acid and dietary therapy in long-term control of hypercholesterolemia and hypertriglyceridemia (Types IIa and IIb hyperlipoproteinemia)
PT Kuo, WC Fan, JB Kostis, K Hayase |
Circulation | 1976 |
|
Low Density Lipoproteins
CE Day, RS Levy |
1976 | |
|
The Year in Metabolism 1975–1976
N Freinkel |
1976 | |
|
Fettstoffwechsel
G Assmann, J Augustin, E Baraona, HU Benz, W Brech, WV Brown, RJ Desnick, WR Fallat, S Ford, D Fredrickson, CJ Glueck, H Greten, K Harzer, P Herbert, GM Kostner, W Krivit, RI Levy, CS Lieber, M Liersch, G Middelhoff, GL Mills, NB Myant, RF ODea, J Papenberg, H Pilz, HM Rauen, S Sailer, G Schettler, G Schlierf, H Schriewer, D Seidel, J Slack, E Stange, O Stein, Y Stein, D Steinberg, A Weizel, H Wieland |
1976 | |
|
Screening for familial hyper-beta-lipoproteinaemia in children in hospital
JV Leonard, AS Fosbrooke, JK Lloyd, OH Wolff |
Archives of disease in childhood | 1976 |
|
Genetics of ischaemic heart disease
FH Epstein |
Postgraduate medical journal | 1976 |
|
The Hepatobiliary System
W Taylor |
1976 | |
|
Cholesterol metabolism in groups of rhesus monkeys with high or low response of serum cholesterol to an atherogenic diet
DA Eggen |
Journal of lipid research | 1976 |
|
Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia
SM Grundy |
Journal of Clinical Investigation | 1975 |
|
Differences among Hyperlipoproteinaemic Subjects in the Response of Lipoprotein Lipids to Resin Therapy
NE Miller, PJ Nestel |
European Journal of Clinical Investigation | 1975 |
|
EFFECTS OF INTRAVENOUS HYPERALIMENTATION ON PLASMA-LIPOPROTEINS IN SEVERE FAMILIAL HYPERCHOLESTEROLÆMIA
H Torsvik, JE Fischer, HA Feldman, RS Lees |
The Lancet | 1975 |
|
Bivariate analyses of cholesterol and triglyceride levels in families in which probands have type IIb lipoprotein phenotype
KK Namboodiri, RC Elston, CJ Glueck, R Fallat, CR Buncher, R Tsang |
The American Journal of Human Genetics | 1975 |
|
Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. I. Analysis of the frequency distribution for evidence of a genetic polymorphism
CF Sing, MA Chamberlain, WD Block, S Feiler |
The American Journal of Human Genetics | 1975 |
|
Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor
JL Goldstein, SE Dana, GY Brunschede, MS Brown |
Proceedings of the National Academy of Sciences | 1975 |
|
Lipidkonstellation in der Betalipoproteinfraktion der primären Typ II-Hyperlipoproteinämie
H Haacke, MR Parwaresch, C Mäder |
Klinische Wochenschrift | 1975 |
|
Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes)
JD Brunzell, D Porte, EL Bierman |
Metabolism | 1975 |
|
Dose-response effect of single and combined clofibrate (Atromidin®) and niceritrol (perycit®) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia
AG Olsson, Orö, S Rössner |
Atherosclerosis | 1975 |
|
Variability of polymorphic cellular enzymes in medical students with different serum lipid levels: A preliminary survey
MH Fox, HC Dessauer, SR Srinivasan, TF Thurmon, GS Berenson |
Clinica Chimica Acta | 1975 |
|
Broad-β disease versus endogenous hypertriglyceridemia: Levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia
WR Hazzard, EL Bierman |
Metabolism | 1975 |
|
The Lipoprotein and Lipid Pattern in Xanthomatosis
A Heiberg |
Acta Medica Scandinavica | 1975 |
|
Mechanisms of cholesterol accumulation in the arterial wall
DB Zilversmit |
The American Journal of Cardiology | 1975 |
|
Familial hypercholesterolemia
JL Goldstein, MS Brown |
The American Journal of Medicine | 1975 |
|
Prospects for genetic screening
B Childs |
The Journal of Pediatrics | 1975 |
|
Risk factors for coronary artery disease in children of affected families
S Blumenthal, MJ Jesse, CH Hennekens, BE Klein, PL Ferrer, JE Gourley |
The Journal of Pediatrics | 1975 |
|
The Pediatric Roots of Coronary Heart Disease
JJ Nora, AH Nora |
Chest | 1975 |
|
It's time to be practical
DS Fredrickson |
Circulation | 1975 |
|
Hypolipidemic Agents
D Kritchevsky |
1975 | |
|
Lipids, Lipoproteins, and Drugs
D Kritchevsky, R Paoletti, WL Holmes |
1975 | |
|
Familial Hypercholesterolemia (One Form of Familial Type II Hyperlipoproteinemia) A STUDY OF ITS BIOCHEMICAL, GENETIC, AND CLINICAL PRESENTATION IN CHILDHOOD
PO Kwiterovich, DS Fredrickson, RI Levy |
Journal of Clinical Investigation | 1974 |
|
Assay of Total Plasma Apolipoprotein B Concentration in Human Subjects
G Schonfeld, RS Lees, PK George, B Pfleger |
Journal of Clinical Investigation | 1974 |
|
Combined hyperlipoproteinemia Evidence for a new lipoprotein phenotype
HG Rose, P Kranz, M Weinstock, J Juliano, JI Haft |
Atherosclerosis | 1974 |
|
Adaptive Responses in Hepatic and Intestinal Cholesterogenesis Following Ileal Resection in the Rat
HJ Weis, JM Dietschy |
European Journal of Clinical Investigation | 1974 |
|
Plasma lipid levels and coronary heart disease in adult relatives of newborns with normal and elevated cord blood lipids
JL Goldstein, JJ Albers, HG Schrott, WR Hazzard, EL Bierman, AG Motulsky |
The American Journal of Human Genetics | 1974 |
|
Linkage studies in a large kindred with familial hypercholesterolemia
J Ott, HG Schrott, JL Goldstein, WR Hazzard, FH Allen, CT Falk, AG Motulsky |
The American Journal of Human Genetics | 1974 |
|
Homozygous familial hypercholesterolemia: specificity of the biochemical defect in cultured cells and feasibility of prenatal detection
JL Goldstein, MJ Harrod, MS Brown |
The American Journal of Human Genetics | 1974 |
|
Effect of phenformin on lipid transport in hypertriglyceridemia
RW Stout, JD Brunzell, D Porte, EL Bierman |
Metabolism | 1974 |
|
Genetic Models in Biomedical Investigation
HL Bleich, ES Boro, H Valtin |
New England Journal of Medicine | 1974 |
|
Treatment of Hyperlipidemia
RI Levy, J Morganroth, BM Rifkind |
New England Journal of Medicine | 1974 |
|
Brave New World?: Current approaches to prevention, treatment, and research of genetic diseases raise ethical issues
AG Motulsky |
Science | 1974 |
|
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
JL Goldstein, WR Hazzard, HG Schrott, EL Bierman, AG Motulsky |
Journal of Clinical Investigation | 1973 |
|
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
WR Hazzard, JL Goldstein, MG Schrott, AG Motulsky, EL Bierman |
Journal of Clinical Investigation | 1973 |
|
Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol
JL Goldstein, MS Brown |
Proceedings of the National Academy of Sciences | 1973 |
|
Advances in Lipid Research
AM Scanu |
Advances in Lipid Research | 1965 |
|
DIET AND ATHEROSCLEROSIS
AR Walker |
The Lancet | 1955 |
|
Arteriosclerosis
R Gubner, HE Ungerleider |
The American Journal of Medicine | 1949 |
|
Oxidative stress, biochemical alterations, and hyperlipidemia in female rats induced by lead chronic toxicity during puberty and post puberty periods
Annabi Alya, Dhouib Bini Ines, Lasram Montassar, Gharbi Najoua, El Fazâa Saloua |
Iranian Journal of Basic Medical Sciences | |
|
A Mouse Model with Features of Familial Combined Hyperlipidemia
L Masucci-Magoulas, IJ Goldberg, CL Bisgaier, H Serajuddin, OL Francone, JL Breslow, AR Tall |
Science | 1997 |
|
Treatment of Hypercholesterolemia
JP Kane, MJ Malloy |
Medical Clinics of North America | 1982 |
|
Hypertriglyceridemia: Mechanisms, Clinical Significance, and Treatment
SM Grundy |
Medical Clinics of North America | 1982 |
|
Birth Defects Compendium
D Bergsma |
Birth Defects Compendium | 1979 |
|
Hyperlipidemia and Coronary Artery Disease: Principles of Diet and Drug Treatment
PT Kuo |
Medical Clinics of North America | 1974 |
|
Genetic Aspects of Hyperlipidemia in Coronary Heart Disease
JL Goldstein |
Hospital Practice | 1973 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)